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ABSTRACT 
Vascular and urinary catheters are the most frequently used indwelling medical devices in the intensive 
care units and, in general, in medical wards. Despite drug/device combination products and 
antimicrobial therapies (including systemic antibiotic prophylaxis), device-related infections are 
difficult to eradicate and pose a severe threat to human health and excess of medical costs. The most 
important factor in the pathogenesis of catheter-related infections is the formation of an adherent 
functional heterogenic microbial consortium, embedded in a self-produced matrix of extracellular 
polymeric substance (EPS), called biofilm. Biofilm formation is an important cause of illness since the 
biofilm lifestyle is associated with the chronic nature of infections, the evasion to the host immune-
response and the enhanced resistance to medical treatments. Indeed, after bacteria become established 
in a bioﬁlm, the individual cells exhibit tolerance up to 1000 folds more than their planktonic 
counterparts and often do not respond to antimicrobial agents. Given the less innovation in the 
discovery and the development of novel antimicrobial compounds over the past 20 years and the 
alarming incidence of recalcitrant device-related infections, the need for an innovative anti-infective 
material is becoming imperative. Bio-inspired molecules able to disarm microorganisms without 
affecting their existence, offer an elegant way to interfere with specific key-steps that orchestrate 
biofilm formation sidestepping drug resistance and extending the efficacy of the current antimicrobial 
agents.  
The general goal of this applied research project is to develop an innovative antibiotic-free 
functionalized material able to hold out against infections of vascular and urinary catheters by means of 
compounds with known anti-biofilm activities. Initially, it was necessary to prepare chemically 
modified anti-biofilm derivatives related to zosteric acid, a natural preventive compound against 
device-related infections, in order to improve their affinity and retention on a surface. The antifouling 
performance was tested against Escherichia coli, selected as the model system for bacterial infections. 
Furthermore, affinity purification experiments of proteins from E. coli extracts allowed the 
identification of targets directly interacting with these antibiofilm compounds. Then, the methodology 
for grafting the modified agents to materials was developed and optimized. The new materials efficacy 
and their ability to increase the susceptibility of microorganisms to traditional antibiotics were tested in 
biofilm reactors using chemical and molecular techniques combined with microscopic investigations. 
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1. INTRODUCTION 
 
Despite the availability of drug-device combination products and antimicrobial therapies, device-
related infections are difficult to eradicate leading high risks to human health and excess of medical 
costs. Regularly, traditional therapies fail without removal of the implanted device. One of the most 
important factor in the pathogenesis of catheter-related infections is the formation of biofilms, complex 
structured communities of microorganisms associated with surfaces and embedded in self-produced 
extracellular polymeric substances.[1] The resistance of biofilms to medical treatments is not caused by 
a single mechanism but by several factors acting together like diffusion limitation and non-genetic 
phenotypic heterogeneity.[2, 3] Bioﬁlms are increasingly recognized as being signiﬁcant in human 
diseases (accounting for 80% of bacterial infections in the body) which include but are not limited to: 
lung infections of cystic ﬁbrosis patients, colitis, urethritis, conjunctivitis, otitis, bacterial endocarditis 
and periodontitis, chronic wound infections and tooth decay.[4] Given the less innovation in the field of 
antimicrobial discovery research and development over the past 20 years and the alarming incidence of 
recalcitrant device-related infections, the need for an innovative anti-infective material is becoming 
essential.[5] A new trend is to develop antibiofilm strategies acting by mechanisms more subtle than 
the simple killing activities such as those influencing the multicellular behavior, by manipulating the 
expression of specific phenotype that represent microbial virulence traits (e.g. binding ability, motility, 
cell-to-cell communication, yeast-hyphae-dimorphism). This goal can be achieved using sub-lethal 
concentrations of antibiofilm agents with a novel targets, unique modes of action and properties that are 
different from those of the currently used antimicrobials.[6] The introduction on the material surface of 
bio-inspired molecules, as well as pharmaceutical compounds endowed with bacteriostatic or 
fungistatic activity, is a promising way to interfere with specific key-steps that orchestrate biofilm 
formation, sidestepping drug resistance and extending the efficacy of the antimicrobials.[7] The future 
of treatment strategies for biofilm infections seems to rest with specifically targeting unique biofilm 
characteristics, either in combination with conventional antibiotic therapy and to target biofilm 
infections when they are most susceptible to antibiotics.  
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1.1 Biofilm: a common cause of bacterial infections 
 
Biofilm plays a key role in healthcare-associated infections (HAIs), especially those related to the 
implant of medical devices, such as vascular and urinary catheters and orthopedic implants. Bacterial 
bioﬁlms have become recognized as a serious threat to both the 
medical and industrial sectors of society within the past 20 
years.[8] As reported by the European Center for Disease 
Prevention and Control, every year approximately 4.1 million 
people in the EU Countries contract an infectious disease in 
European hospitals. The number of deaths, occurring as a direct 
consequence of these infections, is estimated to be at least 40000. 
Only in the United State, nosocomial infections account for 1.7 
million infections and 99000 associated deaths each year.[9] 
Vascular and urinary catheters are the most frequently used 
indwelling medical devices in the intensive care units and in 
general in medical wards (Figure 1). Their wide use is associated 
with an increasing risk of infectious complications that prolong hospital stay and healthcare cost. Not 
surprisingly, catheter-related infections are the most common cause of nosocomial infections and the 
duration of catheterization as well as the anatomical location are among the major risk factors.  
 
1.1.1 Biofilm organization 
Bacteria are able to switch between two different “life-styles”: single cells (planktonic mode) and 
biofilms (sessile mode). A biofilm is defined as a microbial community characterized by adhesion to a 
solid surface and by production of a matrix, which surrounds the bacterial cells and includes 
extracellular polymeric substances (EPS), proteins and DNA.[1] Transition from planktonic cells to 
biofilm is regulated by a variety of environmental and physiological cues, such as bacterial cell density, 
nutrient availability and cellular stress.[10] The most detrimental property of biofilms is the expression 
of specific features that make sessile microorganisms less susceptible to antimicrobial agents in 
comparison to their planktonic counterparts. Indeed, it was established that the proteome of adhered 
cells essentially differs from that of their planktonic forms as well as their physiology and morphology. 
Figure 1. Three examples of possible points of 
entry into the body for infectious biofilms.[2] 
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Within biofilm, each bacterium occupies a specific microenvironment determined by surrounding cells 
and closely related to the EPS matrix and channels which are responsible for pH and for the availability 
of nutrients and oxygen.[11] The microcolony is actually the basic structural unit of the biofilm. 
Depending on the species involved, it is composed of 10-25 % cells and 75-90 % EPS matrix, and often 
appears to be most dense in the area closest to its core. Bacterial cells within the matrix are 
characterized by the lack of Brownian movements and a structural analysis of many microcolonies 
reveals a mushroom-like shape. Although biofilms are commonly referred to as “slime”, which implies 
that they are not rigid structures, their mechanical stability is mainly due to the exopolysaccharides in 
the matrix. In addition, the cells within biofilms secrete signal molecules that regulate the expression of 
a panel of genes, allowing microorganisms to adapt to modified environmental conditions.  
The biofilm structure and water channels, that act as a primitive circulatory system for the delivery of 
nutrients and the removal of metabolic waste products, turned out to be influenced by fluid flow and by 
intercellular small messenger molecules, or quoromones (acylated homoserine lactones, AHLs), that 
are used for bacterial communication (for detail see „Paragraph 1.1.4‟). This system of nutrients and 
metabolic end products distribution have been observed only in peripheric regions of biofilms, since 
the cells within biofilms are more tightly packed. Differences in nutrients and oxygen availability 
within the biofilm structure affect the metabolic activity among the cells.  
In general, biofilms also display viscoelastic properties. They undergo both reversible elastic responses 
and irreversible deformation, strongly depending on the forces acting on the EPS matrix. Elastic 
materials absorb stress energy through deformation and transient stress events might be resisted by 
reversible deformation. The result is a rearrangement of the biofilm to mitigate exposure to external 
shear stress. It is possible that, on an intermediate timescale, a biofilm can increase the strength of its 
structural matrix in response to mechanical stresses by increasing EPS production. The interaction of 
multivalent inorganic ions with EPS can greatly influence the mechanical properties of biofilms. 
 
1.1.2 EPS matrix 
Matrix is the extracellular material, mostly produced by the organisms themselves, in which the biofilm 
cells are embedded. It consists of a conglomeration of different types of biopolymers, known as 
extracellular polymeric substances (EPS), that form the scaffold for the three-dimensional architecture 
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of the biofilm and are responsible for adhesion to surfaces and for cohesion. Several functions of EPS 
have been determined (Table 1), proving many advantages for the biofilm mode of life.[12] 
 
 
Table 1. Functions of extracellular polymeric substances (EPS) in bacterial biofilms.[12] 
 
EPS have been called „the dark matter of biofilms‟ because of the large range of matrix biopolymers 
and the difficulty in analyzing them.[13] They can vary greatly between biofilms, depending on the 
microorganisms present, the shear forces experienced, the temperature and the availability of nutrients. 
EPS were initially denoted “extracellular polysaccharides” but then were renamed, as it became clear 
that the matrix also contains proteins, nucleic acids, lipids and other biopolymers such as humic 
substances (Figure 2).  
Polysaccharides are the major fraction of the EPS matrix. Most are long molecules, linear or branched, 
with a molecular mass of 0.5 × 10
6
 Daltons to 2 × 10
6 
Daltons.[1] Two different kinds of 
polysaccharides have been found: the homopolysaccharides, including the sucrose-derived glucans, 
Function Relevance for biofilms EPS component involved 
Adhesion 
Allows the initial steps in the colonization of abiotic and biotic surfaces by planktonic 
cells, and the long-term attachment of whole biofilms to surfaces 
Polysaccharides, proteins, DNA and 
amphiphilic molecules 
Aggregation of 
bacterial cells 
Enables bridging between cells, the temporary immobilization of bacterial populations, 
the development of high cell densities and cell–cell recognition 
Polysaccharides, proteins and DNA 
Cohesion of biofilms 
Forms a hydrated polymer network (the biofilm matrix), mediating the mechanical 
stability of biofilms (often in conjunction with multivalent cations) and, through the 
EPS structure (capsule, slime or sheath), determining biofilm architecture, as well as 
allowing cell–cell communication 
Neutral and charged polysaccharides, 
proteins (such as amyloids and lectins), and 
DNA 
Retention of water 
Maintains a highly hydrated microenvironment around biofilm organisms, leading to 
their tolerance of desiccation in water-deficient environments 
Hydrophilic polysaccharides and, possibly, 
proteins 
Protective barrier 
Confers resistance to nonspecific and specific host defences during 
infection, and confers tolerance to various antimicrobial agents 
Polysaccharides and proteins 
Sorption of organic 
compounds 
Allows the accumulation of nutrients from the environment and the sorption of 
xenobiotics (thus contributing to environmental detoxification) 
Charged or hydrophobic polysaccharides 
and proteins 
Sorption of inorganic 
ions 
Promotes polysaccharide gel formation, ion exchange, mineral formation and the 
accumulation of toxic metal ions (thus contributing to environmental detoxification) 
Charged polysaccharides and proteins, 
including inorganic substituents such as 
phosphate and sulphate 
Enzymatic activity 
Enables the digestion of exogenous macromolecules for nutrient acquisition and the 
degradation of structural EPS, allowing the release of cells from biofilms 
Proteins 
Nutrient source 
Provides a source of carbon-, nitrogen- and phosphorus-containing compounds for 
utilization by the biofilm community 
Potentially all EPS components 
Exchange of genetic 
information 
Facilitates horizontal gene transfer between biofilm cells DNA 
Electron donor or 
acceptor 
Permits redox activity in the biofilm matrix 
Proteins (for example, those forming pili and 
nanowires) and, possibly, humic substances 
Export of cell 
components 
Releases cellular material as a result of metabolic turnover 
Membrane vesicles containing nucleic 
acids, enzymes, lipopolysaccharides and 
phospholipids 
Sink for excess 
energy 
Stores excess carbon under unbalanced carbon to nitrogen ratios Polysaccharides 
Binding of enzymes 
Results in the accumulation, retention and stabilization of enzymes 
through their interaction with polysaccharides 
Polysaccharides and enzymes 
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fructans and cellulose, and the heteropolysaccharides, a mixture of neutral and charged sugar residues. 
They can contain organic or inorganic substituents that greatly affect their physical and biological 
properties. Due to the presence of uronic acids, many known exopolysaccharides 
(including alginate, xanthan and colonic acid) are polyanionic, while intracellular 
adhesin is one of the polycationic exopolysaccharides. The biofilm matrix also 
contains a large amount of proteins. Several extracellular enzymes have been 
detected, many of which are involved in the degradation of biopolymers. The 
substrates of these extracellular enzymes include water-soluble polymers (i.e. 
many polysaccharides, proteins and nucleic acids), water-insoluble compounds 
(i.e. cellulose, chitin and lipids) and organic particles that are trapped in biofilms. 
Moreover, enzymes that are able to degrade EPS components makes the matrix 
an external digestive system breaking down biopolymers to low-molecular-mass products that can be 
taken up and utilized as carbon and energy sources and can be 
involved in the degradation of structural EPS to promote the 
detachment of bacteria from biofilms. Other enzymes act as virulence 
factors in medical biofilms during infectious processes. Extracellular 
enzymes can be efficiently retained in the biofilm matrix by their 
interactions with polysaccharides. This arrangement retains the 
enzymatic activity close to the cell and keeps the diffusion distances 
of enzymatic products short, thereby optimizing their uptake by 
bacteria. Moreover, the interactions between enzymes and structural 
exopolysaccharides enhance the thermostability of the enzymes and their resistance to proteolysis. The 
non-enzymatic proteins in the matrix, such as the cell surface-associated and extracellular 
carbohydrate-binding proteins (called lectins), are involved in the formation and stabilization of the 
polysaccharide matrix network and constitute a linker between the bacterial surface and extracellular 
EPS.  
In general, EPS components are kept together by weak physicochemical interactions such as hydrogen 
bonds, van der Waals forces and electrostatic interactions (Figure 3). 
Biofilms are also an ideal place for exchanging genetic material. Indeed, horizontal gene transfer is 
promoted, since the cells are maintained in close proximity to each other and can exchange genetic 
Figure 3. Classes of weak psychochemical 
interactions presented in the EPS matrix. 
Figure 2. The extracellular 
polymeric substances (EPS) 
matrix. 
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information. Recently, different types of biofilm contain extracellular DNA (eDNA), whose 
localization can widely varied, have been found. Although eDNA was initially considered as residual 
material from lysed cells, it is actually an integral part of the matrix and of the biofilm mode of life.[1] 
Extracellular polysaccharides, proteins and DNA are highly hydrated hydrophilic molecules, but EPS 
can also possess hydrophobic properties, mainly due to the presence of lipids and polysaccharides-
linked methyl and acetyl groups.[14]   
 
1.1.3 Biofilm life cycle 
Biofilm formation occurs as a result of a sequence of events (Figure 4).  
 
 
Figure 4. Conceptualization of biofilm development and dynamic behaviors. The figure was compiled from laboratory and natural 
observations of pure culture (both Gram-positive and Gram-negative organisms), and mixed-culture biofilms (P. Dirckx, Center for 
Biofilm Engineering, USA). 
 
The formation of microbial biofilms begins with the reversible adhesion of a small number of cells to a 
surface. During this first stage, both organic and inorganic molecules in the bulk flow are carried 
toward the surface either by diffusion or turbulent flow. The adsorption of organic molecules on the 
surface plays a crucial role in bacterial attachment, as it may alter the physical-chemical properties of 
the surface. Affecting factors can include surface free energy, hydrophobicity and electrostatic charges. 
[15] The planktonic bacterial cells release both protons and signaling molecules as they move through 
the bulk fluid. If bacteria are not adjacent to any surface, these protons and molecules diffuse radially 
away from the floating cells. When bacterial cells found themselves next to a surface, the concentration 
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of both protons and signaling molecules become higher since diffusion is limited on that side. In this 
way bacteria can sense their proximity to a surface and elaborate species-specific behavior pattern, 
leading to the initial stage of adhesion and biofilm formation. Mechanisms by which bacteria are 
transported to a surface can include Brownian motion, sedimentation due to differences in specific 
gravity between the bacteria and the bulk liquid, or convective mass transport, by which cells are 
physically transported towards the surface by the movement of the bulk fluid.[16] In turbulent flow, the 
presence of multiple small turbulent eddies may drive small particles, including bacterial cells towards 
surfaces which may in turn override the Gibbs energy barrier required by bacteria to come into contact 
with a surface. The Gibbs energy barrier is the sum of the van der Waals interactions, commonly 
attractive and electrostatic interactions, usually negative, due to both bacteria and substratum surfaces 
negatively charged. Moreover, active transport, mediated by bacterial flagella activity and chemotaxis, 
has been considered an important mechanism enabling bacteria to interact with a surface. The presence 
of cell appendages such as flagella, pili, and fimbriae enhances the successful adhesion of bacteria to a 
surface, overcoming repulsive electrostatic forces that may exist between the cell surface and the 
surface of material. [17,18] 
On an abiotic surface, initial attachment is governed by nonspecific interactions such as electrostatic, 
hydrophobic, or van der Waals forces. During this initial stage bacteria can be easily removed by fluid 
shear forces such as rinsing. After binding to the surface, bacterial cells begin the process of 
irreversible adhesion, proliferation, and accumulation as multilayered cell clusters. Then attached cells 
synthesize new EPS material to strengthen their adhesion to the surface and to other cells. In the 
transition from reversible to irreversible attachment, various short range forces are involved, including 
covalent and hydrogen bonding as well as hydrophobic interactions. At the end of this stage much 
stronger physical or chemical forces are required to remove bacteria from the surface such as scraping, 
scrubbing or chemical cleaners.[19] The subsequent stage is characterized by active binary division of 
attached cells and cell recruitment. This cell accumulation requires coordinated efforts from the 
microbial community to produce a well-organized structure. Once having irreversibly attached to a 
substratum, bacterial cells undergo phenotypic changes. Mature biofilms typically consist of 
differentiated mushroom-like structures of cells embedded within extracellular polymer matrix, which 
contains voids open to the bulk fluid to allow the transport of nutrients and oxygen from the interface to 
the inner parts of the biofilm and to remove metabolic wastes.  
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Biofilm dispersal is a naturally occurring process which may represent a mechanism to escape 
starvation or other negative environmental conditions within a biofilm, allowing bacterial cells the 
opportunity to migrate to a more favorable environment. Indeed, as biofilms grow in size, cells that 
reside in the inner layers of the biofilm do not have access to nutrients and suffer from accumulation of 
toxic waste products making their microenvironment unfavorable. In response to the adverse 
conditions, bacterial cells are able to detach from the biofilm getting back to the planktonic state and 
start a new biofilm formation cycle. In most cases, dispersal is induced by the biofilm itself due to 
environmental cues, such as changes in nutrient availability, fluctuation in local oxygen concentrations 
or increase in nitric oxide.[20] Although the exact mechanism of dispersal has not been fully 
elucidated, several studies highlighted that it involves the synthesis of degradative enzymes with 
specificity for biofilm matrix components [21], the return of motility [22], the surfactant production 
[23] and the cell lysis [24]. 
 
1.1.4 Quorum Sensing 
Quorum sensing (QS) is a complex regulatory process based on bacterial cell density. This 
communication process among cells plays a pivotal role in modulating not only the expression of genes 
associated with the production of specific enzymes, virulence factors and metabolites but also the 
development of microbial communities as biofilms.[25] Indeed, QS is a regulatory mechanism that 
allows sessile microorganisms to respond to the needs that are related to the increasing population 
density through the expression of specific sets of genes, adapting to modified environment conditions 
such as a low availability of nutrients. During QS, bacteria communicate with each other by small 
diffusible signal molecules called autoinducers that are produced and secreted by bacterial cell. 
Although regulation by QS is highly conserved, its molecular mechanisms, as well as the chemical 
nature of the autoinducers and receptors, differ significantly between Gram-positive and Gram-negative 
bacteria.[9] The most common classes of signal molecules in Gram-negative bacteria are N-acyl 
homoserine lactones (AHLs) and quorum sensing mediated by AHLs represents one of the best-
understood bacterial systems at the molecular level. To date, the majority of natural AHLs reported in 
literature share conserved structural characteristics: a homoserine lactone ring unsubstituted at the β- 
and γ-positions which is N-acylated at the α-position with a group derived from fatty acid biosynthesis 
(a fatty acyl group).[26] AHLs are able to freely diffuse in and out of bacterial cells, allowing the total 
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AHLs concentration to correlate to the total bacterial concentration, thus enabling population density-
based control of gene expression. This cascade of events ultimately leads to the control of gene 
expression resulting in virulence factor production and biofilm formation and maintenance. The first 
AHL-based quorum sensing system was discovered in the bioluminescent marine bacterium Vibrio 
fischeri, which was observed to produce light only at high cellular densities. The quorum sensing 
circuit outlined in Figure 5 represents the basic paradigm for AHL-mediated signaling. AHL 
autoinducers are synthesized by enzymes of the LuxI family and can bind transcription regulators of 
the LuxR family. AHL binding to LuxR activates the transcription of QS-dependent genes.[27]  
 
 
 
Figure 5. Schematic of LuxI/LuxR quorum sensing system in V. fischeri.[27] 
 
In each bacterial cell, the enzyme LuxI (belonging to the family of signal generators) catalyzes the 
production of a small signaling molecule, the N-(3-oxohexanoyl)-HSL („„OHHL‟‟), a derivative of 
AHL which freely diffuses within the population. Although the level of OHHL produced by a single 
cell is low, at high population density the signaling molecule accumulates, passes across cell 
membranes and binds to the transcription regulator LuxR. High cell densities are required to achieve an 
intracellular ligand concentration sufficient for LuxR binding. Without the OHHL ligand, the LuxR 
protein is unstable and rapidly degrades. Once activated, LuxR* stimulates transcription of luxICDAB 
cluster, leading to rapid amplification of the OHHL signal and emission of light. The complex LuxR*-
OHHL further increases the expression of LuxI itself, leading to an autoinduction of the signaling 
molecule, which is therefore considered an autoinducer. Althought, the luxI gene is not present in 
Escherichia coli, N-acyl-l-homoserine lactone must be synthesized by other microorganisms.[28, 29]  
The quorum sensing signaling process that occurs in some Gram-negative bacteria is often more 
complex. Several bacterial species have been shown to use intricate network-type architectures for cell-
cell signaling, involving two or more AHL signals, and even other types of quorum sensing pathways. 
For instance, Pseudomonas aeruginosa uses at least three types of QS signaling systems, two of these 
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are AHL-based.[29] There are two AHL derivatives, N-(3-oxododecanoyl)-L-homoserine lactone 
(OdDHL) and N-butanoyl- L-homoserine lactone (BHL) which are obtained by two separate signaling 
systems, each involving a LuxI-type synthase and a LuxR-type receptor. OdDHL is generated by LasI, 
while BHL synthetized by the synthase RhlI and detected by the RhlR protein. These AHL-dependent 
signaling systems are integrated with a third system that employs a chemically distinct signal molecule, 
2-heptyl-3-hydroxy-4(1H)-quinolone (termed the Pseudomonas quinolone signal or PQS).  
Quorum-sensing is frequently found in pathogens because it is a powerful global regulatory mechanism 
which allows the concomitant modulation of the expression of several genes in accordance with cell 
density. The simultaneous regulation (activation or repression, or both) of multiple genes acts as a 
biological switch that produces phenotypic modifications within the population.  
In contrast to Gram-negative bacteria, Gram-positive signal molecules belong to the class of 
oligopeptides (short peptides of 5-50 amino acids) synthesized by ribosomes and often subjected to 
extensive post-translational modifications. In Gram-positive bacteria quorum sensing system the signal 
does not diffuse into the bacterial cell to reach cytoplasmic receptors, but binds to a two-component 
membrane system.[30] Binding of signaling peptides to sensor proteins in the cell membrane triggers a 
signal transduction cascade, which leads to phosphorylation of a response regulator and QS-dependent 
gene expression. A model of QS systems in Gram-positive bacteria is the agr (accessory gene 
regulation) system of S. aureus, where autoinducer-dependent phosphorylation of the AgrA regulator 
leads to transcription activation of genes encoding virulence factors (Figure 6).[31] 
 
Figure 6. Quorum sensing and two-component signaling in the staphylococcal agr system.[32] S. aureus produces an autoinducing 
peptide (AIP) that accumulates extracellularly and activates the T-cell receptors (TCRS). The TCRS involves signal recognition by a 
histidine kinase (AgrC) (1), followed by histidine phosphorylation (2) and phosphotransfer to a response regulator (AgrA) (3), which then 
binds to the RNAIII transcript that encodes a small RNA that functions to modulate gene expression of S. aureus genes (4). 
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The quorum-sensing agr system consists of a two component trans-membrane transduction complex 
(AgrA and AgrC), a signaling peptide (AgrD) and a membrane component (AgrB), responsible for the 
externalization of the post-translationally modified signaling peptide. The effector molecule is a 
regulatory RNA, called RNAIII, whose synthesis is dependent on agr activation and driven by the P3 
promoter. Many virulence factors of S. aureus are controlled by agr, which is thus considered a 
regulator of virulence. Also colonizing factors such as adhesins are regulated differently by agr. At the 
beginning of infection, when the level of signaling molecules is low, the expression of colonization 
factors is favored and staphylococci can establish in host tissues. When then the infection progresses, 
the activity of agr is higher and the expression of aggressive virulence factors is up-regulated in order 
to defeat host defenses, and allow bacteria to acquire nutrients from the impaired host tissues.[32]  
In many bacterial species, QS has been shown to play a crucial role in biofilm survival and for this 
reason QS inhibitors and antagonists represent one of the most promising therapeutic tools for the 
treatment of biofilm-based infections (for detail see „Paragraph 1.3.1‟). The different chemical nature 
of signal molecules and of the molecular mechanisms involved in QS would suggest that QS inhibitors 
can only be directed against either Gram-positive or Gram-negative bacteria.  
As mentioned before, AHLs and peptides represent the two major classes of known bacterial signaling 
quorum sensing molecules, used by Gram-negative and Gram-positive bacteria, respectively, for 
intraspecies communication. Recently, a family of molecules generically termed autoinducer-2 (AI-2) 
has been found.[33] AI-2-based quorum sensing was first identified in the early 1990s in the Gram-
negative bacterium V. harveyi. It was observed that an AHL-deficient strain of the bacterium remained 
capable of producing bioluminescence even in the absence of the natural AHL autoinducer 3-hydroxy-
C4-HSL. This suggested that a second quorum sensing pathway, employing a different signaling 
molecule, was operating. This novel autoinducer was termed AI-2. It is produced and recognized by 
many Gram-negative and Gram-positive bacteria and may represent a potential tool by which different 
bacterial species can communicate with each other, as opposite to the intraspecies communication 
typically mediated by the other autoinducers discovered.[27] The gene responsible for its production 
is luxS since the enzyme LuxS is responsible for AI-2 biosynthesis. LuxS is a metalloenzyme 
containing a divalent metal in the active site: the type of metal cation present is presumed to vary 
during the course of the reaction. The substrate for the LuxS enzyme is S-ribosyl-L-homocysteine 
(SRH), which is derived from S-Adenosyl methionine (SAM) (Figure 7).  
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Figure 7. Enzymatic synthesis of DPD. 
 
SAM is converted to SAH via the action of SAM dependent methyl transferases. This latter is 
hydrolyzed to SRH by the 5′-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) 
enzyme (also known as Pfs nucleosidase). SRH is then cleaved by LuxS to form L-homocysteine (Hcy) 
and 4,5-dihydroxy-2,3-pentanedione (DPD) which undergoes spontaneous rearrangements to form a 
variety of DPD derivatives that interconvert and exist in equilibrium (known as the AI-2 pool). 
Different bacterial strains recognize different DPD derivatives; the interconversion of molecules within 
the AI-2 pool therefore presumably allows bacteria to respond to their own AI-2 and also to AI-2 
produced by other bacterial species. The discovery of antagonists of AI-2 quorum sensing may provide 
a possible means to achieve broad-spectrum antivirulence and has thus attracted significant attention in 
recent years. 
 
1.2 Mechanisms of Biofilm Resistance 
 
Antimicrobial resistance is one of the most serious health threats. The constant increase of antibiotic 
resistance, coupled with the insufficient investment in antibacterial research, has led to a decline in the 
efficacy of the existing therapies and a paucity of novel structural classes of antimicrobial able to 
replace them or to complete their use. Due to the compact nature of biofilm structures, the presumed 
reduced rates of cellular growth and respiration of biofilm bacteria and the protection conferred by 
biofilm matrix, natural and synthetic agents are unable to adequately attack and destroy infectious 
biofilm populations.[34] Once adhered, bacteria show a profound resistance, making biofilm cells 10-
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1,000 fold less susceptible to several antimicrobial agents than the same bacteria grown in planktonic 
(free-floating) culture.  
Antimicrobial compounds are often classified according to their major modes of action: 
 interference with cell-wall synthesis (β-lactams and glycopeptides); 
 inhibition of protein synthesis by binding to 50S ribosomal subunit (macrolides, 
chloramphenicol, clindamycin, linezolid) and by binding to 30S ribosomal subunit 
(aminoglycosides, tetracyclines); 
 interference with nucleic acid synthesis by inhibition of DNA synthesis (fluoroquinolones) and 
by inhibition of RNA synthesis (rifampin); 
 inhibition of metabolic pathway (sulfonamides and folic acid analogues); 
 disruption of bacterial membrane structure (polymyxins and daptomycin). 
Some of these agents, such as those that inhibit cell-wall construction actively bring about bacterial cell 
death are termed bactericidal. Other agents, such as the tetracyclines, which inhibit protein synthesis, 
are referred to as bacteriostatic, as they simply prevent the growth of the bacteria. Some antibacterial 
agents are effective only against a narrow spectrum of bacteria, for example, the glycopeptides display 
activity against Gram-positive organisms, whereas others, such as the β-lactams that target processes 
that are common across species are classified as broad-spectrum 
antibacterial agents.  
Bacteria may manifest resistance to antibacterial drugs through a 
variety of mechanisms.[35] Firstly, the organism may acquire 
genes encoding enzymes, such as β-lactamases, that destroy the 
antibacterial agents before they could have an effect. Then 
efflux pumps, able to extrude the antibacterial agents from the 
cell before they can reach the target site and exert their effect, 
may be gained. Moreover, bacteria may acquire several genes 
for a metabolic pathway, which ultimately produces altered 
bacterial cell walls that no longer contain the binding site of the 
antimicrobial agent, or mutations that limit access of antimicrobial agents to the intracellular target site 
via down-regulation of porin genes. Microorganisms also develop resistance through the acquisition of 
new genetic material from resistant strains of bacteria. This is termed horizontal evolution and may 
Figure 8.  Mechanisms of resistance 
acquisition.[34] 
Chapter 1 - INTRODUCTION 
14 
 
occur between strains of the same or different species. Mechanisms of genetic exchange include 
conjugation, transformation or transduction (Figure 8). [36] During the conjugation process, a 
bacterium transfers plasmid-containing resistance genes to an adjacent bacterium by means of an 
elongated structure known as pilus which joins the two microorganisms. The conjugation frequency 
appears to be higher in bacteria growing in the sessile mode than in the planktonic mode. Transduction 
occurs when the resistance genes are transferred from one bacterium to another via bacteriophage while 
transformation is the process where microorganisms acquire and incorporate DNA segments from 
another ones that have release their DNA complement into the environment after cell lysis. Mutation 
and selection, together with the mechanisms of  genetic exchange, enable bacterial species to adapt 
quickly to the introduction of antibacterial agents into the environment. 
Treatment of biofilms with antibiotics often results in an ineffective therapy. Several factors have been 
suggested to account for the extraordinary resistance of biofilm bacteria [4, 9]:  
a) the reduced metabolic and growth rates. Different concentrations of the key metabolic 
substrates within the biofilm proved that surface-bound communities contain cells at all phases 
of bacterial growth and cells at the different activity levels (Figure 9). This leads to microbial 
population heterogeneity.  
Better access to nutrients and oxygen in 
the periphery region of biofilm promotes 
metabolic activity of cells. In this part of 
biological layer the bacteria are able to 
proliferate. On the contrary, in the 
deeper part of biofilm the metabolic 
potential of bacteria is limited by the worse diffusion process of nutrients. Since most of 
biocides killing metabolically active bacteria, it has been proposed that bacteria at the dormant 
growth phase in the deeper region of biofilm are less susceptible to antimicrobial agents which 
are active against growth factors in planktonic bacteria.[37]  
b) the EPS matrix, able to decrease the amount of antibacterial agents available to interact with  
biofilm cells (additionally, the biofilm structure might physically reduce the penetration of 
antimicrobial agents by walling off access to regions of the biofilm). Furthermore, the 
aggregation of bacteria into the EPS-coated biofilm might make them less susceptible to 
Figure 9. Metabolic activity in a biofilm cell cluster is a function of 
depth within the biofilm and is influenced by nutrient transport. 
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phagocytosis. The process of disaggregation of biofilm cells is of considerable interest as a 
means of increasing the antibiotic sensitivity of biofilm bacteria.[38]  
c) biofilm cells are physiologically distinct from planktonic bacteria and express specific 
protective factors, such as multidrug efflux pumps and stress response regulators. Differences 
between planktonic and sessile bacteria involved physiological alterations following the 
attachment to a surface which result in biofilm bacteria that are morphologically and 
biochemically distinct from their free-floating counterparts. Bacterial efflux pumps are 
implicated in the multidrug resistance (MDR) phenotype combined with other more specific 
resistance systems, including target mutation and enzymatic modification of antimicrobial 
agents. The identification of a unique biofilm phenotype and genes that could contribute efflux 
system-mediate resistance of bacterial biofilms is a crucial point to identify new targets for 
controlling bacterial infections.[39] 
d) the inability of antibiotics to penetrate to all areas of the biofilm. Resistant biofilm bacteria 
become susceptible to antimicrobial agents following dispersion or disaggregation of biofilm. 
One promising solution to this problem has emerged from the manipulation of electrical fields 
that surround bacteria in a biofilm. This bioelectric effect alters the configuration of the EPS 
matrix and perhaps also enhances the penetration of antimicrobial agents across the bacterial-
cell envelope. Using alternating-current densities of less than 100 micro-Amperes per cm
2
, it 
has been found that the antibiotic concentrations required to kill biofilm cells are greatly 
reduced in comparison with untreated biofilm bacteria. These concentrations, however, were 
still higher than those needed to kill planktonic bacteria of the same species.[40]   
e) the presence of sub-populations of cells referred to as “persister”. These cells neither grow nor 
die during exposure to bactericidal agents exhibiting multidrug tolerance (MDT) that shut down 
the antibiotic targets and their formation is dependent on the bacteria growth state and not on 
bactericidal agents exposure. Only the persister fraction is responsible for survival of the whole 
sessile population. Indeed, persister cells are responsible for biofilm regrowth when the 
antibiotics concentration decrease or when the treatment is discontinued. The phenomenon of 
tolerance to antimicrobial agents has also been linked with programmed cell death (PCD) 
system.[41]  
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f) the production of stress-response proteins, conferring increase resistance to the environmental 
conditions such as immune attack and antibiotic treatment. The general stress response acts both 
as a rapid emergency response and as a long-term mechanism, that enables the cell adaptation to 
nutrient deprivation and other environmental stresses that cause changes in cellular metabolism. 
Activation of the general stress response in the cells, immobilized in biofilm matrix, may results 
in increasing resistance to biocides action.[42] 
In this context, a new antimicrobial-free strategy might be designed to reduce consumption of 
antimicrobial agents, ensuring the prudent use of these fragile strategies, protecting and empowering 
antibiotics that are critically important for human and animal health and wellbeing. 
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1.3 Biofilm inhibitors
1
 
 
As most pathogenic bacteria exist as biofilm communities, the discovery and development of agents 
able to limit biofilm formation or even wipe out established biofilms, could enhance the efficacy of 
antibiotics that are ineffective against biofilm bacteria. First of all, it is essential to recognize molecular 
scaffolds having the ability to affect biofilm development through non-microbicidal mechanisms from 
their microbicidal counterparts, as the resistance to compounds that are not microbicidal will be 
significantly reduced compared to the conventional bactericidal entities.[44]  
This Chapter provides an overview of the several approaches that have been applied to the discovery of 
small molecules that have been shown to have an anti-biofilm behaviour in a non-bactericidal 
manner.[43] These approaches are grouped into:  
 the identification and development of small molecules that target one of the bacterial signaling 
pathways involved in biofilm regulation (included quorum sensing inhibitors); 
 chemical library screening for compounds with anti-biofilm activity; 
 the identification of natural products that possess anti-biofilm activity, and the chemical 
manipulation of these natural compounds to obtain analogues with increased activity. 
 
1.3.1 Compounds that modulate biofilm by targeting bacterial signaling pathways 
Quorum sensing pathways considerably influence biofilm formation as well as the production of 
virulence factors. As mentioned before (see „Paragraph 1.1.4‟), there are different classes of 
autoinducers, based upon on shared molecular features, which represent potential targets: the acyl 
homoserine lactones (AHLs), the autoinducing peptides (AIPs) and the autoinducer-2 (AI-2). 
Therefore, an extensive research in this area has led to the discovery of several analogues with the 
ability to modulate QS-dependent enzymes.  
 
1.3.1.1 Acyl homoserine lactones (AHLs) 
Gram-negative bacteria predominantly employ N-acyl homoserine lactones (AHLs) as autoinducers, 
and more than 70 species of bacteria communicate via AHL-mediated QS with specificity modulated 
                                                          
1
 This Chapter is a summary of the review published by Villa and coworkers.[43] 
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Figure 11. Derivatives of the AHL scaffold that possess biological activity. 
by variation in the length and oxidation state of the acyl side chain (Figure 10).[45] Native AHLs, 
found in bacteria, are L-isomers, while the D-isomers are known to have no biological activity. 
 
 
 
 
 
 
AHLs has been one of the primary scaffolds studied over the past thirty years for the design of potential 
biofilm inhibitors (Figure 11). The AHL analogues are compounds that contain a carbon chain (of any 
functionality or substitution) or an aryl group linked to an amide group whose nitrogen atom is in 
general directly bound to a ring system at a chiral carbon.  
 
 
  
Significant inhibition of biofilm formation was observed for all these derivatives. Blackwell group has 
demonstrated that two of their most active synthetic AHLs (6, 7) could retard biofilm formation in P. 
aeruginosa  PA01.[46] Other studies about the modification of AHLs to evaluate their effects on 
quorum sensing and biofilm formation in P. aeruginosa includes that of Suga and Spring. The work by 
Suga et al. [47] involved the synthesis of a 96-member library, constructed through solid phase 
protocols, to mimic AHLs by replacing the homoserine lactone moiety with a variety of functionalities. 
Noteworthy, among the compound identified within this study, the AHL derivative 8 had no effect on 
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12 
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1 
P. aeruginosa 
 
 
2 
V. harveyi 
 
3   n=2  V. fischeri 
4   n=4  A. tumefaciens 
5   n=8  P. aeruginosa   
 
 
Figure 10. AHLs utilized by Gram-negative bacteria for quorum sensing. 
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biofilm growth. Spring et al.‟s research investigated analogues of P. aeruginosa AHLs in which the 
lactone functionality was replaced by a ketone, with additional difluorination between the β-keto amide 
positions (9-11).[48]  
Other analogues have been reported involving ureas, thiolactones, sulfonamides and N-acylated 
cyclopentylamides as viable modifications of AHLs to drive QS inhibition and thereby affect biofilm 
formation (e.g. 12-13). Moreover, a series of inhibitors bearing electrophilic functional groups 
including isothiocyanates, bromoacetamides and chloroacetamides, were designed. The lead compound 
14 was also shown to inhibit biofilm formation by wild type PA01 by almost 50% at a concentration of 
50 μM.[45] Furthermore, homoserine lactones themselves are notoriously prone to hydrolysis at 
physiological pH and the ring-opened product is QS inactive. In order to avoid the problem of lactone 
hydrolysis, the thiolactone AHL analogues have been investigated.[49] The half-life of a representative 
active analogue 15 was shown to be almost double that of its parent AHL in bacterial growth medium. 
Although these analogues have not yet been tested for their activity as inhibitors of biofilm formation, 
the thiolactone could be a promising scaffold for the development of stable modulators of QS 
controlled biofilm formation. 
 
1.3.1.2 Autoinducing peptides (APIs) 
QS in Gram-positive bacteria is predominantly mediated by autoinducing peptides (AIPs), though it has 
been shown that bacteria do not use only peptide signaling molecules for communication but also small 
molecules known as γ-butyrolactones that have been identified in some species of Streptomyces. Many 
AIPs possess hydrophobic domains, which have been found to be essential for activity. These motifs 
play a crucial role in promotion of hydrophobic interactions influencing receptor activation. Moreover, 
the agr QS systems in S. aureus regulate a number of virulence phenotypes, including biofilm 
formation.  
Additional studies using peptides and 
peptidomimetics as potential quorum sensing 
probe have identified the analogue of S. aureus 
AIP-1 16 that can also influence QS pathways in 
S. aureus. Truncated peptides such as compiound 16 
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17 have been found to be potent QS antagonists while the peptidomimetic 18 has been shown to 
promote biofilm formation in S. aureus (Figure 12).  
 
  
 
1.3.1.3 Autoinducer-2 (AI-2) 
One of the QS mechanisms shared by both Gram-negative and Gram-positive bacteria involves the 
production of a small molecule termed autoinducer- 2 (AI-2). All AI-2 molecules are derived from the 
precursor molecule (S)-4,5-dihydroxy-2,3-pentanedione (DPD) 19. 
 
 
 
 
 
 
Two AI-2 molecules are shown in Figure 13:  20 has been isolated and characterized from Salmonella 
typhimurium and 21 from Vibrio harveyi as a borate diester, resulted from the high concentrations of 
boron in the natural marine water habitat of this bacterium. To define their effects on  QS, the synthesis 
of a small number of DPD analogues has been performed. As the biosynthesis of DPD begins from 
SAM, the screening of a small library of nucleoside analogues has also been investigated. The 
adenosine analogue 22 has been found to block AI-2-based QS without interfering with bacterial 
growth. 
  
17 
 
18 
 
Figure 12. Peptide derived molecules with activity against S.aureus. 
19 20 21 
Figure 13. DPD and AI-2 molecules isolated from S. typhimurium and V. harveyi and SAM analogue 22. 
22 
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1.3.1.4 c-di-GMP 
Bis-(3′5′)-cyclic di-guanylic acid (c-di-GMP) 23 is a second messenger signaling molecule that is 
ubiquitous in bacteria. Diguanylate cyclases (DGCs) and 
phosphodiesterases (PDEs) are responsible for the synthesis 
and the degradation of c-di-GMP, respectively. These proteins 
are highly regulated by various environmental and intracellular 
signals such as oxygen, light and small molecules. c-di-GMP is 
also involved in biofilm dispersion. A P. aeruginosa mutant, 
showing elevated c-di-GMP levels, has exhibited defective 
detachment in response to environmental signals that typically elicit biofilm dispersion, such as 
changes in nutrient availability. It has been demonstrated that c-di-GMP levels may be high in order to 
promote the initial stages of biofilm formation, where motility is required, but then they decrease to 
allow biofilm maturation. Since QS and c-di-GMP signaling pathways likely 
regulate some of the same complex processes in bacteria, (e.g. biofilm 
formation), it is possible that the two signaling pathways could be linked. 
Interfering with c-di-GMP signaling is an attractive target for control of 
biofilm formation by means of c-di-GMP analogues or with small molecules that interfere with the 
synthesis or degradation of c-di-GMP. A screening of a 1120 compounds library with known biological 
activities against diguanylate cyclase DGC identified sulfathiazole 24 as promising for E. coli DGC 
activity inhibition (IC50 = 5.8 μM). 
 
1.3.1.5 Indole signaling 
Indole is another intercellular signal molecule that plays an important role in the control of many 
bacterial behaviours such as antibiotic resistance, virulence and biofilm formation. It has been shown to 
decrease biofilm formation in E. coli in a non-toxic manner and in several bacterial species it is 
immediately converted by oxygenases to various oxidized indole derivatives, such as hydroxyindoles 
25–27, isatin 28, and isoindigo 29 (Figure 14).  
 
 
 
23 24 
24 
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Screening of these compounds for the ability to inhibit biofilm formation by a strain of 
enterohemorrhagic E. coli (EHEC) have revealed that 5-hydroxyindole 25 and 7-hydroxyindole 26 are 
able to inhibit biofilm formation at the concentration of 1 mM. Moreover, 2-hydroxyindole 27 at the 
same concentration had no effect on biofilm formation, while isoindigo 29 (at a concentration of 250 
μM, which is the limit of its solubility) has no effect. Finally, isatin 28 has increased biofilm formation 
in a dose-dependant manner. As many pathogenic bacteria rapidly degrade indole into some of its 
various metabolites, the ability of indole derived plant secondary metabolites to modulate bacterial 
biofilm formation has also been investigated. The most active derivatives for suppression of biofilm 
formation by this E. coli strain have been 3-indolylacetonitrile (IAN) 30 and indole-3-carboxyaldehyde 
(I3CA) 31 (Figure 15). 
 
 
 
 
 
In a further study aimed to discover novel indole compounds with an increased anti-virulence activity 
compared to IAN 30, the synthetic 7-fluoroindole (7FI) 32 has been identified as the most active 
derivative since was able to reduce biofilm formation at 1 mM concentration. Indeed, it was 
demostrated that 32 suppresses swarming motility, protease activity, and extracellular polymeric matrix 
production in P. aeruginosa and furthermore reduces the production of QS-regulated virulence factors.  
  
25 26 27 28 29 
Figure 14. Indole derivatives that affect biofilm formation. 
30 31 
Figure 1. Indole derivatives that affect biofilm formation. 
32 
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1.3.1.6 Two-component systems 
Two-component signal transduction systems (TCS) are a class of regulatory systems found mainly in 
bacteria, though some have been identified in a small number of eukaryotic organisms, and consist of a 
histidine kinase and a response regulator. In response to an extracellular signal, the histidine kinase 
undergoes autophosphorylation at a conserved histidine residue. The histidine kinase then transfers the 
phosphate group to a conserved aspartate residue on the response regulator, resulting in activation of an 
effector domain, which then leads to the response. This typically involves the control of gene 
expression by binding of the phosphorylated response regulator to a DNA upstream regulatory region. 
TCS are activated by a variety of environmental factors including pH, nutrient level, redox state, 
osmotic pressure, quorum signals and the presence of antibiotics. The role of TCS in the regulation of 
biofilm formation and maintenance makes them potential targets for the development of anti-biofilm 
compounds, which have been underexploited to date. Indeed, it has been shown that both the histidine 
kinase and response regulator of TCS are targetable by small molecules (Figure 16).  
 
 
 
 
Walkmycin C 33 is a known histidine kinase inhibitor isolated from a screening perfomed on Bacillus 
subtilis. In addition, at levels below the minimum inhibitory concentration (MIC), walkmycin C 
resulted in the formation of abnormal biofilms and a reduction in biofilm mass. The bacterial secondary 
metabolite carolacton 34, affects the viability of S. mutans biofilms at nanomolar concentrations. This 
compound has only minor effects on planktonic bacteria growth but kills bacterial cells within a 
biofilm state. Although the ability of carolacton to modulate S. mutans biofilms is not through a strictly 
non-microbicidal mechanism, the fact that this compound does not affect planktonic growth represents 
an alternative strategy for the small molecule control of biofilms and further validates targeting of TCS 
as a means of controlling bacterial biofilms. 
 
33 34 
Figure 16. TCS inhibitors walkmycin C 33 and carolacton 34. 
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1.3.1.7 Other signaling molecules 
A fatty acid signaling molecule, cis-2-decenoic acid 35, produced by P. aeruginosa during growth, has 
been shown to inhibit biofilm development. It induces the dispersion of 
established biofilms formed by a number of bacteria including E. coli, 
Klebsiella pneumoniae, B. subtilis, and S. aureus at low nanomolar 
concentrations, as evidenced by microcolony disaggregation and measurement of the number of cells 
released into the bulk biofilm culture medium.  
In addition, some D-amino acids, which are produced by bacteria during stationary phase, turned out to 
be a native signal for biofilm dispersion in B. subtilis and able to inhibit biofilm formation. The 
inhibitory activity of the D-amino acids is a consequence of disruption of the connection between the 
extracellular matrix protein and the bacterial cell. Against B. subtilis, D-tyrosine, D-leucine, D-
tryptophan, and D-methionine inhibite biofilm formation while the analogous L-amino acids, and other 
D-amino acids, including D-alanine and D-phenylalanine, are inactive. The individual amino acids 
have showed inhibitory activity at concentrations from low micromolar (D-tyrosine) to millimolar (D-
leucine). Nevertheless, the combination of the four amino acids led to a significant increase of activity 
compared to any alone. 
 
1.3.2 Chemical library screening 
Due to the lack of  knowledge about the molecular scaffolds able to interfere with biofilm formation at 
sub-lethal concentration, High Throughput Screening (HTS) of compound libraries has been used as an 
effective tool for the identification of novel antibiofilm molecules. The screening of 13,000 compounds 
carried out by Wood and co-workers [50] revealed that ursolic acid 36 inhibited E. coli biofilm 
formation at concentrations as low as 22 μM without affecting growth. DNA microarrays analyses 
demonstrated that ursolic acid had no effects on quorum-sensing, but it induced chemotaxis in E. coli  
and ensured cells to remain too motile for a proper biofilm formation. Among the naturally occurring 
ursolic acid derivatives (Figure 17), compound 37 has shown an antibiofilm activity at sub-lethal 
concentrations against the P. aeruginosa PA01 biofilm.  
35 
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Clardy and Junker reported a comprehensive HTS, in which they sought to identify novel small 
molecules that inhibited and dispersed PA01 biofilms.[51] A total of 66095 molecules, derived from 
libraries containing known bioactive compounds, natural 
products, and commercially available entities, were screened 
using a luminescence-based assay. Among these, compound 42 
was found to be one of the most active biofilm modulators ever 
disclosed against either Gram-positive or Gram-negative 
bacteria (IC50 = 530 nM).  
An HTS of 8000-compound chemical library identified several molecules that inhibited Vibrio 
cholerae motility without exhibiting toxicity.[52] The lead compound, the quinazoline-2,4-diamino 
analogue 43, showed inhibition of biofilm formation at the sub-lethal concentration of 10 μg/mL. 
Also computer-aided drug design (CADD) techniques have been employed 
in the search for new biofilm modulators. One such study involved the 
investigation of 51 active compounds derived from traditional Chinese 
medicines, whose antibacterial properties 
had been previously documented.[53] The 
most active compound, baicalein 44, a flavonoid that is speculated to 
play a role in apoptosis and to also inhibit lipid peroxidation, had no 
remarkable effect on bacterial growth but when dosed together with an antibiotic a significant 
synergistic effect has been seen. In a recent study, 147 recognized drugs and natural compounds has 
been selected from the SuperNatural and SuperDrug databases on the basis of their two-dimensional 
(2D) structural similarity to the following quorum-sensing inhibitors: furanone C30 45, patulin 46, the 
Figure 17. Compounds with an antibiofilm activity identified by HTS. 
37  R1=H, R2=cis-p-coumaroyl, R3=OH 
38  R1=OH, R2=trans-p-coumaroyl, R3=H 
39  R1=OH, R2=cis-p-coumaroyl, R3=H 
40  R1=OH, R2=trans-feruloyl, R3=H 
41  R1= R2= R3=H 
 
 
 
 
42 
43 
36 
43 
44 
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P. aeruginosa LasR natural ligand (3-oxo-C12-AHL 47) and a known quorum-sensing receptor agonist 
TP-1 48 (Figure 18).[54]   
 
 
 
 
This screening led to the discovery of three compounds, salicylic acid 49, nifuroxazide 50 and 
chlorzoxazone 51, which significantly inhibite the quorum sensing-regulated gene expression at 
concentrations at which they do not affect bacterial growth (Figure 19). In addition biofilms treated 
with these compounds appeare thinner and less structured than control biofilms and the total biofilm 
mass is reduced. 
 
 
 
 
 
A high-throughput epifluorescence microscopy imaging based HTS has been developed for the 
identification of small molecule inhibiting biofilm formation in V. cholerae. Among the number of 
compounds that reduced biofilm formation without altering bacterial cell viability, the two lead 
compounds 52 and 53 (Figure 20), analogues of the antimalarial drug mefloquine, have been 
identified.[55]  
45 46 47 48 
Figure 18. Structures of furanone C30, patulin, 3-oxo-C12-AHL and TP-1. 
49 50 51 
Figure 19. Structures of salicylic acid, nifuroxazide and chlorzoxazone. 
Chapter 1 - INTRODUCTION 
27 
 
54 
 
 
 
1.3.3 Natural products and their analogues 
Nature has been proven to be an outstanding source for new and innovative antibiofilm compounds 
active at sub-lethal concentrations. Plants and microbes of terrestrial and marine origin are known to 
produce small molecules offering chemical diversity with structural complexity and biological potency. 
Some of these molecules exhibit novel biological activities that make them indispensable tools in 
biomedical research and unique prototypes for the development of innovative therapies. A number of 
natural products that possess the ability to inhibit or disperse bacterial biofilms have been used as the 
starting points for the design of more efficacious compounds through modifications of their scaffolds. 
 
1.3.3.1 Plant extracts 
Studying natural products derived from plant sources for the discovery of new biologically active 
compounds is not uncommon as many traditional medicines use plant 
extracts for the treatment and cure of disease symptoms. For instance, 
extracts from Rubus ulmifolius, rich in the polyphenol ellagic acid 54 and 
glycosylated derivatives, showed an inhibitory effect on S. aureus biofilm 
formation at concentrations below those required to limit bacterial 
growth.[56] Meanwhile, a number of flavonoids found in citrus species, including naringenin 55 and 
quercetin 56 (Figure 21), which are antagonists of homoserine lactone and AI-2-mediated cell-cell 
signaling are able to inhibit biofilm formation by V. harveyi  and E. coli in a dose-dependent 
manner.[57]   
52 53 
Figure 20. Structures of mefloquine analogues. 
Chapter 1 - INTRODUCTION 
28 
 
 
 
 
 
Another plant derived natural product, recently identified as potential biofilm formation inhibitor, is 4-
epi-pimaric acid 57 isolated from Aralia cachemirica. It inhibites biofilm formation by S. mutans at 
sub-MIC concentrations and was shown by confocal microscopy to inhibit clumping and 
attachment.[58] 
Tannic acid 58, the main component of the extract of Quercus infectoria G. 
Olivier nutgalls (a traditional Thai medicinal plant) shows the same MIC (0.13-
0.50 mg/mL) of the whole extract against methicillin-resistant S. aureus 
suggesting that it might be the active component of the herb extract influencing 
bacterial cell surface hydrophobicity that is involved in antibiofilm mechanisms. 
At sub-MIC only antibiofilm activity and not bacterial growth is inhibited.[59] 
 
 
  
55 56 
Figure 21. Structures of molecules isolated from plants. 
57 
58 
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1.3.3.2 Halogenated furanones 
Comprehensive research reports have detailed the biological activities and effects that halogenated 
furanones (HFs) have on bacterial QS. These small molecules are natural products native to the marine 
red algae Delisea pulchra and primarily serve as a defense mechanism by acting as natural chemical 
deterrents. Several studies have shown that natural HFs isolated from the algae possess the ability to 
prevent biofilm formation and swarming in E. coli and B. subtilis. It is possible to evidence several 
structural similarities between HFs and AHLs such as the presence of a non-polar aliphatic carbon 
chain linked to a relatively polar group. As seen in AHLs, the length of the carbon chain linked to the 
furanone ring is varied in addition to the presence of hydroxyl or acyl functionalities. Besides, the 
presence of bromine atoms in these small molecules is one of the most significant structural differences 
between HFs and AHLs.  
 
 
 
 
Starting from the natural furanones 59 and 60 (Figure 22), the influence of the number and the position 
of bromine atoms on the activity have been explored. Compounds 61 and 62 (Figure 23) at 224 μM 
concentration reduce E. coli biofilm formation by 75% and 63% respectively, while the tetrabromo 
derivative 63 at 141 μM concentration causes a reduction of biofilm formation by 80%.[60]  
 
 
 
 
Nevertheless, other synthetic furanones 64-68 (Figure 24), lacking bromine atoms but bearing an 
exocyclic ester functionality, are able to inhibit P. aeruginosa biofilm formation.[61]  
  
59 60 
Figure 22. Structure of natural halogenated furanones. 
61 62 63 
Figure 23. Synthetic halogenated furanones bearing in their structure some bromine atoms. 
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Moreover, 5-bromomethylene-5H-furan-2-one 69, lacking a side chain but bearing a vinyl bromide 
moiety, was able to penetrate P. aeruginosa biofilm and interfere with QS without 
any associated microbicidal properties.[62] To date, the halogenated furanones 
cannot be used for human treatment therapies since they are characterized by 
toxicity, carcinogenic properties, and instability under aqueous conditions. 
 
1.3.3.3 Marine natural products and analogues 
Nowadays, some of the most active discovered anti-biofilm compounds have been based on the 
molecular scaffolds of marine natural products. Oroidin 70 and Bromoageliferin 71 (Figure 25) are 
alkaloids produced by the sponge Agelasidae as chemical anti-feeding defense mechanism against 
predator. They are structurally characterized by the presence of 2-aminoimidazole (2-AI) subunits. 
 
 
 
The simplification of bromoageliferin structure has led to the couple of analogues TAGE (trans- 
bromoageliferin) 72 and CAGE (cis-bromoageliferin) 73 (Figure 26) showing a biofilm formation 
inhibition against P. aeruginosa PA01 and PA14. In details, TAGE inhibits PA01 and PA14 biofilm 
formation with IC50 values of 100 μM and 190 μM respectively, similarly to CAGE.[63]  
 
64 
65  n=0 
66  n=1 
67  n=2 
68  n=3 
Figure 24. Synthetic halogenated furanones bearing in their structure an exocyclic ester functionality. 
69 
70 71 
Figure 25. Structures of oroidin and bromoageliferin. 
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Since Oroidin shows a similar activity to TAGE and CAGE on P. aeruginosa (IC50 = 190 μM and IC50 
= 166 μM against PA01 and PA14 respectively), structure–activity-relationships (SARs) for anti-
biofilm activity have been investigated. In order to delineate which structural features of the molecule 
could be required for biological activity, three regions within the 
oroidin template have been systematically varied: the pyrrole tail 
group, the linker chain, and the 2-AI head group. These studies 
have revealed that any modifications to the 2-AI head of the 
molecule completely abolish the activity. Among these, the most 
active molecule discovered was dihydrosventrin (DHS) 74.[64] In addition, derivatives presenting the 
reversed amide bond have been synthesized. In particular, compounds bearing an aliphatic chain have 
shown the inhibition of biofilm development by PA01 and PA14 at low micromolar concentration and 
their potency is directly related to chain length. Moreover, the introduction of a triazole moiety has 
been explored. In particular, 2-aminoimidazole-triazole (2-
AIT) 75 shows a broad spectrum inhibitory activity against 
both Gram-positive and Gram-negative bacteria.[65] Further 
efforts to increase the activity of 75 through modification of 
the aryl moiety were carried out through the use of Suzuki–Miyaura coupling. A number of these 
compounds were found to be effective biofilm dispersion agents against A. baumannii. Moreover, the 
effect of different substituents to modulate biofilms has been investigated through a synthetic approach 
involving Grignard addition to α-amino Weinreb amides. The introduction of alkyl substituents at the 
1-position of the 2-AI ring also modulates the activity: in general short chain substituents led to a 
decrease of activity, while the most active analogues against P. aeruginosa biofilm formation are those 
possessing an alkyl chain of intermediate length. 
Also the 2-aminopyrimidine (2-AP) scaffold has been investigated and the obtained derivatives exhibit 
a lower activity in comparison with 2-AI compounds against the Gram-negative bacteria. Among the 
72 73 
Figure 26. Structures of TAGE and CAGE. 
73 
75 
74 
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most active derivatives, 76 and 77 have been found to inhibit biofilm formation with an IC50 value of 
72 μM and 67 μM respectively (Figure 27).[66] 
 
 
 
 
1.3.3.4  Zosteric acid 
Seagrasses, a group of about 60 species of flowering plants, live completely submerged in marine 
waters and form the most widespread coastal systems in the world. Several studies on marine plants 
highlighted a lack of correlation between antimicrobial activities and abundance of surface-associated 
microorganisms, suggesting that chemical defences may function by mechanisms more subtle than the 
simple killing activities, like those influencing the multicellular behaviour by manipulating the 
expression of specific phenotypes that represent different stages of the biofilm process.[67] In this 
context, sub-lethal concentration represents one mechanism by which the host minimizes the risk of 
counter adaptation which would be likely to occur if secondary metabolites were toxic.[68] Zosteric 
acid (ZA, 1), the natural extract from Zostera marina or eelgrass, has shown to prevent biofouling from 
some bacteria, algae, barnacles and tubeworms at non-toxic concentrations.[69] The chemical name of 
zosteric acid is p-(sulpho-oxy) cinnamic acid (Figure 28). 
 
     
Figure 28. Zosteric acid formula. 
 
Recently, the efficacy of zosteric acid sodium salt as inhibitor of biofilm formation was evaluated 
against two bacteria (Escherichia coli and Bacillus cereus) and two filamentous fungi (Aspergillus 
niger and Penicillium citrinum).[70] The anti-biofilm activity of ZA sodium salt was species-specific, 
and the reduction in microbial adhesion ranged from 23 % to 99 %, depending on the environmental 
76 77 
Figure 27. Structures of 2-AP derivatives. 
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conditions. Previously studies demonstrated that zosteric acid also possesses the ability to significantly 
reduce, at sublethal concentrations, both bacterial and fungal adhesion and to successfully counteract 
the effects of colonization-promoting factors like temperature, time and pH. It was found that ZA is not 
a chemorepellent but it is able to stimulate individual E. coli cell motion by increasing the production 
of flagella, causing the bacteria to wander away from the surface instead of adhering firmly and 
developing biofilm. In addition, this anti-biofilm compound retards E. coli biofilm development with a 
significant decrease in biofilm biomass and thickness, plays a role in shaping biofilm architecture, in 
thwarting budded-to-hyphal-form transition, in extending the performance of antimicrobial agents and 
shows cytocompatibility towards soft and hard tissue. A deeper proteomic investigation highlights that 
this anti-biofilm compound leads to global stress on bacterial cells promoting the expression of several 
protective proteins and the synthesis of flagella to escape from unfavourable conditions.[71]  
To date, the mode of its antifouling action has not yet been fully elucidated. Stanley and coworkers 
[72] hypothesized that the reason of the antifouling effect of zosteric acid lies in the high affinity for 
water due to its sulfate group. As a result, its antifouling capability could be the attributed to the free-
floating molecules that interact with bacteria. Moreover, it was hypothesized that zosteric acid 
molecules in aqueous environment can block the surface interaction sites of the organisms, thus 
preventing their attachment to a surface. A recent study demonstrated that the antifouling agent did not 
affect cell surface wettability of both bacterial and fungal cells but increased by 40% bacterial 
swimming motility. [71] The hyper-motile phenotype observed in the zosteric acid sodium salt-treated 
samples, suggested that zosteric acid sodium salt impacts the transition between motile and sessile 
lifestyle by causing Escherichia coli to wander across the surface instead of firmly adhering and 
developing biofilm. Whole cell proteome of E. coli was analysed to study protein patterns expressed by 
the surface-exposed planktonic cells without and with the zosteric acid sodium salt. Two principal 
groups of proteins, energy metabolism related and stress-associated proteins, were differently 
expressed in presence of zosteric acid sodium salt (Figure 29). 
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Figure 29. Functional classification of proteins modulated in E. coli cells treated with zosteric acid sodium salt. This chart shows 
the different groups to which the 27 identified proteins with a known or predicted function can be assigned.  
In summary, the interaction of zosteric acid sodium salt with E. coli cells seems to involve complex 
cross-talk regulating various genes. This indicates that it may target key-steps involved in biofilm 
formation by modulating the threshold level of AI-2 and inducing a hypermotile phenotype unable to 
firmly adhere on surfaces. In addition, it is possible that the antifouling action of zosteric acid sodium 
salt is caused by cell envelop defects leading to modifications of physicochemical properties of cell 
surface and thus changes in bacterial adhesion to abiotic surfaces. The presence of zosteric acid sodium 
salt acts as environmental cue leading to a global stress on E. coli cells, increasing the ability to express 
various protective proteins, the production of AI-2 and the synthesis of flagella to escape from adverse 
conditions. 
 
1.3.3.5  Conclusions 
Nature represents an immense source of new bioactive substances with unrivalled structural diversity 
and complexity. Plants have adaptively developed fascinating strategies over millions of years to 
prevent harmful bacterial colonization on their living tissues in response to an ever-present pathogen 
pressure. These natural strategies have inspired anti-biofilm strategies and could be a promising starting 
point for novel therapeutic approaches. In this context, zosteric acid has been found to be suitable for 
implementation as a preventive or integrative approach against biofilm formation. 
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2. REASEARCH PROJECT 
 
The aim of my research project is the development of an innovative antibiotic-free functionalized 
material to resist infections of vascular and urinary catheters using compounds with known anti-biofilm 
activities. The search of suitable non-toxic, active plant-derived compounds to incorporate into the 
antifouling coating could be a successful approach for the prevention of biofilm-related infections. This 
new perspective is based on the concept of using sub-lethal doses of bio-inspired molecules to interfere 
with the key-steps that orchestrate biofilm formation (like surface sensing process and/or cell-to-cell 
signaling pathways), thus infection cascade might be hampered. In addition, as this approach do not 
directly kill cells or prevent their growth, there is presumably a less evolutionary pressure for the 
development of resistance than with traditional antimicrobial agents.  
This project began from the investigation of zosteric acid or p-(sulfo-oxy) cinnamic acid, a secondary 
metabolite produced by the seagrass Zostera Marina, which turned out to be suitable for 
implementation as a preventive or integrative approach against device-related infections. With the aim 
to identify the essential requirements for zosteric acid antifouling activity, several derivatives were 
synthesized and submitted to biological assays in order to evaluate both their planktonic growth 
inhibition and their anti-adhesion properties.   
This thesis is divided into two main sections. Within each section, I firstly provided a basic outline of 
the concepts under discussion. In the first one, I included some observations about the structure-activity 
relationships (SARs) exhibited by a small library of molecules (45 compounds), whose chemical 
structures are related to the scaffold of zosteric acid. Moreover, also two derivatives of salicylic acid 
were taken into account in this first stage, since salicylic acid, whose antimicrobial activity is well-
known in biological world, was used in the subsequent section as reference compound to evaluate the 
efficiency of cinnamic acid functionalized surface. Initially, it was necessary to prepare chemically 
modified anti-biofilm compounds. The anchorage of these compounds to the polymeric material, used 
for the preparation of medical devices, was performed functionalizing these derivatives with chemical 
groups able to allow their binding to reactive positions on the polymer by an opportune spacer. The 
chemical modifications have conserved the parts of molecule responsible for the antifouling activity. 
The obtained results prove to be valuable in the rational design of the next generation chemical tools, 
with an improved activity and selectivity, to study and modulate bacterial adhesion. In addition, the 
Chapter 2 – RESEARCH PROJECT 
36 
 
identification of the cellular target of zosteric acid analogues constituted a crucial step in understanding 
their true mode of action and for the structure-led design and improvement of any potential therapeutic 
compound and material. Then, a further goal of this work was to understand the molecular mechanism 
by which zosteric acid and its derivatives affected the biofilm formation in E. coli, by identifying the 
target proteins bound by the antibiofilm compounds using an affinity pull-down approach. 
The second branch of this thesis was focused on the functionalization of materials with molecules, 
selected from the previous biological evaluation, showing interesting antifouling properties, with the 
aim to hinder biofilm formation. In literature, various synthetic approaches based on immobilization or 
release of bactericidal substances were extensively explored to produce antibacterial coatings. 
Although providing encouraging results, these approaches suffer from the use of active agents which 
may be associated with side-effects such as cytotoxicity, hypersensibility, inflammatory responses or 
the progressive alarming phenomenon of antibiotic resistance.  
In this context, a bio-inspired method devoted to the development of an antibiofilm surface using 
derivatives which mechanisms of action are different from that of the traditional antimicrobial 
compounds can be a promising approach to prevent biofilm formation.  
In this second section, two different strategies were employed to achieve this purpose:  
- a physical coating or passive coating, that consists in depositing an antifouling layer on the 
material surface (lacking of long-termed activity);  
- a covalent linkage of molecules to the surface, which offers better stability.   
Advantages were conferred with the covalently linkage of selected bioactive molecule to the surface of 
a material in a way to expose the active moiety to the cellular target. Indeed, in this approach, no 
molecule were leached from the surface, sidestepping the problem of the compound kinetics release, 
providing a long-term protection against bacterial colonization and reducing the risk of developing 
resistant microbial strains, as the concentration of the anti-biofilm agents were constantly below the 
lethal concentration. 
Finally, in this dissertation I also inserted a brief description of the work I performed during my six 
months experience in the Department of Chemistry at the University of Cambridge (UK), under the 
supervision of Professor David Spring, involving the design and the synthesis of potential Plk1 
macrocyclic inhibitors.  
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This project was founded by Cariplo Foundation and the scientific background of involved researchers 
includes:  
1) competence in biocide-free antifouling strategies and biofilm analysis (DEFENS-UNIMI: Dr. 
Cristina Cattò, Dr. Federica Villa, Dr. Francesca Cappitelli*);  
2) competences in the immobilization of enzymes on inorganic and organic surfaces (ICRM-CNR: Dr. 
Francesco Secundo);  
3) enzyme modification with polymer or with small hydrophobic molecules (isoprenylation, acylation) 
(ICRM-CNR, DEFENS-UNIMI: Dr. Francesco Secundo, Dr. Federica Villa, Dr. Francesca 
Cappitelli*); 
 4) functional studies about the activity of antifouling molecules and redox-cycling agents based on 
comparative proteomics (DEFENS-UNIMI: Dr. Cristina Cattò, Dr. Fabio Forlani, Dr. Alberto Vitali);  
5) chemical modification of molecules with well-known antifouling activity and clear mechanism of 
action by reaction through the available functional group or, if necessary, introducing new reactive 
groups to link them directly or by a spacer to the material surface (DISFARM-UNIMI: Dr. Silvia 
Dell’Orto, Dr. Stefania Villa, Dr. Arianna Gelain); 
 6) functionalization of the polymer surfaces which are employed for production of the medical devices 
(DISFARM-UNIMI: Dr. Silvia Dell’Orto, Dr. Stefania Villa, Dr. Arianna Gelain). 
 
* Project Coordinator 
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3. SECTION A: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION 
OF ANTI-BIOFILM DERIVATIVES 
 
3.1. Project Description (A) 
 
Zosteric acid (ZA, 1), a natural product extracted from the seagrass Zostera Marina, has been shown to 
deter, at non-toxic concentrations, fouling by marine bacteria, algae, barnacles and tubeworms.[69] It 
turned out to be a powerful antibiofilm agent able to significantly reduce, at sublethal concentrations, 
both bacterial and fungal adhesion (for details see „Paragraph 1.3.3.4‟).  
 
 
ZOSTERIC ACID (ZA, 1) 
 
 
 
 
 
 
 
 
 
 
 
Since zosteric acid has shown antifouling properties only at 1.83 mM, a series of derivatives related to 
its structure were designed and synthesized in order to understand the structural requirements essential 
for the antifouling activity. 
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Chart 1. Cinnamic acid derivatives (1-45) 
 
In detail, the performed modifications are summarized in Chart 1 and consist of: 
i. the introduction of substituents, characterized by different steric and electronic features, at 
various positions on the phenyl ring; 
ii. several side chains modifications, such as the removal of the unsaturation;  
iii. the insertion of a methyl group in alfa or beta position of the carboxylic acid; 
iv. the replacement of the carboxylic moieties with an aldehyde, an alcohol or ester functionalities. 
Several compounds were purchased from Sigma-Aldrich, some others were prepared following slightly 
modified literature procedures.[73, 74, 75] The zosteric acid analogues were divided in six groups 
according to the structural changes made on zosteric acid scaffold: 
 Group 1: molecules bearing different substituents at the para position on the phenyl ring, 
maintaining unchanged the carboxylic function and the trans configuration of the double bond.  
Group Cmp  R E/Z 
1 1 ZOSTERIC ACID OSO3H E 
1 2 COUMARIC ACID* OH E 
1 3 CINNAMIC ACID* H E 
1 4 4-METHOXYCINNAMIC ACID* OCH3 E 
1 5 4-NITROCINNAMIC ACID* NO2 E 
1 6 4-CHLOROCINNAMIC ACID* Cl E 
1 7 4-AMINOCINNAMIC ACID HYDROCHLORIDE* NH3
+Cl- E 
1 8 4-AMINOCINNAMIC ACID * NH2 E 
1 9 4-CYANOCINNAMIC ACID CN E 
1 10 (4-TRIFLUOROMETHYL)CINNAMIC ACID CF3 E 
1 11 4-CARBOXYCINNAMIC ACID COOH E 
1 12 4-FORMYLCINNAMIC ACID* COH E 
1 13 4-FLUOROCINNAMIC ACID* F E 
1 14 4-METHYLCINNAMIC ACID CH3 E 
 
R= OH, OCH3, Cl, F, CF3, NO2, NH2, COOH, CHO, CH3 
R1, R2= CH3  
R3= CH2OH, CHO, COOH, COOMe, COOEt  
 
*commercially available   
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 Group 2: molecules bearing different substituents at ortho and meta position on the phenyl ring, 
maintaining unchanged the carboxylic function and the trans configuration of the double bond. 
 
 
 
 
 
 
 
 
 
 
 Group 3: molecules whose carboxylic acid was replaced by different functionalities.  
 
Group Cmp  R R1 R2 R3 E/Z 
3 25 METHYL COUMARATE* OH H H COOCH3 E 
3 26 METHYL CINNAMATE* H H H COOCH3 E 
3 27 METHYL 4-METHOXYCINNAMATE OCH3 H H COOCH3 E 
3 28 ETHYL CINNAMATE* H H H COOCH2CH3 E 
3 29 ETHYL β-METHYLCINNAMATE* H H H COOCH2CH3 E 
3 30 ETHYL 2-HYDROXYCINNAMATE* H H OH COOCH2CH3 E 
3 31 CINNAMALDEHYDE* H H H COH E 
3 32 α-METHYLCINNAMALDEHYDE* H H H COH E 
3 33 CINNAMYL ALCOHOL* H H H CH2OH E 
 
 
 Group 4: molecules characterized by a saturated side chain.  
 
Group Cmp  R R1 E/Z 
4 34 3-PHENYLPROPIONIC ACID* H H E 
4 35 3-(4-HYDROXY)PHENYLPROPIONIC ACID* OH H E 
4 36 3-(4-METHOXY)PHENYLPROPIONIC ACID* OCH3 H E 
4 37 (3,4-DIHYDROXY)HYDROCINNAMIC ACID* OH OH E 
  
Group Cmp  R R1 R2 E/Z 
2 15 2-HYDROXYCINNAMIC ACID* H H OH E 
2 16 3-HYDROXYCINNAMIC ACID* H OH H E 
2 17 2-CHLOROCINNAMIC ACID H H Cl E 
2 18 3-CHLOROCINNAMIC ACID* H Cl H E 
2 19 2-METHOXYCINNAMIC ACID* H H OCH3 E 
2 20 2-CHLORO-4-FLUOROCINNAMIC ACID* F H Cl E 
2 21 2,4-DICHLOROCINNAMIC ACID* Cl H Cl E 
2 22 3,4-DICHLOROCINNAMIC ACID* Cl Cl H E 
2 23 CAFFEIC ACID* OH OH H E 
2 24 3-HYDROXY-4-AMINO CINNAMIC ACID NH2 OH H E 
2 46 3-HYDROXY-4-NITRO CINNAMIC ACID NO2 OH H E 
*commercially available  
*commercially available    
*commercially available    
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 Group 5: molecules characterized by the side chain in cis configuration.  
 
Group Cmp  R R1 E/Z 
5 38 ZOSTERIC ACID  OSO3H COOH Z 
5 39 CINNAMIC ACID H COOH Z 
5 40 COUMARIC ACID* OH COOH Z 
5 41 4-METHOXYCINNAMIC ACID OCH3 COOH Z 
5 42 METHYL 4-METHOXYCINNAMIC ACID OCH3 COOCH3 Z 
5 43 METHYL COUMARATE OH COOCH3 Z 
5 44 ETHYL CINNAMATE H COOCH2CH3 Z 
5 45 COUMARIN* H - Z 
 
  
*commercially available    Coumarin 45 
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Subsequently, besides cinnamic acid analogues, another different class of molecules, which derived 
from the structure of the natural compound salicylic acid (SA), has been investigated. To date, 
salicylates are known to be powerful antifouling agents against a wide range of fungi and bacteria [44] 
and they are able to prevent bacterial adhesion on medical devices. [76] 
 
 
 
SALICYLIC ACID (SA) 
 
 
 
 
 
 
 
 
In this case, I focused my attention only on the substitution at the para position since it was the most 
interesting for the subsequent grafting to the polymeric support (Chart 2). 
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Chart 2. Salicylic acid derivatives (47, 48) 
 
R= NH2, NHCOCH3 
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3.2 General chemistry 
 
3.2.1 Synthesis of (E, Z) zosteric acid (1, 38) 
Zosteric acid was synthesized either in conventional conditions, as already described in a previous 
work [69], or under microwave irradiation. In this latter case, the yield is comparable to that obtained 
by conventional method but the reaction time is greatly reduced. The cis isomer 38 was obtained 
starting from cis 4-hydroxycinnamic acid 40 under microwave irradiation in the presence of sulphur 
trioxide pyridine complex in dry acetonitrile. The final products were isolated as sodium salts (Scheme 
1). 
  
 
Scheme 1. Reagents and conditions: i) Py·SO3, dry DMF, 120 °C, 25 min, mw. ii) Py·SO3, dry CH3CN, 120 °C, 25 min. 
 
3.2.2 Synthesis of substituted cinnamic acid derivatives (9-11, 14, 17, 46) 
The majority of the substituted cinnamic acid derivatives were prepared in very good yield (> 90%) by 
Knoevenagel-Doebner procedure.[73] In detail, compound (9-11, 14, 17, 46) were obtained through a 
one-pot reaction between the suitable substituted benzaldehyde and malonic acid in refluxing pyridine 
to induce decarboxylation (Scheme 2). The trans geometries of the ethenyl π-bonds were confirmed by 
proton-proton coupling constants. 
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Scheme 2. Reagents and conditions: i) malonic acid, Py, piperidine (cat.), reflux, 80-180 min. 
 
3.2.3 Synthesis of  3-hydroxy-4-aminocinnamic acid (24) 
The 3-hydroxy-4-aminocinnamic acid 24 was prepared starting from the corresponding nitro derivative 
46 by tin (II) chloride reduction in concentrated hydrochloric acid (Scheme 3).  
 
 
Scheme 3. Reagents and conditions: i) SnCl2, conc. HCl, 80 °C, 4 h; 1 M NaOH up to pH = 4.6. 
 
3.2.4 Synthesis of ethyl cinnamate (44) and cis cinnamic acid (39)  
Cis cinnamic acid was synthesized from the commercially available ethyl phenylpropiolate. The 
subsequent hydrogenation of alkyne, in presence of Lindlar catalyst and pyridine in methanol, led to 
the corresponding cis-alkene 44. The ester group was then hydrolyzed under alkaline condition to 
provide the cis cinnamic acid 39 (Scheme 4).[74]  
 
 
Scheme 4. Reagents and conditions: i) Lindlar catalyst, H2, Py, MeOH, rt, 16 h; ii) 1 M NaOH, EtOH/THF (1:1), rt, 12 h. 
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3.2.5 Synthesis of trans methyl coumarate (25), trans methyl 4-methoxycinnamate 
(27) and cis methyl coumarate (43) 
Esters of cinnamic acid derivatives in trans (25, 27) or cis configuration 43 were prepared by Fischer 
esterification of the carboxylic group of the suitable starting material in methanol with sulfuric acid as 
catalyst (Scheme 5). 
 
 
Scheme 5. Reagents and conditions: i) H2SO4, MeOH, reflux, 1 h. 
 
3.2.6 Synthesis of cis methyl 4-methoxycinnamate (42) 
The protection of the hydroxyl group as methyl ether in the presence of iodomethane in dry N,N-
dimethylformamide provided compound 42 (Scheme 6).[75] 
 
 
Scheme 6. Reagents and conditions: i) CH3I, anhydrous K2CO3, dry DMF, N2, reflux, 1.5 h. 
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3.2.7 Synthesis of cis 4-methoxycinnamic acid (41) 
Hydrolysis of ester was performed in alkaline conditions to afford compound 41 (Scheme 7). 
 
 
Scheme 7. Reagents and conditions: i) 1 M NaOH, EtOH, reflux, 2 h. 
 
3.2.8 Synthesis of 4-acetamidosalicylic acid (48) 
The commercially available 4-aminosalycilic acid 47 was protected at the amino function with acetic 
anhydride obtaining compound 48 (Scheme 8). 
 
 
Scheme 8. Reagents and conditions: i) acetic anhydride, EtOH, 40 °C, 30 min. 
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3.3 Biological studies 
 
All the molecules were submitted to biological assays using Escherichia coli as a model system for 
bacterial infections. They were tested at different concentrations starting from 1830 µM which was 
figured out as the best concentration at which zosteric acid performed its anti-biofilm activity.[69] The 
derivatives were tested in order to evaluate their ability to affect both planktonic growth and surface 
cell adhesion (Appendix 1). With the aim to identify common behaviors related to the biological 
activity of molecules with different structural features (TRENDs), planktonic growth and cells 
adhesion data were grouped to obtain a global picture of the anti-biofilm activity of each ZA related 
compound at the different concentrations (Appendix 2). Compounds showed:  
i) no biological activity (no reduction of the number of adhered cells and no planktonic growth effect); 
ii) anti-biofilm activity (reduction of the number of adhered cells and no planktonic growth effect);  
iii) increased biofilm formation (increase of the number of adhered cells and no planktonic growth 
effect);  
iv) transition from planktonic to biofilm mode of life (no reduction or increase of the number of 
adhered cells and planktonic growth effect);  
v) biocidal effect (reduction of the number of adhered cells and planktonic growth effect). 
Each ZA related compound was also associated to a global anti-biofilm performance value (Appendix 
3), considering the occurrence that ZA related compounds induced a different bacterial response 
depending on their concentration and the positive or negative contribution of each single concentration. 
A reduction of adhered cells was considered a positive contribution to the anti-biofilm performance 
value, while both the increase of the adhered cells and the decrease of planktonic growth were 
considered negative contributions. 
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3.3.1 Planktonic growth and cellular adhesion in the presence of DMSO 
As DMSO was necessary to dissolve molecules in the aqueous medium, its impact on E. coli as 
possible carbon and energy source and on growth and cell adhesion was assessed. 3 % DMSO was not 
a carbon and energy source for the microorganisms. In addition, no significant differences among the 
number of planktonic and adhered cells with or without 3 % DMSO were observed (Table 2). 
 
DMSO  
concentration 
Planktonic growth  
(OD600/min) (x10
3
) 
Cells adhesion 
(No. adhered cells) (x10
7
) 
0 % 1.33±0.01
a
 2.02±0.39
a
 
3 % 1.28±0.03
a
 1.92±0.18
a
 
 
Table 2. Planktonic growth and cells adhesion with and without 3 % DMSO. According to post hoc analysis (Tukey‟s HSD, p < 
0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
 
3.3.2 Cellular growth with zosteric acid related compounds as the sole carbon and 
energy source 
The ability of  E. coli to grow with zosteric acid related compounds at 1830 µM as the sole carbon and 
energy source was tested and compared with a positive control with glucose at the same concentration. 
E. coli in the positive control did not grow and showed a 600 nm optical density (OD600) lower than 
0.05 after 48 h of incubation.  
The minimum glucose concentration in a mineral medium that supported E. coli growth was 10 mM 
(OD600 = 0.201 ± 0.007). Consequently, E. coli with glucose 10 mM was used as a positive control.  
E. coli did not grow in the presence of each zosteric acid related compounds as the sole carbon and 
energy source and it showed a OD600 lower than 0.05 after 48 h of incubation with each molecules. 
All derivatives were submitted to further biological assays in order to evaluate their ability to affect 
both planktonic growth and surface cell adhesion. 
 
3.3.3 Planktonic growth in the presence of zosteric acid related compounds  
E. coli maximum speciﬁc growth rates in the presence of each zosteric acid related compounds at 
0.183, 1.83, 18.3, 183 and 1830 µM were calculated and compared with a negative control grown 
without the molecules by ANOVA statistic test (Appendix 1).  
Molecules able to reduce the maximum specific growth rate respect to the negative control less than 10 
% (0) were considered not affecting E. coli planktonic growth, between 10 % and 20 % (-) were 
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considered weakly affecting E. coli planktonic growth, between 20 % and 30 % (- -) were considered 
fairly affecting E. coli planktonic growth and more than 30 % (- - -) were considered highly affecting 
E. coli planktonic growth. 
At the concentration of 0.183 µM and 1.83 µM no molecules were considered affecting E. coli growth 
since they showed any maximum speciﬁc growth rate values significantly different to the negative 
control (p < 0.05) and a percentage reduction of planktonic growth rate under 10 %. 
At the concentration of 18.3 µM forty-two molecules were considered not affecting E. coli planktonic 
growth. Among them:  
- thirty-four molecules did not show growth rate values significantly different to the negative control (p 
< 0.05); 
- six molecules (2, 3, 8, 37, 42, 44) showed maximum speciﬁc growth rate values significantly different 
to the negative control with a reduction of planktonic growth rate less than 10 % and therefore could be 
considered not affecting E. coli planktonic growth too; 
- only compound 4 showed a reduction of planktonic growth rate between 10 % and 20 % and was 
considered weakly affecting E. coli planktonic growth. 
At the concentration of 183 µM thirthy-three molecules were considered not affecting E. coli 
planktonic growth.  
Among them:  
- twenty-nine molecules did not show growth rate values significantly different to the negative control 
(p < 0.05); 
- four molecules (4, 5, 19, 24) showed maximum speciﬁc growth rate values significantly different to 
the negative control but they presented a reduction of planktonic growth rate less than 10 % and 
therefore were considered not affecting E. coli planktonic growth too; 
Ten molecules showed planktonic growth rate statistically different to the control and differently 
affected E. coli planktonic growth:   
- nine molecules (3, 6, 13, 25, 27, 30, 41, 43, 44) showed a reduction of planktonic growth rate between 
10 % and 20 % and were considered weakly affecting E. coli planktonic growth;  
- compound 42 showed a planktonic growth rate reduction between 20 % and 30 % and was considered 
fairly affecting E. coli planktonic growth. 
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Finally, at the concentration of 1830 µM, four molecules were considered not affecting E. coli 
planktonic growth.  
Among them:  
- compound 40 did not show growth rate values significantly different to the negative control (p < 
0.05);  
- three molecules (24, 37, 38) showed maximum speciﬁc growth rate values significantly different to 
the negative control but it presented a reduction of planktonic growth rate less than 10 % and therefore 
was considered not affecting E. coli planktonic growth too.  
The remaining thirty-nine molecules showed a planktonic growth rate statistically different to the 
negative control and differently affected E. coli planktonic growth:  
- nine molecules (13, 16, 17, 20, 23, 27, 29, 35, 44) showed a reduction of planktonic growth rate 
between 10 % and 20 % and were considered weakly affecting E. coli planktonic growth;  
- eleven molecules (2, 4, 5, 9, 12, 15, 18, 19, 21, 36, 41, 45) showed a planktonic growth rate reduction 
between 20 % and 30 % and were considered fairly affecting E. coli planktonic growth;  
- nineteen molecules (3, 6-8, 10, 13, 14, 22, 25, 26, 28, 30-34, 39, 42, 43) showed a planktonic growth 
rate reduction more than 30 % and were considered highly affecting E. coli planktonic growth. 
 
3.3.4 Microplate-based cell adhesion assay in the presence of zosteric acid related 
compounds 
The number of adhered cells in the presence of each zosteric acid related compound at 0.183, 1.83, 
18.3, 183 and 1830 µM was assessed quantitatively using fluorochrome labeled cells and compared to a 
negative control in the absence of any molecules by the ANOVA statistic test (Appendix 1).  
Molecules able to reduce the number of adhered cells respect to the negative control less than 20 % (0) 
were considered not affecting  E. coli cell adhesion, between 20 % and 30 % (-) were considered 
weakly affecting E. coli cell adhesion, between 30 % and 40 % (- -) were considered moderatly 
affecting E. coli cell adhesion and more than 40 % (- - -) were considered highly affecting E. coli cell 
adhesion. Molecules that are able to increase the number of adhered cells respect to the negative 
control more than 20 % were coded +.  
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3.3.5 Biological activity of zosteric acid derivatives 
With the aim to identify specific trends, planktonic growth and cells adhesion data were combined 
together to obtain an overall view of the biological activities of ZA derivatives at the different 
concentrations (Appendix 2).  
Compounds showed five different behaviors related to their biological activities:  
 
a) TREND 1 
Five molecules (5, 9, 19, 20, 36) induced no biological activity at low and middle concentrations and 
transition from planktonic to biofilm mode of life (19, 20, 36) or biocidal effect at the maximum 
concentration (5, 9). 
 
b) TREND 2 
Eight molecules (27, 29, 31-35, 45) showed no biological activity at middle concentrations and 
transition from planktonic to biofilm mode of life (27, 29, 35, 45) or biocidal effect at the maximum 
concentration (31-34), but at the lowest concentration they promoted biofilm formation.  
 
c) TREND 3: 
Seventeen molecules (2, 3, 6-8, 10, 11, 13-16, 18, 22, 23, 25, 26, 28) had no biological activity at low 
concentration, showed an anti-biofilm activity at middle concentrations since significantly reduced the 
number of adhered cells without affecting planktonic growth and induced biocidal effect (2, 3, 6-8, 10, 
13-15, 18, 23, 25, 28) or transition from planktonic to biofilm mode of life (11, 16, 22, 26) at the 
maximum concentration. 
Among these: 
- six molecules (2, 10, 11, 13, 14, 23) displayed an excellent anti-biofilm activity with a percentage 
reduction of adhered cells respect to the negative control more than 40 % (14 maximum reduction = 
75.4 %); 
- seven molecules (6, 8, 15, 16, 18, 25, 28) displayed a moderate anti-biofilm activity with a percentage 
reduction of cell adhesion between 30 % and 40 %;  
- two molecules (22, 26) showed a weak anti-biofilm activity.  
Moreover, compound 4 showed a good anti-biofilm activity only at 1.83 µM (maximum reduction = 
39.1 %), since highest concentrations led to transition from planktonic to biofilm mode of life and 
biocidal effect.   
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At the lowest and the highest concentration only few molecules displayed a biological activity. At the 
concentration of 0.183 µM only two molecules (3, 12) showed an interesting anti-biofilm activity with 
a percentage reduction of adhered cells more than 30 % (3 maximum reduction at 1.83 µM = 38.8 %; 
12 maximum reduction at 1.83 µM = 61.9 %), while at the concentration of 1830 µM only compound 
37 showed anti-biofilm activity with a percent reduction of 63.3 %.  
Molecules bearing different substituents at the para position on the phenyl ring (2, 3, 4, 6, 7, 8, 10, 11, 
12, 13, 14) showed the best biological profile with an excellent or good activity in a wide range of 
concentrations. In any case, the reduction of adhered cells respect to the negative control was more than 
37 % depending on the nature of the substituents (minimum reduction: 37.9 % in the presence of 8 at 
18.3 µM; maximum reduction: 75.4 % in the presence of 14 at 1.83 µM).  
 
d) TREND 4 
Nine molecules (1, 17, 21, 24, 30, 41-44) showed a promising biological activity at middle 
concentrations but at the lowest concentration they promoted biofilm formation. Moreover, some of 
these molecules at the highest concentration induced the transition from planktonic to biofilm mode of 
life (41, 42, 44), biocidal effect (30) or both of them (17, 21, 43).  
 
e) TREND 5 
Compounds 38, 39 and 40 showed particular behaviors and cannot be included in the previously trends. 
As for 38, biofilm formation was promoted in a wide range of concentrations as well as for compound 
39. This latter showed an anti-biofilm activity only at 18.3 µM, while at the maximum concentration 
induced the transition from planktonic to biofilm mode of life. At last, molecule 40 showed a biological 
activity at the lowest concentration, had no anti-biofilm activity at middle concentrations and promoted 
biofilm formation at 1830 µM. 
 
3.3.6 Anti-biofilm performance of zosteric acid derivatives 
Beside the anti-biofilm activity, the global anti-biofilm performance of each compounds was also 
evaluated (Appendix 3). The anti-biofilm performance value was calculated as:  
 
Anti-biofilm Performance = (sum of cell adhesion codes of all concentrations) - (sum of planktonic 
growth code of all concentrations) 
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This value included: 
i) the occurrence that ZA related compound induced a different bacterial response depending on the 
concentration; 
ii) the positive contribution of concentrations that reduce the number of adhered cells; 
iii) the negative contributions of concentrations that enhance the number of adhered cells; 
iv) the negative contribution of concentrations that reduce planktonic growth.  
Molecules with an anti-biofilm performance:  
i) = 0 were considered globally lacking of anti-biofilm performance;  
ii) < 0 were considered globally able to exert an anti-biofilm activity (-1: low anti-biofilm performance; 
-2: moderate anti-biofilm performance; ≤ -3: optimal anti-biofilm performance);  
iii) > 0 were considered globally able to improve biofilm performance (+1: slight improvement of 
biofilm performance; +2: moderate improvement of biofilm performance; ≥ +3: optimal improvement 
of biofilm performance).  
In datails:  
- four molecules (5, 9, 16, 40) presented anti-biofilm performance equal to 0;  
- twenty molecules presented anti-biofilm performance < 0 (-1: 21; -2: 4, 13, 15, 18, 25, 28; ≤ -3: 1, 2, 
3, 6, 8, 10-12, 14, 17, 23, 24, 37); 
- twenty molecules presented anti-biofilm performance > 0 (+1: 20, 26, 33, 43, 44; +2: 22, 29, 30, 35, 
36, 45; ≥ +3: 19, 27, 31, 32, 34, 38, 39, 41, 42).  
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3.4 Proteomic studies
1
 
 
Consistently with biological evaluation, the natural compounds, cinnamic acid and salicylic acid (used 
as reference compound), can be considered promising agents for preventive or integrative approach 
against biofilm formation and for the development of a new generation of anti-biofilm derivatives. 
Since the mechanism of action and the cellular target involved in their biological activity are still 
unknown, in this study an affinity chromatography proteomic approach coupled with a mass 
spectrometry analysis was employed to scan the entire Escherichia coli proteome with the aim to 
identify the molecular targets that interact with these molecules. In order to capture proteins of interest 
by affinity, this approach was based on a covalent immobilization on a pre-activated matrix (Sepharose 
4 Fast Flow matrix, prepared with 6-aminohexanoic acid spacer arm and activated by esterification 
with N-hydroxysuccinimide) of 4-aminocinnamic 8 and 4-aminosalicylic acid 47 by an amidic covalent 
coupling. The functionalization of the solid support was demonstrated by fluorescence analysis. The 
mass spectrometry analysis of SDS-PAGE-resolved pull-down proteins (Figure 30) was used for target 
identification and revealed that both cinnamic acid and salicylic acid directly interact with the same 
protein WrbA (P0A8G6) in E. coli (Table 3). In addition, protein FkpA (P45523) and Tdh (P07913) 
were also identified as possible additional targets for salicylic acid (Table 3).  
 
 
                                                          
1
 An in-depth analysis and „Materials and methods‟ are included in Cristina Cattò (DEFENS-UNIMI research unit) PhD 
thesis, entitled “New strategies based on natural compounds for controlling biofilm formation” (December, 2014). 
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Figure 30. SDS-page analysis of the affinity chromatography of E. coli protein extract. Each gel is representative of three 
independent replicates. M: molecular mass marker; S: total soluble proteins from E. coli extract; U: proteins unbound; W: washing 
fraction; E: proteins bound to p-aminocinnamic acid/matrix and eluted with cinnamic acid (E1) and zosteric acid (E2), proteins bound to 
p-aminosalicylic acid/matrix and eluted with salicylic acid (E3), proteins bound to control matrix and eluted with cinnamic acid (E4), 
proteins bound to control matrix and eluted with zosteric acid (E5), proteins bound to control matrix and eluted with salicylic acid (E6). 
 
 
Matrix
a 
Cmp
b
 
Accession 
number
c
 
Gene 
name
d
 
Protein
e
 Score
f
 Coverage
g
 
p-aminocinnamic 
acid/matrix 
CA P0A8G6 wrbA NAD(P)H quinone dehydrogenase 189.78 70.2 
p-aminocinnamic 
acid/matrix 
ZA P0A8G6 wrbA NAD(P)H quinone dehydrogenase 684.32 71.72 
p-aminosalicylic 
acid/matrix 
SA P0A8G6 wrbA NAD(P)H quinone dehydrogenase 1079.55 71.72 
p-aminosalicylic 
acid/matrix 
SA P45523 fkpA 
FKBP-type peptidyl-prolyl cis-trans 
isomerase 
156.99 43.33 
p-aminosalicylic 
acid/matrix 
SA P07913 tdh L-threonine 3-dehydrogenase 521.32 59.53 
 
Table 3. Proteins identified by mass spectrometry analysis. a) the matrix from which the protein was eluted; b) the competitor used in 
the elution step; c) the alphanumeric unique protein sequence identifier; d) the gene name; e) the protein name provided by UniProtKB 
protein knowledgebase; f) the protein identification‟s SEQUEST HT Score; g) percentage of protein sequence covered by identified 
peptides (Coverage). 
 
 
Kda          M        S        U         W         W       E1       W        W           E2           E3          E4           E5         E6     
97  -    
 
66  -  
 
45  -  
 
 
30  -  
 
 
 
20  - 
 
 
14  - 
* * * 
* 
* 
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3.4.1 WrbA protein and supposed mechanism of action of cinnamic acid derivatives 
WrbA-like proteins (tryptophan [W] repressor-binding proteins) are widely distributed flavoproteins 
and supposed to be implicated in defence against oxidative stress. Crystallographic studies reported that 
E. coli WrbA is characterized by a tetrameric quaternary structure with a hydrophobic active site 
pocket that provides an ideal stacking environment for aromatic moieties [77], indeed well adapted to 
accommodate compounds such as cinnamic acid and salicylic acid (Figure 31).  
 
 
Figure 31. Cartoon representation of the WrbA monomer from E. coli. The stereo image of the protein chain shows the N terminus in 
blue and the C terminus in red. Strands of the central, parallel β-sheet and the surrounding α-helices are numbered according to their 
occurrence in the protein sequence. The flavin mononucleotide (FMN) cofactor is bound peripherally at the C-terminal end of the β-sheet. 
Protein Data Bank identifier [PDB ID] 3B61. [77] 
 
WrbA is endowed with the NADH:quinone oxidoreductase (NQO) activity involved in the maintaining 
quinones in a fully reduced state.[78] Quinones are compounds generally tethered to the plasma 
membrane or freely traversing the lipid bilayer. Although these compounds are essential for normal 
electron transport by cycling between the oxidized (hydroquinone) state and the two-electron reduced 
(hydroquinol) state, it has been demonstrated that quinonoids also participate in deleterious redox 
cycling through direct interactions with single-electron acceptors such as O2, leading to the 
accumulation of reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, and the 
hydroxyl radical responsible of devastating consequence in the cells.[79] In order to guard against the 
production of ROS from one-electron redox cycling, cells have evolved NQOs to maintain quinones in 
a reduced state as a measure of protection against oxidative stress. A previous study [71] demonstrated 
that zosteric acid makes E. coli cells more prone to accumulate ROS leading a stress condition to which 
bacterium responds by activating defensive mechanisms against oxidative damage.  
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Indeed, although further studies will be necessary, it can be hypothesized that cinnamic acid scaffold 
may negatively modulate the oxidoreductase activity of WrbA leading to a ROS accumulation inside 
cells affecting biofilm formation. Furthermore, recent data proved the ability of ROS to modulate 
quorum sensing and showed their important role in biofilm formation.[80] Finally, the upset of ROS 
level caused by the cinnamic acid scaffold might interfere with the quorum sensing signal destabilizing 
the biofilm formation.  
In the past E. coli WrbA was reported to promote complex formation between the tryptophan repressor 
(TrpR) and its DNA operator sequences.[81] Subsequent experiments demonstrated that WrbA did not 
specifically bind to DNA and its involvement in transcription regulation was revoked. Anyway, 
although a direct connection to tryptophan repressor was retracted, a role in the tryptophan metabolism 
was considered possible especially related to the indole production. Indole is known as a metabolite of 
tryptophan which has recently been proved to participate in various aspects of bacterial life including 
virulence induction, cell cycle regulation, stress resistance, genetic stability, controlling metabolic 
feedback and it is also proposed to be a quorum sensing signal with an important role in bioﬁlm 
formation process.[44, 82] It is generated by the hydrolyses of tryptophan due to the activity of the 
cytoplasmic enzyme tryptophanase. This reaction occurs exclusively in bacteria and in E. coli is 
catalysed by TnaA.[83] In particular, sigma factor sigma-38 (RpoS), a 37.8 kD protein in E. coli, 
appears to promote tryptophan degradation by inducing the tryptophanase gene tnaA, which results in 
the production of indole, and by stimulating expression of the WrbA protein, which might strengthen 
negative regulation of the trp biosynthetic operon by an unknown mechanism.[84, 85]  
Moreover, it is reported that either high and low levels of indole can abolish the ability to increase 
bioﬁlm formation, in a dose dependent manner and with a strain specific activity. In a previous study 
[71], it was found that E. coli, grown in the presence of zosteric acid, exhibited an enhanced 
tryptophanase activity and an increased amount of indole. Therefore, it can be hypothesized that 
cinnamic acid derivatives interacts with WrbA with subsequent consequences on the indole production.  
The blast search assay inside Bacteria and Fungi databases revealed that WrbA sequences exist in a 
diversity of microorganisms with a high percentage of identity, suggesting a potential role in the 
microorganism life, probably associated to the response against environmental stresses. Indeed, in 
support of these results, recent studies demonstrated that ZA is able to significantly reduce 
Pseudomonas spp biofilm [86] and Candida albicans biofilm [70].  
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Only related to salicylic acid, other two proteins were identified as possible molecular targets. In 
details, FkpA is a peptidyl-prolyl isomerase that in the E. coli periplasm was found to work in co-
operation with other three proteins (PpiA, PpiD, and SurA) known as periplasmic cis-trans prolyl 
isomerases (PPIase) that facilitate the proper protein folding by increasing the rate of transition of 
proline residues between the cis and trans states. It is reasonable to suppose that salicylic acid may 
interact with FkpA altering the PPIase and/or chaperone activity and resulting in incorrect assembling 
of pili with consequences on biofilm formation.[87] The second protein by which salicylic acid seems 
to exert its anti-biofilm activity is Tdh, an L-threonine 3-dehydrogenase that catalyses the first step in 
the L-threonine degradation pathways in both prokaryotes and eukaryotes.[88] Threonine has been 
shown to have an observable effect on the E. coli motility, significantly promoting swimming and 
twitching motility at low concentrations and significantly inhibiting biofilm formation at higher 
concentration.[89]  
Since salicylic acid interacts with different proteins, it probably has different cell targets. This is in line 
with the amount of researches present in the literature that report various effects of SA on bacterial 
biofilm, suggesting the presence of complex and overlapping regulatory networks controlling quorum 
sensing, motility and biofilm formation. 
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3.5 Discussion 
 
Our studies involved the preparation and the biological evaluation of zosteric acid analogues 
characterized by substitutions at different position on the phenyl ring as well as a variety of side chains. 
This investigation highlighted features that could be useful for the design of a new generation of  
derivatives, with the aim to find compounds endowed with a better antifouling activity compared to 
zosteric acid.  
As for biological evaluation, all the tested compounds showed a non-linear response pattern in which 
the best anti-biofilm activity of the cinnamic acid derivatives in the range of sub-lethal concentrations 
was obtained at a specific threshold level. The results showed that the most common and generally 
applicable dose–response model is the hormetic U-shaped biphasic model rather than the linear 
one.[90] This dose-response behavior has been demonstrated by several published studies [91, 92, 93] 
and followed a parabola-like shape profile in which the minimum point of the response corresponds to 
the minimum number of adhered cell and thus to the best activity for each compound.  
In line with the obtained results, derivatives showed different biological activities depending on their 
concentration. At the highest concentrations, it was found that most molecules inhibited biofilm 
formation and drastically reduced planktonic growth. Therefore, it was reasonable to suppose that the 
suppression of biofilm formation was a result of the inhibition of bacterial growth rather than from 
specific anti-biofilm effects of the substances. Other molecules at the highest concentrations enhanced 
biofilm formation and also reduced bacteria planktonic growth. In this case the transition to the sessile 
mode of life was assumed as a protective response to survival in hostile environments. Moreover, the 
movement of cells toward surfaces could be considered the step immediately before the killing effect as 
a kind of protecting way against hard stress condition.[94] At the lowest concentrations, an increase of 
biofilm formation was also observed for many of the molecules investigated. Low concentrations of 
small molecules released as exudates by plants can act as chemical signals inducing bacteria to 
colonize specific plant areas developing a complex biofilm that positively interacts with the plant itself.   
Since the present work highlighted that the zosteric acid sulfate ester was not essential for its 
antifouling properties, the cinnamic acid scaffold was identified as fundamental for the anti-biofilm 
activity.    
Indeed, cinnamic acid 3, a natural compound obtained by cinnamon (well-known in literature for its 
various pharmacological activities, including antimicrobial properties), has shown an interesting anti-
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biofilm activity at a 1000-fold lower inhibitory concentration (sub-lethal concentration) than zosteric 
acid with a mechanism of action not directly related to quorum sensing (for detail see „Paragraph 3.8‟).  
The substitution pattern of the phenyl ring and the nature of the substituents were found to have a 
significant effect on the biofilm inhibitory activity. In the first instance, a broad variety of substituents 
with different electronic and steric properties were introduced at position 4 on the phenyl ring: 
compounds (2, 4, 6, 8, 10-14) showed an interesting activity (Trend 3) compared to the unsubstituted 
cinnamic acid 3, meanwhile the presence of nitro 5 and cyano 9 groups caused a loss in activity (Trend 
1). Comparing the derivatives bearing a hydroxyl group (2, 16), as well as the chlorine atom (6, 18), 
respectively at position 4 and 3 on the phenyl ring, highlighted that the substitution at the para position 
was preferred (2 and 6 were more active than 16 and 18) although following the same trend. On the 
contrary the substitution at position 2 was not well tolerated. Indeed, as for the m-chloro derivative 17, 
the activity was reduced 10-fold compared to the 6, while in the other cases the biological activity was 
almost completely abolished. To determine whether the introduction of a second substituents on the 
phenyl ring would enhance activity, a series of disubstituted derivatives (20-24) were synthesized. In 
general, each disubstituted compound was found to have a different behavior and a less anti-biofilm 
activity compared to the corresponding monosubstituted. This effect was most evident for the 3,4-
dichlorocinnamic acid 22, whose activity was 10-fold lower than the monosubstituted counterpart 6. 
Following on from this, the side chain modifications were also explored. In general, the unsubstituted 
compounds having the carboxylic function protected as esters (26, 28) showed lower activity in 
comparison with cinnamic acid 3, and in particular the ethyl ester 28 was less active than methyl ester 
26. Besides, among the para-substituted cinnamic acid esters (25, 27), the presence of a hydroxyl 
group 25 seemed to be important for the antibiofilm activity, since the corresponding 4-methoxy 
derivative 27 was inactive. Moreover, derivatives bearing an aldehyde (31, 32) or an alcohol (33) in 
replacement of the carboxylic functionality were inactive (Trend 2) confirming that the carboxylic 
moieties was essential for a good anti-biofilm activity. To investigate the importance of the 
configuration of the double bond, cis derivatives (38-44) were synthesized and the majority of these 
were found to have a different behavior (Trend 4) compared to the trans counterparts. Interestingly, 
exceptions to this rule were the cis isomers of zosteric acid 38 and cinnamic acid 39, that had lost their 
anti-biofilm activity (Trend 5). Additionally, specific concentrations of 38 and 39 seemed to enhance 
the biofilm formation.  
Chapter 3 – SECTION A  
61 
 
Similarly, some saturated derivatives (34-37) were chosen to investigate the role of the double bond. 
All the compounds exhibited the same trend (Trend 2) except for compound 37, a catechol derivative, 
that did not follow this general behavior (Trend 3) probably due to a different mechanism of interaction 
(as compound 23).  
Finally, coumarin 45, which could be considered the cyclic derivative of 3, was unable to inhibit the 
biofilm growth, confirming the essential role of the side chain in trans configuration.  
It is noteworthy that growth curve analysis revealed that in most cases compounds have a broad range 
of concentrations in which they exhibited anti-biofilm activity (not due to a bactericidal effect). 
Therefore, the evaluation of the anti-biofilm performance could be a useful tool to draw some 
additional observations.  
Generally, cinnamic acid derivatives followed the same behaviors described for the anti-biofilm 
activity, with some exceptions:  
- derivatives 4 and 13, which have a methoxy group and a fluorine atom in the para position on the 
phenyl ring respectively, showed anti-biofilm performances slightly lower than that of the cinnamic 
acid 3, which was still a positive result; 
- compound 17 anti-biofilm performance turned out to be better than that of the corresponding 
analogue 6, in which the chlorine atom was at position 4 on the phenyl ring. However, the general 
trend, according to which the substitution at position 2 was not well tolerated, was confirmed; 
- the antibiofilm performance of the disubstituted halogen derivatives (20-22) was in general lower than 
that of the monosubstituted counterparts as well as its anti-biofilm activity. The same was not observed 
for compounds (23, 24), which were characterized by electron donating substituents, whose 
monosubstituted analogues showed a decreased anti-biofilm performance; 
- the esters 26 and 28 showed the opposite behavior, since the methyl ester 26 showed an anti-biofilm 
performance lower than that of the ethyl ester 28; 
- the majority of cis derivatives (38-44) were found to have a global anti-biofilm performance 
promoting biofilm formation. 
Among the tested molecules, six molecules (2, 3, 10, 11, 23) had the most interesting antibiofilm 
performance by showing antibiofilm activity in a wide range of concentrations with maximum at 
micromolar level and with no effect on planktonic growth. 
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Therefore, in the light of all aforementioned considerations, at physiological conditions (pH = 7.4 used 
for biological assays), inhibition of cell adhesion appeared to be the result of molecules negative 
charge. An overall view of the obtained results highlighted that compounds typically containing a 
carboxylate anion in a conjugated system, showed the best anti-biofilm activity. Derivatives with para 
substituents on the phenyl ring displayed different degrees of E. coli inhibition. Since the strength of a 
carboxylic acid depends mainly on the extent of its ionization, analogues 5 and 9 with strong electron-
withdrawing groups on the phenyl ring (nitro and cyano groups, respectively), reduced the nucleophilic 
character of the oxygen atoms, leading to loss of activity. Similarly, compounds bearing moderate and 
strong electron-realising groups enhance the negative charge and exhibited good values of inhibition.  
Moreover, it was demonstrated that also the position of the anionic charge was crucial: compounds in 
which the conformation of the double bond was varied (trans/cis isomers), as well as saturated 
derivatives, decreased the ability to inhibit biofilm formation probably due the impairment of the 
conjugated aromatic system in delocalizing the negative charge that not allow electrons to move freely.         
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3.6 Final remarks 
 
The ability to inhibit biofilm formation of a series of cinnamic acid related derivatives was evaluated in 
order to identify the structural requirements essential for their activity and to select the best candidates 
for the subsequent grafting to a polymeric materials.  
An exhaustive biological evaluation pointed out that the synthesized compounds are endowed with 
different behaviors depending on their concentrations. In most cases, the tested compounds were found 
to be more active than zosteric acid at lower concentrations. In summary, the carboxylic acid moiety 
conjugated to a double bond in trans configuration is an essential requirement for the inhibition of the 
biofilm growth. Side-chain modifications led to derivatives showing a lower activity by comparison 
with the reference compound suggesting that the side chain has a key-role for the biological activity. 
Moreover, the anti-biofilm activity of the tested compounds in general decrease by the introduction of 
substituents at different position on the phenyl ring: only the substitution at the para position is well 
tolerated and could be considered a good point for the coupling to the polymer. It is also interesting to 
observe the different effect of electron donating and electron withdrawing groups on the phenyl ring, 
indicating that the electron density of the carboxylate may be important for the interaction with the 
target.  
Finally, in order to identify targets that directly interact with cinnamic acid derivatives and salicylic 
acid, affinity purification experiments of proteins from E. coli extracts were performed. Mass 
spectrometry analysis of SDS-PAGE-resolved pull-down proteins reveal that both cinnamic acid and 
salicylic acid in E. coli directly interact with the same protein WrbA, which is involved in the biofilm 
formation process, leading to an altered production of both indole and ROS. Moreover, protein FkpA 
and Tdh were also identified as possible target for salicylic acid, suggesting the presence of complex 
and overlapping regulatory networks controlling quorum sensing, motility and biofilm formation. 
Many interpretations about the effect of interaction of cinnamic acid and salicylic acid with these 
proteins are possible and further experiments are necessary to clarify this question. 
In conclusion, the cinnamic acid scaffold can be considered the starting point for the development of a 
new generation of derivatives characterized by improved activity to study and modulate bacterial 
adhesion. 
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In particular, two terms (8, 47), able to significantly reduced biofilm formation, were selected as the 
best candidates to obtain a novel anti-biofilm material, due to the presence of an amine at the para 
position on the phenyl ring (which allowed the covalent linkage to the polymeric surface), although 
some derivatives (11, 12, 14) had shown a better anti-biofilm activity compared to them.  
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3.7 Experimental 
 
3.7.1 Chemistry 
 
3.7.1.1 Materials and methods 
All the reagents including solvents were purchased from Sigma-Aldrich and were used without any 
further purification. The reactions involving air-sensitive reagents were performed under nitrogen 
atmosphere and anhydrous solvents were used when necessary. The Biotage-Initiator microwave 
synthesizer was used. The course of the reaction was monitored by thin layer chromatography (TLC) 
analysis on aluminium-backed Silica Gel 60 plates (0.2 mm, Merck) and were visualized under a UV 
lamp operating at wavelengths of 254 and 365 nm. Visualization was aided by opportune staining 
reagents. Intermediates and final compounds were purified by flash chromatography using Merck 
Silica Gel 60 (70-230 mesh). The purity of final compounds were determined by HPLC analysis and 
were > 95 %. 
1
H and 
13
C NMR spectra were recorded at room temperature on a Varian 300 MHz 
Oxford instrument. CDCl3, CD3OD, D2O, acetone-d6 and DMSO-d6 were used as deuterated solvents 
for all spectra run. Chemical shifts are expressed in ppm from tetramethylsilane resonance in the 
indicated solvent (TMS: 0.0 ppm) and coupling constants (J-values) are given in Hertz (Hz). 
1
H NMR 
data are reported in the following order: ppm, multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; br, broad), and number of protons. Melting points and NMR data are consistent with 
literature data. The ionization constants and lipophilicity parameters of zosteric acid were determined at 
25°C by potentiometric titration with the GlpKa apparatus (Sirius Analytical Instruments Ltd., Forest, 
Row, East Sussex, UK). 
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3.7.1.2 Experimental procedures 
Synthesis of trans zosteric acid sodium salt 1 under microwave irradiation 
 
 
 
In a microwave vessel, to a solution of trans coumaric acid 2 (50 mg, 0.30 mmol) in dry pyridine (1.5 
mL), sulphur trioxide pyridine complex Py•SO3 (145 mg, 0.91 mmol) was added under an inert 
atmosphere. The resulting mixture was irradiated in a microwave synthesizer at 300 Watts at the 
temperature of 125°C for 25 minutes. After cooling, the solvent was evaporated under reduced 
pressure. Then 1N NaOH was added dropwise to pH=7. The resulting mixture was extracted with 
dichloromethane (3 x 2 mL) and the aqueous phase was evaporate to dryness. The residue was treated 
with methanol (5 mL) and the undissolved material filtered out. The evaporation of solvent provided 
compound 1.  
Yield: 90 %. Old-rose solid. 
1
H NMR (D2O): 6.33 (d, 1H, CH, J=16.2), 7.16 (d, 2H, ArH, J=8.8), 7.22 
(d, 1H, CH, J=16.2), 7.48 (d, 2H, ArH, J=8.8). 
13
C NMR (D2O): 121.7, 121.8, 124.0, 129.1, 129.2, 
133.1, 140.1, 152.0, 175.4.   
 
Physiochemical profiling 
A weighted sample of 1 (10-25 mg) was supplied manually whereas the diluent and all the other 
reagents were added automatically. Zosteric acid was solubilized in water and acidified with 0.1 M HCl 
to pH =1.8. The solutions were then titrated with standardized 0.1 M KOH up to a pH of 12.2. Bjerrum 
difference plots were deduced from each titration and used to calculate precise pK value. To obtain 
lipophilicity parameters, separate titrations of the compounds were carried out using various volumes 
of n-octanol. In the presence of n-octanol, the pK value shifts as a consequence of the partitioning of 
the substance into the organic phase, allowing a new poK constant to be determined. These shifts in the 
pK values were used to determine log P. All measurements were performed in triplicate. 
pKa (20 °C): 4.261 ± 0.18 
log P (20 °C): 0.250 ± 0.081 
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Synthesis of cis zosteric acid sodium salt 38 under microwave irradiation 
  
 
 
In a microwave vessel, to a solution of cis coumaric acid 40 (100 mg, 0.61 mmol) in dry acetonitrile 
(1.5 mL), sulphur trioxide pyridine complex Py•SO3 (194 mg, 1.22 mmol) was added under an inert 
atmosphere. The resulting mixture was irradiated in a microwave synthesizer at 300 Watts at the 
temperature of 120°C for 25 minutes. After cooling, the solvent was evaporated under reduced 
pressure. Then 1N NaOH was added dropwise to pH=7. The resulting mixture was extracted with 
dichloromethane (3 x 2 mL) and the aqueous phase was evaporate to dryness. The residue was treated 
with methanol (5 mL) and the undissolved material filtered out. The evaporation of solvent provided 
compound 38. 
Yield: 50 %. Brown solid. 
1
H NMR (CD3OD): 6.44 (d, 1H, CH, J=12.4), 7.30 (d, 2H, ArH, J=8.8), 
7.44 (d, 1H, CH, J=12.4), 7.52 (d, 2H, ArH, J=8.8). 
13
C NMR (DMSO-d6): 121.1, 125.3, 128.7, 131.2, 
139.0, 154.8, 170.9. HPLC: Ascentis RP (15 cm x 4.6 mm, 2.7 μm) H2O-CH3CN (0.1 % trifluoroacetic 
acid) 70-30, 1 mL min
-1, 254 λ, tR = 1.603 (starting material 40: tR = 2.407). LCMS (ESI+) m/z = 289 
[M+H]
+
. 
 
General procedure A for the synthesis of substituted cinnamic acids (9-11, 14, 17, 46) 
 
 
To a solution of the suitable substituted benzaldehyde (1 mmol) in pyridine (1 mL), malonic acid (2.20 
mmol) and piperidine (0.2 mmol) were added. The reaction mixture was stirred under reflux for a 
period of time different from each substrates (80-180 min) and then cooled to room temperature. The 
solution was poured into 2 N ice-cold aqueous HCl (2 mL) and the precipitate was collected by 
filtration, washed with water and died under vacuum. 
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4-cyanocinnamic acid 9. Yield: 60 %. White solid. TLC: DCM/MeOH (9:1) Rf = 0.37. M.p.: 245-249 
°C. 
1
H NMR (DMSO-d6): 6.70 (d, 1H, CH, J=16.2), 7.62 (d, 1H, CH, J=16.2), 7.83-7.90 (m, 4H, 
ArH). 
13
C NMR (DMSO-d6): 112.8, 119.3, 123.5, 129.5, 133.4, 139.5, 142.6, 167.8.  
4-trifluoromethylcinnamic acid 10. Yield: 66 %. White solid. TLC: DCM/MeOH (9:1) Rf  = 0.38. 
M.p.: 202-205 °C. 
1
H NMR (DMSO-d6): 6.67 (d, 1H, CH, J=15.9), 7.65 (d, 1H, CH, J=15.9), 7.75 (d, 
2H, ArH, J=8.4), 7.91 (d, 2H, ArH, J=8.4). 
19
F NMR (DMSO-d6): -62 (s, 3F). 
13
C NMR (DMSO-d6): 
122.8, 126.3, 129.5, 130.7, 139.0, 142.7, 167.8. 
4-carboxycinnamic acid 11. Yield: 75 %. White solid. TLC: DCM/MeOH (9:1) Rf  = 0.12. M.p.: 250-
260 °C. 
1
H NMR (DMSO-d6): 6.62 (d, 1H, CH, J=15.9), 7.62 (d, 1H, CH, J=15.9), 7.78 (d, 2H, ArH, 
J=8.1), 7.93 (d, 2H, ArH, J=8.1). 
13
C NMR (DMSO-d6): 122.5, 128.9, 130.4, 132.5, 139.0, 143.3, 
167.5, 168.0. 
4-methylcinnamic acid 14. Yield: 70 %. White solid. TLC: DCM/MeOH (9:1) Rf = 0.52. M.p.: 196-
198 °C. 
1
H NMR (DMSO-d6): 2.29 (s, 3H, CH3), 6.45 (d, 1H, CH, J=15.9), 7.19 (d, 2H, ArH, J=7.8), 
7.53 (d, 2H, ArH, J=7.8), 7.54 (d, 1H, CH, J=15.9), 12.33 (br s, 1H, COOH). 
13
C NMR (DMSO-d6): 
21.7, 118.8, 128.8, 130.2, 132.2, 140.8, 144.6, 168.4.  
2-chlorocinnamic acid 17. Yield: 50 %. White solid. TLC: DCM/MeOH (9:1) Rf = 0.53. M.p.: 207-
209 °C. 
1
H NMR (CDCl3): 6.46 (d, 1H, CH, J=15.9), 7.27-7.38 (m, 2H, ArH), 7.44 (dd, 1H, ArH, 
J=1.5, J=6.9), 7.65 (dd, 1H, ArH, J=1.5, J=6.9), 8.22 (d, 1H, CH, J=15.9). 
13
C NMR (DMSO): 123.0, 
128.5, 129.0, 130.6, 132.4, 132.5, 134.2, 139.4, 167.8.  
3-hydroxy-4-nitrocinnamic acid 46. Yield: 72 %. Yellow solid. TLC: DCM/MeOH (9:1) Rf = 0.45. 
M.p.: 246-247 °C. 
1
H NMR (CD3OD): 6.62 (d, 1H, CH, J=15.9), 7.28 (d, 1H, ArH, J=8.7), 7.36 (s, 
1H, ArH), 7.63 (d, 1H, CH, J=15.9), 8.10 (d, 1H, ArH, J=8.7). 
13
C NMR (DMSO-d6): 119.2, 119.5, 
123.8, 137.6, 141.5, 142.3, 153.0, 167.7. 
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Synthesis of 3-hydroxy-4-aminocinnamic acid 24 
 
 
To 3-hydroxy-4-nitrocinnamic acid 46 (500 mg, 2.39 mmol) in 37 % HCl  was added SnCl2 (1.360 g, 
7.17 mmol) and then the mixture was stirred at 80°C for 4 hours. The precipitate was filtered off, 
washed with cold EtO2 (3 x 1 mL) and dried. Therefore, the aqueous layer was basified with 30 % 
NaOH (up to pH = 4.5) and then extracted with ethyl acetate (6 x 3 mL). The organic layer was dried 
over anhydrous Na2SO4, filtered and concentrated under reduced pressure to give compound 24. 
Yield: 83 %. Brown solid. TLC: DCM/MeOH (9:1) Rf = 0.21. 
1
H NMR (CD3OD): 6.13 (d, 1H, CH, 
J=15.9), 6.67 (d, 1H, ArH, J=7.8), 6.88 (d, 1H, ArH, J=7.8), 6.93 (s, 1H, ArH), 7.50 (d, 1H, CH, 
J=15.9). 
13
C NMR (DMSO-d6): 112.9, 113.4, 114.1, 122.8, 123.0, 140.9, 144.4, 145.9, 168.9.  
 
Synthesis of cis ethyl cinnamate 44 
 
 
 
To a stirred solution of the commercially available ethyl phenylpropiolate (300 mg, 1.72 mmol) in 
methanol (4 mL) were added Lindlar catalyst (5 % Pd on CaCO3 poisoned with lead) and pyridine 
(0.15 mL, 1.72 mmol). The reaction mixture was hydrogenated at room temperature for 3 hours. At the 
end of the reaction, the catalyst was filtered off through a Celite pad and the solvent was concentrated 
under reduced pressure. The crude was purified by column chromatography (cyclohexane/ethyl acetate 
95:5) to afford compound 44. 
Yield: 51 %. Colourless oil. TLC: cyclohexane/ethyl acetate (9.5:0.5) Rf = 0.39. 
1
H NMR (CDCl3): 
1.25 (t, 3H, CH3, J=7.2), 4.19 (q, 2H, CH2, J=7.2, J=14.1), 5.97 (d, 1H, CH, J=12.6), 6.96 (d, 1H, CH, 
J=12.6), 7.34-7.36 (m, 3H, ArH), 7.58-7.59 (m, 2H, ArH). 
13
C NMR (CDCl3): 14.4, 60.5, 120.1, 128.2, 
129.2, 130.0, 135.1, 143.3, 166.5. 
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Synthesis of cis cinnamic acid 39 
 
 
To a stirred solution of cis ethyl cinnamate 44 (100 mg, 0.57 mmol) in ethanol (1 mL) and 
tetrahydrofuran (1 mL), 1 M aqueous solution of NaOH (1 mL) was added. The solution was stirred at 
room temperature for 12 hours. The reaction was monitored by TLC until completion, then the solvent 
was evaporated and water (2 mL) was added. The aqueous layer was acidified to pH = 1 with 2 N HCl 
and then extracted with ethyl acetate (3 x 1 mL). The combined organic layers were washed with brine, 
dried over anhydrous sodium sulfate and the solvent was evaporated under reduced pressure. The crude 
was purified by flash chromatography eluiting dichloromethane/methanol (9.5:0.5) to afford compound 
39. 
Yield: 93 %. Colourless oil. TLC: DCM/MeOH (9.5:0.5) Rf = 0.18. 
1
H NMR (CDCl3): 5.98 (d, 1H, 
CH, J=12.6), 7.08 (d, 1H, CH, J=12.6), 7.36-7.39 (m, 3H, ArH), 7.60-7.64 (m, 2H, ArH). 
13
C NMR 
(CDCl3): 118.9, 128.3, 129.6, 130.2, 134.6, 145.9, 170.1. 
 
General procedure B for the esterification of cinnamic acid derivatives (25, 27, 43) 
 
 
The suitable cinnamic acid (1 mmol) was dissolved in methanol (1 mL) and 96% H2SO4 (0.13 mL) was 
added dropwise. The obtained solution was refluxed for 1 hour. Then, the solvent was removed, the 
residue was diluted with ethyl acetate (1 mL), washed with water (1 x 2 mL) and a saturated solution of 
sodium hydrogencarbonate (1 x 2 mL). The organic layer was dried over anhydrous Na2SO4 and 
concentrated in vacuo.  
trans methyl coumarate 25. Quantitative yield. White solid. TLC: DCM/MeOH (9.5:0.5) Rf = 0.62. 
M.p.: 139-140 °C. 
1
H NMR (CDCl3): 3.81 (s, 3H, CH3), 6.30 (d, 1H, CH, J=16.2), 6.87 (d, 2H, ArH, 
J=8.7), 7.41 (d, 2H, ArH, J=8.7), 7.65 (d, 1H, CH, J=16.2). 
13
C NMR (CDCl3): 55.1, 114.9, 116.2, 
127.0, 130.3, 145.4, 158.5, 168.8. 
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trans methyl 4-methoxycinnamate 27. Quantitative yield. White solid. TLC: cyclohexane/ethyl acetate 
(7:3) Rf = 0.55. M.p.: 88-90 °C. 
1
H NMR (CDCl3): 3.80 (s, 3H, CH3), 3.84 (s, 3H, CH3), 6.31 (d, 1H, 
CH, J=16.2), 6.90 (d, 2H, ArH, J=8.7), 7.47 (d, 2H, ArH, J=8.7), 7.65 (d, 1H, CH, J=16.2). 
13
C NMR 
(CDCl3): 51.5, 55.8, 114.0, 115.2, 127.1, 130.0, 145.3, 161.7, 169.1.  
cis methyl coumarate 43. Quantitative yield. White solid. TLC: DCM/ethyl acetate (8:2) Rf = 0.58. 
M.p.: 86-88 °C. 
1
H NMR (CDCl3): 3.80 (s, 3H, CH3), 5.32 (br s, 1H, OH), 6.30 (d, 1H, CH, J=16.2), 
6.85 (d, 2H, ArH, J=8.5), 7.43 (d, 2H, ArH, J=8.5), 7.64 (d, 1H, CH, J=16.2). 
13
C NMR (DMSO-d6): 
51.9, 114.6, 116.4, 125.7, 131.0, 145.4, 160.5, 167.7. 
 
Synthesis of cis methyl 4-methoxycinnamate 42 
 
 
To a solution of the required methyl coumarate 43 (500 mg, 2.80 mmol) in dry N,N-
dimethylformamide (1.5 mL), anhydrous potassium carbonate (580 mg, 4.20 mmol) and iodomethane 
(0.26 mL, 4.20 mmol) were added under an inert athmosphere. The reaction mixture was stirred at 
reflux for 1.5 hours. After the evaporation of N,N-dimethylformamide, the resultant residue was 
extracted with ethyl acetate (3 x 2 mL) and washed with brine (1 x 2 mL). The collected organic phase 
was dried over anhydrous sodium sulfate, filtered and the solvent was evaporated under reduced 
pressure. The crude was purified by flash chromatography (cyclohexane/ethyl acetate 7:3) to provide 
compound 42. 
Yield: 94 %. White solid. TLC: cyclohexane/ethyl acetate (7:3) Rf = 0.54. 
1
H NMR (CDCl3): 3.79 (s, 
3H, CH3), 3.83 (s, 3H, CH3), 6.31 (d, 1H, CH, J=16.2), 6.90 (d, 2H, ArH, J=8.7), 7.47 (d, 2H, ArH, 
J=8.7), 7.65 (d, 1H, CH, J=16.2). 
13
C NMR (CDCl3): 51.5, 55.8, 114.0, 115.2, 127.1, 130.0, 145.3, 
161.7, 169.1. 
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Synthesis of cis 4-methoxycinnamic acid 41 
 
 
To a stirred solution of cis methyl 4-methoxy cinnamate 42 (500 mg, 2.60 mmol) in ethanol (1mL), 1 
M aqueous solution of NaOH (1 mL) was added. The solution was stirred at reflux for 2 hours. The 
reaction was monitored by TLC until completion, then the solvent was evaporated and water (2 mL) 
was added. The aqueous layer was acidified to pH = 1 with 2 N HCl and then extracted with ethyl 
acetate (3 x 1 mL). The combined organic layers were washed with brine, dried over anhydrous sodium 
sulfate and the solvent was evaporated under reduced pressure. The crude was purified by flash 
chromatography eluting with dichloromethane/methanol (9:1) to afford product 41.  
Quantitative yield. White solid. TLC: DCM/MeOH (9:1) Rf = 0.46. M.p.: 64-66 °C. 
1
H NMR 
(CDCl3): 3.85 (s, 3H, CH3), 6.33 (d, 1H, CH, J=16.2), 6.93 (d, 2H, ArH, J=8.5), 7.51 (d, 2H, ArH, 
J=8.5), 7.75 (d, 1H, CH, J=16.2). 
13
C NMR (CDCl3): 115.2, 126.4, 130.5, 147.1, 162.1, 172.9. 
 
Synthesis of 4-acetamidosalicylic acid 48 
 
 
A suspension of 4-aminosalicylic acid 47 (1 g, 6.53 mmol) in ethanol (10 mL) and acetic anhydride 
(0.62 mL, 6.58 mmol) was stirred at 40 °C for 30 min and then allowed to cool at room temperature. 
The mixture was then concentrated in vacuo and extracted with ethyl acetate (3 x 2 mL). The organic 
phase was dried over Na2SO4, filtered and then concentrated under reduced pressure. The crude product 
was purified by flash column chromatography using dichloromethane/methanol (9:1) as eluent to afford 
the final product 48. 
Yield: 48 %. Brown solid. TLC: DCM/MeOH (9:1) Rf = 0.52. M.p.: 230-231 °C (decomp). 
1
H NMR 
(DMSO-d6): 6.40 (dd, 1H, ArH, J=1.2, J=8.1), 6.87 (d, 1H, ArH, J=8.1), 7.02 (t, 1H, ArH, J=8.1), 7.16 
(s, 1H, OH), 9.30 (s, 1H, NH), 9.76 (s, 1H, COOH). 
13
C NMR (CD3OD): 22.7, 107.2, 111.0, 129.3, 
139.8, 157.7, 170.4. 
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3.7.2 Biology 
 
3.7.2.1 Escherichia coli strain and growth condition  
The well characterized E. coli ATCC 25404 was used as a model system for bacterial biofilms. The 
strain was stored at –80 °C in suspensions containing 20 % glycerol and 2 % peptone, and was 
routinely grown in Luria-Bertani broth (LB, Sigma-Aldrich) at 30 °C for 16 h.  
 
3.7.2.2 Planktonic growth in the presence of zosteric acid related compounds 
Planktonic growth of E. coli in LB medium supplemented with 0 (negative control), 0.183, 1.83, 18.3, 
183 and 1830 µM of the synthesized molecules and 3 % of DMSO were carried out in 384-well 
microtiter plates. Growth curves at 30°C were generated using the PowerWave XS2 microplate reader 
(Biotek). Growth was followed by measuring the optical density (OD) at 600 nm (OD600) every 10 
min for over 24 h in wells inoculated with 3 µl (3 % v/v) of an overnight culture (10
7
 cells mL
-1
). OD-
based growth kinetics were constructed by plotting the OD of suspensions minus the OD of the non-
inoculated medium against incubation time. The polynomial Gompertz model was used to ﬁt the 
growth curves to calculate the maximum speciﬁc growth rate µm, using GraphPad Prism software 
(version 5.0, San Diego, CA, USA). Six biological replicates of each treatment were performed. 
Obtained data were normalized to the negative control and reported as the mean of these. Percentage 
reduction in comparison with the control was also calculated. 
 
3.7.2.3 Cellular growth with the zosteric acid related compounds as the sole carbon and energy 
source 
The ability of bacteria to grow with each compound as the sole carbon and energy source was tested 
using a mineral medium (KH2PO4 30 g/L, Na2HPO4 70 g/L, NH4Cl 10 g/L, pH = 7) supplemented with 
1830 µM of each synthesized molecule and 3 % of DMSO. Bacteria were added 10
7
 cells/mL and 
grown at 30 °C for 72 h. The positive control was the mineral medium supplemented with glucose at 
both 1830 µM and 10,000 µM concentration. Microbial growth was followed by measuring the optical 
density (OD) at 600 nm (OD600). All the experiments were repeated three times. 
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3.7.2.4 Microplate-based biofilm assay in the presence of zosteric acid related compounds 
Biofilm was assessed quantitatively using fluorochrome labeled cells in hydrophobic 96-well 
blacksided plates. Briefly, 200 μL of phosphate buffered saline (PBS, 0.01 M phosphate buffer, 0.0027 
M potassium chloride pH = 7.4, Sigma-Aldrich) containing 107 cells supplemented with 0 (negative 
control), 0.183, 1.83, 18.3, 183 and 1830 µM of each synthesized molecule and 3 % of DMSO was 
placed in microtiter plate wells. Cells were incubated 18 hours at 30 °C. The microtiter plate wells were 
washed two times with 200 μL PBS and adhered cells were stained using 10 µg/mL 4,6-diamidino-2-
phenylindole (Sigma-Aldrich) in PBS for 20 min in the dark at room temperature. Fluorescence 
intensity was measured using the fluorometer VICTOR™ X Multilabel Plate Readers (Perkin Elmer) at 
excitation wavelength of 335 nm and emission wavelength of 433 nm. A standard curve of 
fluorescence intensity versus cell number was determined and used to quantify the anti-biofilm 
performance of the zosteric acid related compounds. Four measurements were performed for each 
condition. Obtained data were normalized to the negative control and reported as the mean of these 
data. Percentage reduction in comparison to the control was also calculated. 
 
3.7.2.5 Statistical analysis 
Analysis of variance (ANOVA) test via a software run in MATLAB (Version 7.0, The MathWorksInc, 
Natick, USA) was applied to statistically evaluate any significant differences among the samples. 
Tukey‟s honestly significant different test (HSD) was used for pairwise comparison to determine the 
significance of the data. Differences were considered significant for p ˂ 0.05. 
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4. SECTION B: FUNCTIONALIZATION OF A SURFACE  
 
4.1 Background 
 
Infection of polymers used for medical devices is one of the major clinical complications causing a 
high rate of mortality and morbidity thereby signiﬁcantly increasing healthcare costs.[95] Bacterial 
adherence to implant surfaces occurs in two phases. Firstly, bacteria compete with host cells for 
binding to the extracellular matrix or plasma proteins on the device surfaces; this is described as “race 
for the surface”.[96] Then, adherent bacteria proliferate and cluster in multilayers of 
exopolysaccharides within biofilms, which have a low metabolism without toxin production. The 
introduction of an implant into the body increases susceptibility to biomaterial-centered infections, due 
to the damage caused to epithelial and mucosal barriers upon implantation. Further the presence of the 
implant, and the resulting extracellular matrix protein adsorbed, favors the bacteria colonization leading 
to a surface that become persistent and refractory to antibiotics. The scientific world view is that the 
etiology of device-related infections is associated with the biofilm mode of growth that offers 
protection against hydrodynamic forces, evasion to the host immune-response and enhanced resistant to 
medical treatments and for these reasons, regularly, traditional therapies fail.[97] Successful treatment 
requires multistep procedures, e.g. removal of the infected surface, intravenous and oral therapy with 
antibiotics for weeks or months and re-implantation of a new device. Therefore, a new approach to 
defeat biofilm-related infections of indwelling device becomes imperative, and a serious change in our 
prospective is necessary. 
To date, approaches that were employed to provide medical polymers with anti-infective properties 
mainly consist of: 
(a) mixing antibacterial reagents in bulk polymers;[98]  
(b) copolymerization of antibacterial reagents with monomer for polymers;[99] 
(c) surface modification to control the physicochemical interactions between the bacteria and polymeric 
surface.[100] 
Many efforts have focused on catheter surface modification in order to create a drug-based material for 
reducing infections incidence.[101] The coating of medical devices with antimicrobial substances or 
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entrapping them within the polymeric material are the most used approaches to obtain devices with 
different antimicrobial spectra and durations of the antimicrobial effect.[102] Up to now, they have 
primarily been based on agents of known bacteriostatic/bactericidal activity already in use as 
disinfectants or antibiotics. Indeed, central venous and urinary catheters coated or impregnated with 
both antibiotic and antiseptic combinations have been approved and commercialized by Food and Drug 
Administration.[103] Even though the idea to combine materials in use with approved antimicrobial 
substances appears simple and straightforward, low drug release from bioactive materials contributes to 
the serious phenomenon of multidrug resistance spreading.[104] Due to the constant release of active 
compounds from the implanted device, that cannot be monitored or quantified, this approach became 
less attractive for a medical application.  
Instead of fighting biofilm with antimicrobial/device combination products, the efforts should be 
directed towards developing an innovative anti-infective material, targeting microbial virulence traits 
(like binding and cell-to-cell communication) and in which active substance would not be leached from 
the surface avoiding the problem of the compound kinetics release and providing long-term protection 
against bacterial colonization. 
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4.2 Project Description (B) 
 
In the light of the aforementioned observations, this section is focused on the functionalization of 
polyethylene, one of most common polymers employed in biomedical applications, with p-
aminocinnamic acid 8 and p-aminosalicylic acid (PAS) 47 (used as reference), selected from the 
previously biological investigation (for detail see „Section A‟ of this thesis) as the best candidates to 
form a covalent linkage with the polymeric support. These compounds not only showed a good 
antibiofilm activity against E. coli, the bacterial model system that has been taken into account, but also 
have an amino groups at the para position that allowed the subsequent grafting with the activated 
polymeric material.  
In literature, different approaches to combine antimicrobial agents to polymers were described and can 
be generally attributed to two main strategies: the passive protection of surface or physical coating, 
obtained by spreading a solution of the anti-biofilm compounds on the material, and the active coating 
or chemical coating, achieved by a covalent linkage between the supporting material and the bioactive 
substances. While the passive approach is characterized by the lack of long term stability and non-
uniform distribution of compounds within the material, a covalent attachment of active molecules 
offers a better stability and uniformity, avoiding the possible limitations due to the release of active 
agents (e.g. toxicity due to the high dose released or the production of endotoxins or other byproducts 
by bacteria which may elicit an inflammatory or another adverse effects).  
Since this project is a part of a multidisciplinary research that involves different work units, at first the 
choice of the material and the polymers used as linkers was made in analogy with the work carried out 
by some colleagues about the surfaces functionalization with enzymes having antibacterial activity.  
The initial step of my work was the passive coating of polycarbonate (PC) membranes with polymers 
such as branched polyethylenimine (PEI) and glutaraldehyde (GA), used as linkers between the surface 
of the materials, and selected anti-biofilm derivatives, in order to set up the coating procedure and to 
obtain preliminary results about the interaction between molecules and a polymeric surface. The PC 
membranes were coated with an aqueous solution of PEI and subsequently with different 
concentrations of aqueous solutions of glutaraldehyde. To detect the presence of the coating on the 
surfaces, Reflection Absorption Infrared Spectroscopy (RAIR) analyses were carried out. The colony-
biofilm culturing system was used to explore the anti-biofilm performance of the modified surfaces. In 
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particular, colony biofilms of E. coli were grown on semipermeable untreated and treated membranes 
resting on agar plates.  
Afterwards, in the light of the previously considerations about the differences between passive and 
active coating, the next step was the covalent grafting of the selected compounds on a solid support. 
Various synthetic routes have been developed for the covalent binding of species onto surfaces (e.g. 
grafting to and grafting from techniques).[105] Polymer brushes, random or block copolymers prepared 
with these methods result in a long term stability with a broad range of chemical functionalities.[106]  
To obtain an efficient immobilization, some requirements need to be satisfy such as:  
- the linkage should be a covalent bond in order to avoid displacement by biological media and to 
be stable enough for all the duration of the intended application;  
- the binding site of the active molecules should be situated far from the biologically active area;  
- the active sites of compounds should face the biological medium;  
- the active molecules should not change configuration upon binding; 
- the grafting reaction should only involve specific groups on the bioactive molecules.[107] 
In my work, the Low Density Polyethylene (LDPE) coupons were grafted with hydroxyethyl 
methacrylate (LDPE-HEMA-OH) by means of O2 plasma pre-treatment and then the hydroxyl groups 
were converted into the corresponding carboxylic acids (LDPE-HEMA-COOH) which were used for 
covalent immobilization. Effect of different parameters, such as the plasma treatment time, the 
monomer concentration and the time of graft-polymerization process were investigated. 
Finally, the anti-biofilm performances of the modified materials were tested by using an in vitro system 
aimed at replicating hydrodynamic flow conditions normally found in vivo. The Center for Disease 
Control (CDC) biofilm reactor was able to reproduce Escherichia coli biofilm under continuous liquid 
shear to simulate conditions to which medical devices were subjected to during their use.   
Unfortunately, the final characterization of the new material was not so easy as expected due to the 
physical properties of polyethylene coupons (e.g. thickness, density). All the techniques used to 
provide information about the characteristics of the samples in each stages of the functionalization 
process are here reported but they are not exhaustive. Further analysis to obtain the whole 
characterization as well as to analyse the stability of the new material will be necessary. 
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4.3 Passive protection of surfaces 
 
The passive protection of the surface is obtained by spreading the polymer and then the solution of the 
anti-biofilm compounds on the material (Figure 32). Poly(ethylene glycol) (PEG) systems have been 
extensively studied, and PEG functionalized surfaces have been demonstrated to drastically reduce 
bioadhesion (protein adsorption, bacterial and cell adhesion) due to the formation of an interfacial 
layer, which prevents direct contact between the surface and the proteins.[108]  
One limitation of PEG based systems is the lack of long 
term stability often observed, which reduces their 
usefulness as surface coatings. Indeed, PEG coatings are 
subjected to oxidative degradation and chain cleavage, 
thus resulting in loss of surface functionality in terms of 
hydrophilicity and resistance to non-specific adsorption. 
However, a detrimental aspect of biopassive surfaces is 
their tendency to the production of defect-free coatings 
to completely prevent bacterial adhesion across the 
whole surface, which is not easy to achieve. Thus, the initial adhesion of the bacteria is reduced but 
then the onset of defects and deterioration of the coating in physiological media lead to the potential 
colonization of the implant. 
This passive approach is also exploited in ship hulls covering in order to protect themselves from 
damages related to marine biofouling and to reduce the maintenance costs. Since 2003, antifouling 
paints were loaded with tributyltin (TBT) as biocide. Although TBT anti-fouling paints are the most 
effective, TBT-derived leachates are highly toxic and damage the marine environment. Nowadays, 
paints include less toxic biocides such as copper-based compounds and metal-free compounds that are 
able to prevent or slow down the growth of algae and marine organisms on the hull. Their antifouling 
activity is exerted by a slow leaching of the biocide included in soluble or insoluble matrices into the 
seawater surrounding the vessel.[109] Enzymes, in particular hydrolytic enzymes such as glycosidases 
and proteases, have been envisaged as alternative additives in antifouling paints. The rationale is that 
immobilization of enzyme environmentally friendly at the surface of polymeric films led to materials 
displaying bacterial growth inhibiting properties.[110]  
Figure 32. Passive protection of surfaces to prevent contact, 
and thereby protein adsorption and bacterial colonisation, of 
the surface.  
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4.3.1 Materials and methods 
Polycarbonate filter circles (25 mm Dia, Black Nuclepore Polycarbonate, 0.2 µm Pore Size) were 
purchased from GE Healtcare. Branched poly(ethylenimine) (average Mw ~25,000 by LS, average Mn 
~10,000 by GPC), glutaraldehyde solution (Grade I, 50 % in H2O, specially purified for use as an 
electron microscopy fixative), cinnamic acid, coumaric acid, p-aminosalicylic acid and p-
aminocinnamic acid were purchased from Sigma Aldrich and used without any further purification. 
Zosteric acid was synthesized and characterized as reported in „Paragraph 3.7.1‟.   
 
4.3.2 Experimental procedure  
The passive coating process for polycarbonate membranes is shown in Figure 33. Polycarbonate was 
firstly immersed in a 3 % w/v solution of 
branched polyethylenimine for 24 hours obtaining 
a surface functionalized by amino groups 
resulting from the physisorption of PEI on the 
surface. The membranes were dried in air 
overnight. Then, aqueous solutions of 
glutaraldehyde with different concentrations 
(0.005 M, 0.05 M) were spread on the PEI-coated 
membranes which are subsequently dried in air 
overnight. It was proved that high concentration of glutaraldehyde (more than 10 % w/v) caused 
membrane rupture. Finally, the treated samples were exposed to a 1.83 mM aqueous solution of the 
selected anti-biofilm compounds (zosteric acid, cinnamic acid, coumaric acid, p-aminosalicylic acid 
and p-aminocinnamic acid).  
Since the passive coating was only a preliminary technique to study the interactions of these molecules 
with a surface, I have used the same concentration that was found to be the best for zosteric acid 
inhibitory activity. 
  
PEI 
GA Cmp 
Figure 33. Passive protection of polycarbonate membranes 
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4.3.3 Characterization  
4.3.3.1 Reflection Absorption Infrared Spectroscopy (RAIR) 
Io order to ensure the presence of the passive coating on the membranes, Reflection Absorption 
Infrared Spectroscopy (RAIR) analyses were carried out. 
Reflection Absorption Infrared Spectroscopy is a sensitive spectroscopic technique that can directly 
detect the presence of molecules at solid/air interface. This technique analyzed the infrared radiations 
reflected by sample surfaces. Nevertheless, the application 
of IRRAS techniques to acquire structural information 
from monolayers at the air-water interface presents three 
main problems.[111] First, IR transition moments are 
relatively weak. Infrared extinction coefficients are 
typically 20- to 1000-fold less intense than their electronic 
counterparts. Second, the IR reflectivity of water is poor. 
Finally, the intense bands of both liquid water and water 
vapor tend to interfere in some spectral regions of interest. 
Unfortunately for these reasons, the results obtained using this technique are not comprehensive, but 
could be considered the starting point to find a way to study the functionalized material.        
 
Materials and methods  
RAIR technique was used to generate spectra of monolayers on a polycarbonate membrane. FT-IR 
spectra were collected using a Perkin Elmer (MA, USA) FTIR Spectrometer “Spectrum One” in the 
4000 and 450 cm−
1
 spectral region fitted with a VeeMAX II (Pike technologies) variable angle 
attachment. Samples, were analyzed by reflectance technique. Prior to data acquisition, a clean 
polycarbonate membrane was used as background.  
 
Results and discussion 
In the graphs below the spectra of the polycarbonate membranes coated with PEI (Figure 35 A) and 
with PEI and different concentrations of glutaraldehyde are shown (Figure 35 B). 
Source Detector 
Sample 
Figure 34. Proprietary beam path within the 
VeeMax II Specular Reflectance accessory. 
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Figure 35. A) Polycarbonate membrane coated with 3 % PEI: PC (black), 3 % PEI (blue), PC + 3 % PEI (red); B) Polycarbonate membrane coated with 3 % PEI and different 
concentrations of glutaraldehyde: 10 % GA (green), 3 % PEI + 0.0 5% GA (blue),  3 % PEI + 1 % GA (red), 3 % PEI + 10 % GA (black). 
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As for the original membrane, despite the presence of a carbonyl group at 1774 cm
-1
, the strongest 
infrared absorptions in polycarbonate are due to the C-O single bond stretches. Intense signals appear at 
1165, 1194 and 1228 cm
-1
. Additional C-O related peaks are found around 1000 cm
-1
, with the 
strongest of these at 1016   cm
-1
. Among the aromatic ring breathing modes, only the 1506 cm
-1
 peak is 
significant. While the methyl stretch at 2970 cm
-1
 is weak, it is well appreciable due to the absence of 
other peaks in this region of the spectra. The data obtained are consistent with those reported in 
literature.[112] To ensure the presence of PEI and detect the interactions between PEI and 
polycarbonate, IR spectra were also collected on PC-PEI surfaces. The major changes have been 
observed in the spectrum of PC-PEI surface by comparing the spectral differences between 
polycarbonate and polyethyleneimine.  As shown in Figure 35 A, the representative peaks between 
3000~2800 cm
−1
 corresponding to ν(NH) and ν(CH) stretching vibrations can be clearly observed in 
the IR of PC-PEI samples, which were consistent with those of pure PEI. The NH bending vibration 
was also discernible at 1570 cm
−1
. Moreover, the band at 1774 cm
−1
, which can be assigned to carbonyl 
groups of polycarbonate, was clearly observed confirming no chemical interactions between the 
supporting material and the polymer. 
As for the coated membranes with PEI and different concentration of the glutaraldehyde, the obtained 
IR spectra are shown in Figure 35 B for comparison. Unfortunately, it was found that concentrations of 
glutaraldehyde lower than 10 % w/v were not detected by the instrument. On the PC-PEI samples with 
higher loading of glutaraldehyde (≥ 10 %), a weaken peak at 1670 cm-1, which can be attributed to the 
C-O stretching vibration, suggested the presence of the cross-linking agent.   
The IR spectra of membranes passively coated with the selected molecules were not recorded since the 
concentration of molecules was lower than the detection limit of the instrument.    
 
4.3.4 Biological evaluation: the colony-biofilm assay 
The colony-biofilm culturing system was used to explore the anti-biofilm performance of the coated 
membranes. In particular, it was evaluated if these 
coated membranes were able to hinder the E. coli 
growth by themselves. This static biofilm system 
was particularly useful for the examination of the 
early stages of biofilm formation, including initial Figure 36. Side view of a biofilm-colony assay. 
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adherence to the surface and microcolony formation and to monitor cell death in biofilms treated with 
antimicrobial agents.  
This assay was performed by growing a colony bioﬁlm on a semipermeable membrane that sits on an 
agar plate (Figure 36). A new supply of nutrients can be given to bacteria just by relocating the 
membrane-grown cells to a fresh agar plate. Therefore it can easily change the carbon source or type of 
drug treatment avoiding the need to wash the cells. The bioﬁlm formed is derived from clonal growth 
of the original population of bacteria deposited on the ﬁlter, whereas in liquid media, motile bacteria 
may be able to “invade” an aggregation of cells. Likewise, in this technique bacteria have limited 
ability to detach and migrate or drift away from the bioﬁlm formed. The stable and spatially restricted 
nature of this system makes the colony bioﬁlm especially useful for observing the effects of 
antimicrobial agents, as changes in cell number can be more easily attributed to inhibition of biofilm 
formation rather than detachment. It is important to ensure that each membrane receives an equal 
amount of cells and that there is only a single point of inoculation in the centre of the membrane. 
 
Materials and methods 
E. coli ATCC25404 was used as a model system for bacterial biofilms. The strain was stored at -80 °C 
in suspensions containing 20 % glycerol and 2 % peptone, and was routinely grown in Luria-Bertani 
broth (LB, Sigma-Aldrich) at 30 °C.  
Colony bioﬁlms of E.coli strains were prepared following the method reported by Anderl et al.[113] 
Brieﬂy, 20 µl of cell suspension containing 105 cells were used to inoculate functionalized and non-
functionalized membranes (negative control) resting on Triptyc Soy Agar (TSA, Sigma Aldrich) 
culture medium. The plates were inverted and incubated at 30 °C for 24 hours. After 24 hours biofilm 
grown on functionalized membranes were compared with biofilm grown on non-functionalized 
membrane. Membranes with a biofilm growth comparable with the negative control were coded +++, 
membrane with a limited reduction in biofilm growth were coded ++, membrane with a considerable 
reduction in biofilm growth were coded + and membrane with no biofilm growth were coded -.  
In order to make more clear the discussion, pictures showing the evaluation of biofilm colony growth  
on a membrane are here reported: 
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Results and Discussion 
The obtained results are presented in Table 4. 
 
POLICARBONATE MEMBRANES 
SAMPLES GROWTH 
UNTREATED MEMBRANE + + +  
    
PEI 3% + + + 
GLUTARALDEHYDE 0.005 M + + +  
GLUTARALDEHYDE 0.05 M + + +  
PEI 3% + GLUTARALDEHYDE 0.005 M + + +  
PEI 3% + GLUTARALDEHYDE 0.05 M + + +  
    
ZOSTERIC ACID 1.83 mM + + +  
ZOSTERIC ACID 1.83 mM + GLUTARALDEHYDE 0.005 M + PEI 3% +   
ZOSTERIC ACID 1.83 mM + GLUTARALDEIDE 0.05 M + PEI 3% +   
    
COUMARIC ACID 1.83 mM + + +  
COUMARIC ACID 1.83 mM + GLUTARALDEIDE 0.005 M + PEI 3% + +  
COUMARIC ACID 1.83 mM + GLUTARALDEIDE 0.05 M + PEI 3% – 
    
CINNAMIC ACID 1.83 mM ++ + 
CINNAMIC ACID 1.83 mM + GLUTARALDEHYDE 0.005 M + PEI 3% + + 
+++ 
+ 
 
- 
++ 
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CINNAMIC ACID 1.83 mM + GLUTARALDEHYDE 0.05 M + PEI 3% +   
    
p-AMINOSALICYLIC ACID 1.83 mM + + +  
p-AMINOSALICYLIC ACID 1.83 mM + GLUTARALDEHYDE 0.005 M + PEI 3% + +  
p-AMINOSALICYLIC ACID 1.83 mM + GLUTARALDEHYDE 0.05 M + PEI 3%  +  
    
p-AMINOCINNAMIC ACID 1.83 Mm + + +  
p-AMINOCINNAMIC ACID 1.83 mM + GLUTARALDEHYDE 0.005 M + PEI 3%  + + 
p-AMINOCINNAMIC ACID 1.83 mM + GLUTARALDEHYDE 0.005 M + PEI 3% +   
 
Table 4. Evaluation of biofilm colony growth on treated and untreated membranes. 
 
The biological investigation showed that polyethylenimine and different concentration of 
glutaraldehyde did not significantly affect E.coli growth, while the coating with these two linkers and 
the selected molecules generally led to a reduction of biofilm formation. Interestingly, the direct 
coating of polycarbonate membranes with the aqueous solution of compounds was ineffective since 
molecules were too close to the surface and were not able to interact with their target. Moreover, the 
best results in terms of bacterial growth inhibition were obtained by using a 0.05 M aqueous solution of 
glutaraldehyde as linker, probably due to the increase of functional groups available for the subsequent 
interaction.   
These preliminary results were useful to confirm the importance of using appropriate linkers to distance 
the bioactive molecules from the polymeric surface in order to obtain a new functionalized material 
able to interfere with biofilm growth. 
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4.4 Active protection of surfaces 
 
An alternative strategy for the prevention of biomaterial infection is based on the covalent attachment 
of an antimicrobial agent to the surface of the polymer (Figure 37).  The most widely explored 
polymeric antimicrobial coatings are based on quaternary 
ammonium compounds (QAC) to actively kill any bacteria that 
adhere to the surface.[114] Numerous studies have revealed that 
the minimum requirements of these systems for antimicrobial 
activity against bacteria is a cationic group and an apolar alkyl 
chain. Additionally the cationic group needs to be immobilized 
via a spacer, typically PEG, to ensure the mobility of the group is 
retained.[115] The synthesis of well defined PEGylated polymers 
with tertiary amines from commercially available monomers, such 
as 2-(dimethylamino)ethyl methacrylate and oligo(ethylene glycol) methyl ether methacrylate was 
achieved by reversible addition–fragmentation chain transfer polymerization (RAFT). The resulting 
tertiary amines were quaternized to generate cationic polymers with different chemical functionalities 
(such as alkyl, primary alcohol, primary amine and carboxylic acid). The antimicrobial activity of the 
polymers was shown to be influenced by both the length of the alkyl spacer and the chemical 
functionality. Among all of these polymers with alkyl, primary alcohol, primary amine and carboxylic 
acid functionalities with fixed propyl spacer, that one characterized by an alkyl group had the highest 
antimicrobial activity.  
Another approach to prepare antimicrobial materials is to incorporate the furanones, which interfere 
with bacterial quorum sensing systems, and its derivatives which have been shown to inhibit growth of 
both Gram-positive and Gram-negative bacteria.[116] Furanones covalently bound to catheters either 
by a copolymerization with a styrene polymer, or with plasma-1-ethyl-3-(dimethylaminopropyl) via 
carbodiimide reaction reduced the adhesion and colonization of S. epidermis in vitro. Furanones, 
incorporating bromine atoms, have also been covalently attached to poly(L-lysine)-graft-poly(ethylene 
glycol) (PLL-g-PEG) polymers and the surfaces prepared via self-assembly of the PLL-g-PEG were 
exposed to S. epidermis.[117] The grafted furanone did not reduce bacterial adhesion compared to 
surfaces functionalized with PLL alone. This indicates that the biopassive properties of the PLL-g-PEG 
Figure 37. Active protection of surfaces.  
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had been abolished by the presence of the furanone and further highlighted the necessity, in this 
instance, of free furanone for an antimicrobial effect. The main limitation of this approach is that once 
the bioactive compounds are grafted to a surface, they can lose much of their mobility and, being 
unable to penetrate in the cells, becoming inactive. Indeed, covalent immobilization of the active 
substance can lead to reduced activity, due to steric hindrance or inability to interact with intracellular 
targets.  
A possible solution is to link the antimicrobial agents to a long, flexible polymeric chain anchored 
covalently to the surface of the material. Although this limitation can be partially resolved employing 
long linkers, the number of antimicrobial substances suitable for immobilization is limited to those 
which do not need to enter the cytoplasm to be active.   
 
4.4.1 The choice of material 
The development of an efficient antimicrobial coating is one of the major current challenges, since the 
presence of biofilms on the surfaces of materials is a serious medical and economical problem. 
Microbial adhesion depends strongly on the physico-chemical properties of the materials constituting 
the medical devices. The main materials currently employed to manufacture catheters are polyethylene 
(PE), polyvinyl chloride (PVC) and silicone. However, it is widely recognized that these polymeric 
materials do not escape microbial colonization leading to device-associated infections.[118] The 
tendency of microorganisms to adhere to surfaces and form biofilms in several environments is 
certainly related to the selective advantages that a surface association offers. First, surfaces provide a 
space to be occupied and a degree of stability in the growth environment and then, biofilm structures 
offer protection from a wide range of environmental injuries like UV exposure, dehydration, 
phagocytosis and against the action of several antimicrobial agents (for details see „Paragraph 1.2‟).  
In the passive approach, the membranes which underwent to the coating process was made of 
polycarbonate, since it was proved that it did not affect E. coli growth. As for the active coating, the 
polymeric material which I have used was low-density polyethylene (LDPE). Similarly to PC, it was 
found that LDPE itself did not affect bacterial growth. 
Polyethylene is a thermoplastic polymer consisting of long hydrocarbon chains and it is produced by 
the polymerization of ethylene. It is classified into several different classes based mostly on the density, 
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the type of branching and molecular weight. As for the degree of polymerization, the most important 
polyethylene grades are: 
- HDPE (High-density polyethylene): the density of high-density polyethylene can range from 
0.93 to 0.97 g/cm
3
.  
- LDPE (Low-density polyethylene): it is defined by a density range of 0.910–0.940 g/cm3.  
- LLDPE (Linear low-density polyethylene) 
Although the density of HDPE is slightly higher than that of low-density polyethylene, HDPE has few 
branching, giving it stronger intermolecular forces and tensile strength than LDPE. On the contrary, 
LDPE has more branching (on about 2 % of the carbon atoms) than HDPE, so its intermolecular forces 
(instantaneous-dipole induced-dipole attraction) are weaker, its tensile strength is lower, and its 
resilience is higher.  
LDPE is produced under high pressures (81-276 MPa) and high temperatures (130-330 °C) with a free-
radical initiator, such as peroxide or oxygen. The choice of initiator is made on the basis of the type of 
reactor, the residence time in each zone, the desired reaction temperature, and initiator cost. The main 
factor in choosing an initiator is its half-life indeed long half-life of the initiator led to high degree of 
polymerization, but also to high peroxide cost. The polymerization mechanism is a free-radical reaction 
that leads to the formation of long-chain branches, which can be as long as the main polymer backbone. 
The free-radical mechanism also leads to the formation of short-chain branches, typically one to five 
carbon atoms long. These short-chain branches normally presented in LDPE include 1,3-diethyl and 2-
ethylhexyl side chains as well as the most common butyl branches. LDPE also contains small amounts 
of amyl branches while hexyl branches are rare. Most of the methyl branches occur when propylene is 
added to the reactor as a chain-transfer agent. The polymerization is carried out in tubular or stirred 
autoclave reactors.[119] 
PE is used in many biomedical application mainly as packaging material for storage of physiological 
fluids, implants or as support for cell growth.[120] It is also characterized by very low wetting 
properties in aqueous media and high resistance against a wide range of reagents, showing an excellent 
resistance to diluted and concentrated acids and bases. This latter was an essential property for the next 
use, since this material underwent to chemical modifications to become suitable to link anti-biofilm 
compounds.  
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For all the aforementioned properties, I choose this polymer for the active coating described in this 
dissertation. It should be noted that up to now, the functionalization of material was performed only on 
polymeric films, whose thickness was around few nanometers. In this pioneering proposal, 1.6 mm 
thickness polyethylene coupons were used, leading to a more difficult characterization of the final 
surface since the conventional analysis methods did not work.    
 
4.4.2 Pre-treatment of surfaces 
Polymeric materials used in medical devices often do not possess the needed physical or chemical 
properties to allow grafting with antibiofilm molecules and require surface modifications.[120] 
Recently, there has been a rapid exploration of low-
temperature plasma technology to improve the 
surface properties of polymeric materials leading to  
physical and chemical modifications of the first few 
molecular layers of the surface without changing 
their bulk properties. Plasma surface modification 
involves the interaction of the plasma-generated 
excited species with a solid interface. Gas phase 
plasma is an electrically neutral mixture of electrons, ions, radicals, photons, recombination products 
and neutrals created by the application of energy, such as radio frequency (RF), to a source gas 
contained within a vacuum chamber. Free electrons are responsible for the beginning of the process. 
Indeed, the exposure of the free electrons to the external energy source allows the electrons to gain 
sufficient kinetic energy, therefore their collision with another atom or molecule results in the 
formation of ions and radicals. The reactive radical species are capable of chemical reactions where the 
ionized atom and molecular species are capable of physical interactions through sputtering. Photon 
emission within a plasma is a result of the excited neutrals, ions and free radicals formed in the plasma 
losing their excess energy. The wavelength of the emission is sufficient to break chemical bonds, and it 
can be useful when treating polymeric materials.[121] Plasma surface activation employs gases (such 
as oxygen, nitrogen, hydrogen) which, when exposed to the plasma, dissociate and react with the 
surface, creating different chemical functional groups.[122] Thus, it is possible the insertion or the 
substitution of chemical functionalities into an otherwise non-reactive surface or to create radicals for 
Figure 38. Active species present in an oxygen plasma. 
Chapter 4 – SECTION B 
91 
 
cross-linking or subsequent grafting. Indeed, in an oxygen plasma, the resulted hydroperoxy groups can 
be used as initiators in the subsequent surface graft-polymerization.[123] The most important 
components of a low-pressure plasma system are the vacuum chamber, the vacuum pump and a high-
frequency generator for plasma creation (Figure 39). 
 
Figure 39. Low-pressure plasma system. 
 
Due to the low surface energy of untreated material, plasma pre-activation of PE films was found to be 
necessary for a successful graft-polymerization, which fails in the absence of such pretreatment.[58, 
124] To understand the complex reaction between the plasma and the polymer surface, it is important 
to understand the plasma parameters and their effects on the surface modification. Plasma technique 
offers several advantages since the process is solvent-free, extremely controllable and the consumption 
of reagents is low. However, one of the major limitations of plasma technology is the diversity of 
functional groups produced by the chemical reactions that occur in the plasma. Moreover, plasma 
polymers also have irregular, non-repeatable polymer structures with much branching and 
crosslinks.[125]  
This technology is based on ecological, clean and dry processes suitable for industrial applications 
without the use of chemicals.[126]  
 
In this study, polyethylene coupons were submitted to two different plasma treatments, using a plasma 
cleaning oxygen system and a oxygen plasma reactor, in order to modify the surface of samples and to 
compare the different results obtained kept unchanged the parameters of the other functionalization 
steps. The plasma reactor system has significant advantages over the cleaning one, such as a better 
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surface modification in terms of uniformity and number of exposed functional groups in a shorter 
processing time. 
    
4.4.3 Graft-polymerization process 
Plasma treatment can be also used to introduce functional groups through deposition of a polymerized 
thin layer of a second polymer. While the attachment of this second layer of the substrate polymer is 
not well defined, the product is in effect functionally modified in a useful way.[128] The substrate is 
firstly immersed in a solution containing the monomer, an initiator and a crosslinking agent. After the 
removal of the excess of the solution, the substrate is exposed to plasma. In the case of an unsuccessful 
plasma pretreatment, the failure of the graft-polymerization step can be occurred. In fact, when solvent 
evaporates from the surface of untreated material after immersion in monomer solution, the monomer 
tends to concentrate in the liquid phase and agglomerates in small drops instead of covering the PE 
surface with a uniform thin film. Moreover, no monomers remains on the surface after washing.[129, 
130] Finally, the substrate is washed and dried. This method can be called plasma-induced graft-
polymerization and is evidently of considerable practical interest.  
 
In this work plasma-induced graft-polymerization of hydroxyethyl methacrylate (HEMA) was 
performed on polyethylene coupons. In particular, I focused my attention on the optimization of plasma 
and solution parameters that regulate the graft-polymerization process such as pre-treatment time for 
surface activation, monomer concentration and treatment time. Indeed, The chemical composition of 
plasma treated surface depends mainly on the gas used and the experimental conditions applied. The 
activation process, as well as the graft-polymerization that occurred on the PE, were followed by the 
characterization of the surface by means of contact angle measurements, attenuated total reflection 
infrared (ATR-IR) spectroscopy, X-ray photoelectron spectroscopic (XPS) and scanning electron 
microscopy (SEM) analyses. 
 
4.4.4 Experimental   
4.4.4.1 Materials and methods 
Polyethylene used in this study was low-density polyethylene (LDPE) purchased from Alfa Aesar as 
sheets (300 x 300 x 1.6 mm). Samples were prepared in the form of 1.6 mm (0.063 in) thick round 
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shape coupons (d=1.27cm). Hydroxyethyl methacrylate (97 %, contains ≤250 ppm monomethyl ether 
hydroquinone as inhibitor), p-aminocinnamic acid and p-aminosalicylic acid were purchase from 
Sigma Aldrich and used as-received without any further purification.  
 
4.4.4.2 Cleaning of PE coupons 
Polyethylene coupons were washed with a 3 % w/v aqueous solution of a neutral detergent efficient in 
removing greasy residues (AUSILAB 101, Carlo Erba Reagents) and then with a 1 M aqueous solution 
of HCl. They were subsequently purified by extraction with acetone overnight and dried prior each 
plasma treatment. 
 
4.4.4.3 Plasma activation of PE
1
 
Low density polyethylene coupons were exposed to a low-pressure oxygen plasma for the process of 
surface activation. In particular, oxygen plasma treatment, followed by exposure to the air, was used to 
introduce new carbon-oxygen functionalities to the polymer surface. A brief description of the low-
pressure plasma system was given in „Paragraph 4.4.2‟. The 
apparatus using for this study consists of a parallel-electrodes, 
capacitive-coupled plasma enhanced chemical vapor deposition 
(PECVD) system, made up of a cylindrical stainless steel vacuum 
chamber of 25 cm inner diameter with an asymmetric electrode 
configuration (Figure 40). The powered electrode is connected to a 
13.56 MHz power supply, associated to an automatic impedance 
matching unit, while the other electrode is grounded and works as 
sample holder. The treatment was performed for 60 s at a total 
plasma process pressure of about 15 Pa, kept constant by balancing 
the incoming oxygen flux with the system pumping speed. 
Commercially (99.998% purity) available oxygen was supplied into 
the discharge vessel through a mass flow controller. The total gas 
pressure was measured by a capacitive vacuum gauge. Plasma treatment was performed as a function 
of RF power of 100 W. At first low pressure was created in the process reactor by means of a turbo-
                                                          
1
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Figure 40. R2000 plasma reactor:  
1) Process reactor  
2) RF power 
3) Vacuum line 
2 
3 
1 
2 
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molecular pump combined with a rotary pump. At a pressure of 0.026 mbar oxygen was fed into the 
chamber (O2 flow= 15 sccm). When the working pressure was achieved, the generator was switched on 
and the process gas was getting ionized. Samples of commercial LDPE, previously washed and inserted 
into the vacuum chamber, were exposed to the plasma.  
 
4.4.4.4 The grafting procedure: LDPE-HEMA-OH surface 
In the graft-polymerization process, monomers were introduced into the vacuum chamber as a layer on 
the plasma pre-treated surface. In details, PE samples were immersed for 10 s in a solution of HEMA in 
ethanol. Concentration of HEMA solutions was varied from 0.05 M to 1 M that seemed to be the best 
range of concentrations found in literature.[129] Indeed, samples prepared with low concentration of 
the monomer led to PE surface that was only partially covered, while with high monomer 
concentrations the failure in the graft-polymerization step was observed.  
PE samples, previously immersed in HEMA solution, were completely dried in air and then oxygen 
plasma treated in order to promote the graft-polymerization of the monomer. Using the plasma cleaner 
system, O2 pressure and treatment time were varied to optimize the process while for the plasma 
reactor system, input power was kept constant at 100 W as well as the grafting treatment time (60 s), in 
order to prevent damaging of substrates.[131] The samples were finally ultrasonically washed in 
ethanol for 5 minutes in order to remove the ungrafted macromolecules and dried in air at room 
temperature.  
 
4.4.4.5 Preparation of the LDPE-HEMA-COOH surface 
The LDPE-HEMA-COOH film was obtained by treatment of the LDPE-HEMA-OH film with succinic 
anhydride. Thus, in a conical flask the LDPE-HEMA-OH coupons were immersed in 10 mL of 
dichloromethane, containing also dry pyridine (2.5 eq). Succinic anhydride (2.5 eq) dissolved in 10 mL 
of THF was added to the reaction mixture. The suspension was allowed to proceed at room temperature 
for 24 h. The film was washed with copious amounts of dichloromethane (10 x 10 mL) prior to dry in 
air. 
Since it was not possible to define exactly the equivalent of hydroxyl groups introduced on 
polyethylene due to the difficulty of analysis, a general estimate of the number per unit area was made 
on the basis of literature data.[129]      
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4.4.4.6 General procedure to graft molecules to the LDPE-HEMA-COOH surface via amide bond 
formation 
The carboxylic functionalities of LDPE-HEMA-COOH coupons (1 eq) were activated by dipping the 
surfaces into a dichloromethane solution (10 mL) of N-hydroxysuccinimide (1.2 eq) and N,N-
dicyclohexylcarbodiimide (1.2 eq) under a nitrogen atmosphere at room temperature for 20 min. Then 
the suitable compound* (1.2 eq) was poured into the suspension and the resulting mixture was stirred at 
room temperature for 16 h. Then the coupons were filtered off and washed with copious amounts of 
dichloromethane (10 x 5 mL). Additional washes with DMF (3 x 5 mL) were necessary to remove 
completely the dicyclohexylurea from the surfaces. Finally the coupons were dried in vacuo to allow 
analytical analysis. 
Similarly to the LDPE-HEMA-OH coupons, the equivalent of carboxylic functionalities introduced on 
the surface was not precisely determined, thus the subsequent grafting was performed using an excess 
of all reagents to ensure the amide bond formation. 
 
* p-aminocinnamic acid or p-aminosalicylic acid respectively, selected from the previously biological investigation (see „Section A‟ of 
this thesis).  
 
4.4.5 Characterization 
4.4.5.1 Contact angle measurements 
Contact angle measurements are generally used for estimating the extent to which a solid surface will 
be wetted. When a drop is totally spread on solid surface and the contact angle is close to 0 degrees, the 
complete wettability of the surface is achieved. However, in many cases only a partial wettability 
occurs. Wettability can be defined as the degree to which a solid is wetted and can be expressed as 
relative strength of cohesion (liquid/liquid) and adhesion (solid/liquid) forces. If the contact angle of 
water is 90 degrees or more the polymeric surface may be considered hydrophobic. This relates with 
poor wettability, low surface energy and weak adhesion of the polymer. On the other side, drop with a 
small contact angle relates to hydrophilic surface, that causes better wettability, adhesion and higher 
surface energy of the investigated material.  
In the present study, the sessile drop technique was used under ambient atmospheric conditions. 
Samples processed at different plasma treatment times and at graft-polymerization process were 
Chapter 4 – SECTION B 
96 
 
evaluated by measuring the water contact angles, both before and immediately after the coating 
deposition to evaluate changes to the surface hydrophilicity resulting from the presence of a polymer 
layer.   
 
Materials and methods 
Contact angle measurements were performed via sessile drop method using a CAM 200 Instrument 
(KSV Ltd), which utilizes a video capture and a subsequent image analysis. Deionized water was used, 
and its purity was confirmed by correlating the measured surface tension based on the pendant drop 
shape to the literature values for pure water (72 mN/m at 25 °C). 
 
Results and discussion 
The water contact angles of polyethylene coupons treated with oxygen plasma at different times are 
reported in Table 5. Similarly, water contact angles of polyethylene coupons after graft-polymerization 
with different HEMA concentration are shown in Table 6. These changes in contact angles 
measurements are here discussed.  
Data represents the average of repeated measurements at two different observation points on three 
sample replicates.   
 
Polyethylene 
samples 
Aging process (hours) 
0 24 48 
P
la
s
m
a
 
tr
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ti
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e
 (
m
in
) 0 99,33 ± 0,78 93,93 ± 0,54 88,83 ± 1,15 
2' 46,43 ± 8,63 51,18 ± 0,93 72,25 ± 2,10 
10' 48,88 ± 11,98 72,51 ± 13,94 76,18 ± 17,05 
20' 33,13 ± 4,09 45,20 ± 1,44 58,91 ± 1,44 
30' 26,95 ± 3,87 46,60 ± 1,14 36,46 ± 2,60 
 
Table 5. Water contact angle measurements at different plasma treatment times. 
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Figure 41. Plots of  water contact angles of untreated and plasma treated samples and corresponding aging process. 
 
The results confirmed that the water contact angles of the untreated LDPE achieved the highest values 
because, as aforementioned, it is a polymer with hydrophobic nature and chemical inert surface (Figure 
41). As it can be observed, the contact angles of the untreated surface were reduced after the oxygen 
plasma treatment even for a short exposure time. This situation indicates that the plasma treatment 
considerably enhances the formation of polar species on the LDPE surface acquiring a more 
hydrophilic nature. These polar groups that consists mainly of carboxyl, carbonyl and hydroxyl groups 
resulted from the interaction between the surface and the O2 plasma. The oxidation of a non-polar 
unreactive polymer such as polyethylene usually leads to a material characterized by high energy and 
thus, high wettability. However, the activated material is also thermodynamically unstable compared to 
the original lower energy hydrophobic polyethylene (in fact the surface activation by the plasma 
treatment is not permanent). This indicates that the plasma treated surface undergoes an aging process 
that can be attributed to a re-arrangement of the hydrophilic groups obtained during the O2 plasma 
exposure. This result is not surprising because the aging of plasma treated surfaces is a well-known 
phenomenon with a rate dependent on the characteristics of the material, plasma and surrounding 
environment. Activated surfaces may have a shelf-life of hours or days.[132]  
The hydrophilic characteristics of the surface was also evaluated after the graft-polymerization process 
with hydroxyethyl methacrylate (Table 6). Concentrations of HEMA and treatment time were varied in 
0
24
48
0,00
20,00
40,00
60,00
80,00
100,00
0
2'
10'
20'
30'
C
o
n
ta
ct
 a
n
gl
e
 (
°)
 
Plasma treatment time (min) 
Chapter 4 – SECTION B 
98 
 
order to optimize the process while the input power and the pressure of the plasma reactor were kept 
constant. 
 
Polyethylene 
samples 
Aging process (hours) 
0 23 46 
H
E
M
A
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 (
M
) 
0 14,41 ± 2,32 43,44 ± 5,33 43,70 ± 4,36 
0,05 14,10 ± 0,65 38,20 ± 12,61 54,88 ± 3,20 
0,1 13,77 ± 5,27 26,07 ± 5,42 38,64 ± 3,54 
0,5 15,36 ± 0,02 28,45 ± 1,48 31,75 ± 7,13 
1 16,49 ± 1,39 44,80 ± 16,50 51,68 ± 8,08 
 
Table 6. Water contact angle measurements of samples grafted with different HEMA concentration and exposed for 20 minutes 
to O2 plasma to induce polymerization. The 0 M  HEMA concentration refers to samples submitted only to the activation process. 
 
 
Figure 42. Plots of  water contact angles of samples treated with different HEMA concentrations and corresponding aging 
process. 
 
Data showed that the decrease of contact angle observed in case of surface covered with HEMA was 
not substantial compared with samples activated by O2 plasma (Figure 42). Indeed, all the samples 
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exhibited similar contact angles values after the graft-polymerization process, providing that this range 
of concentrations did not significantly affect the hydrophilicity of the substrate.  
In the light of these results, 0.1 M HEMA concentration and 20 minutes graft-polymerization time 
process were conventionally selected as the best conditions to activated polyethylene using a plasma 
cleaner system, while using a plasma reactor system, the best time for both the activation and graft-
polymerization process is 60 s, as reported in literature [131]. Moreover, it was found that the aging 
process occurred also after graft-polymerization, since most of the polar groups changed their 
orientation towards the bulk, thus reducing the hydrophilic nature of the treated surface. In detail, 
samples prepared with 0.1 M and 0.5 M HEMA concentration showed a contact angle aging lower than 
the samples covered with higher (1 M) and lower (0.05 M) HEMA concentrations.    
Obtained data suggested that it was necessary to perform the reaction for the conversion of hydroxyl 
groups into the corresponding carboxylic functionalities (and obviously, the subsequent linkage with 
bioactive molecules) immediately after the graft-polymerization treatment to ensure the highest yield of 
the complete material functionalization.  
 
4.4.5.2 Scanning Electron Microscope (SEM) analysis
1
 
The changes of morphology of the samples prepared after activation with oxygen plasma was evaluated 
by low-vacuum-SEM analysis. This analysis allowed to compared SEM images of different samples 
prepared using both a plasma cleaning system and a plasma reactor for the activation process.  
 
Materials and methods  
Surfaces of the oxygen plasma activated polyethylene was examined with a Leo 1430 scanning electron 
microscopy (Zeiss, Oberkochen, Germany) to gather data on the overall physical organization of the 
polymer network.  
 
Results and discussion 
The clearly visible surface morphology changes obtained at different plasma treatments were evident 
from SEM images (Figure 43). The topology and the roughness of the originally smoothed surfaces of 
the original substrates were dramatically changed after plasma treatment. In particular, considerable 
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modifications of the surface roughness were detected in the oxygen-plasma-treated samples both 
activated by a plasma cleaning system and by plasma reactor. Using a plasma cleaning treatment, a 
wavy surface was obtained, while by means of the plasma reactor system the resulting polyethylene 
was characterized by small holes that covered uniformly all the surface. It is well-known that cleaning 
plasma treatment is considerably less aggressive than oxygen plasma reactor, therefore significantly 
activation was achieved only if an extended treatment (20 min) was performed. Conversely, the plasma 
reactor treatment for 60 s produced a noticeable increase of polyethylene roughness. Moreover, in this 
latter same structures were clearly visible also in different parts of the studied sample surfaces 
reflecting high reproducibility and homogeneity of the applied plasma treatment. 
 
 
Figure 43.SEM images of coupons subjected to different treatments. A) clean polyethylene;  B) PE after plasma cleaning treatment; 
C) PE after plasma reactor treatment. 
 
In the light of the obtained results, among the two employed systems, plasma reactor seemed to be 
most relevant for the activation process, since sample surfaces turned out to be more uniform than 
using the plasma cleaning system in a shorter time.  
   
4.4.5.3 X-ray Photoelectron Spectroscopy (XPS) analysis
1
 
The most common technique used to characterize polymeric surfaces is the X-ray photoelectron 
spectroscopy (XPS). In general, this technique allows the identification of chemical groups on 
materials and their quantification. 
In this study, C, O and N at the surface of treated samples were detected using the XPS spectroscopy. 
The qualitative information resulted from XPS analysis of the oxidized surface after plasma treatment, 
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which contained at least carbon and oxygen, and of the functionalized surface composed of an 
undefined amount of carbon, nitrogen and oxygen. 
Only coupons functionalized with p-aminocinnamic acid (LDPE-CA) were submitted to this analysis, 
since it was reasonable to suppose that coupons grafted with p-aminosalycilic acid (LDPE-SA), which 
underwent to the same functionalization process, might show the same results.         
 
Materials and methods  
Measurements were carried out using a Perkin Elmer PHI 5400 ESCA System equipped with a 
monochromatic X-ray source (Mg Ka anode) operating at 10 kV and 200 W. Analyzed volume was 
given by the diameter of the photon beam at the sample surface (5 mm) and by the depth of analysis of 
about 8-10 nm. The base pressure was kept at 10
-8
 Pa. Curve fitting and quantification of elements were 
accomplished using the software and the sensitivity factors supplied by the manufacturer.  
 
Results and discussion  
The surface composition detected from XPS analysis of plasma activated polyethylene and PE 
functionalized with the selected molecule is shown in Table 7. 
 
Samples O N C Si Al 
1 16.9 - 76.4 2.0 4.7 
2 17.9 2.7 75.9 - 3.5 
3 20.7 9.2 70.1   
 
Table 7. Surface composition obtained from XPS analysis of the analyzed samples. 1) plasma activated PE; 2) PE functionalized with 
p-aminocinnamic acid; 3) Theoretical composition of the graft molecule calculated from molecular formula without H atoms.      
 
Typically, the XPS analysis of activated polyethylene yielded surface concentration values of 60-70 % 
carbon, 20-30 % oxygen and < 10 % nitrogen. An increase of the nitrogen content after the coupling 
was observed from XPS analysis of functionalized PE (LDPE-CA), as shown in Figure 44. It should be 
noted that the oxidized layer could be, and in general is, non-homogenous in the vertical direction, with 
a decreasing concentration of oxygen in relation with an increased depth. However, the error 
introduced by the assumption of a non-homogeneous distribution of carbon and oxygen is negligible. 
Chapter 4 – SECTION B 
102 
 
 
Figure 44. XPS wide scan spectra of oxygen plasma activated polyethylene (Sample 1) and polyethylene functionalized with p-
aminocinnamic acid (LDPE-CA) (Sample 2). 
 
According to the obtained data, some observations could be drawn: 
 the surface composition of Sample 1 (Figure 44, Panel A) was in agreement with the results 
expected for a polyolefin which underwent oxygen plasma treatment. The signal 
concentration value of oxygen peak (O1s, ~17 %) indicates a remarkable introduction of 
oxygen functionalities on the surface, as confirmed from the detailed analysis of carbon peak 
(C1s, ~77 %).  
SAMPLE 1 - Plasma activated PE 
SAMPLE 2 - PE grafted with p-aminocinnamic acid 
A 
B 
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 the graph of Sample 2 (Figure 44, Panel B)  showed a well-defined nitrogen peak (N1s, ~3 
%) in addition to the others peaks detected for Sample 1. The analysis of N1s peak revealed 
that the binding energy of the main component was closed to 400 eV. This results indicated 
that the nitrogen was not oxidized (absence of nitrite or nitrate groups). As for quantitative 
analysis, the calculated concentration was less than the theoretical one, but it was worth 
reminding that the depth of samples analysis was around few nanometers, in particular about 
8-10 nm in the case of polymers. Differently, the monolayer made of linker and molecule 
was less than 1 nm. Therefore, the contribution of signal is almost completely due to the 
polymer rather than to the chemical agents although the signal did not decay linearly from the 
outside layers to the internal ones and the major contribution was due to the external layers. 
 in both samples, some elements (Si, Al) were detected at low concentrations (≤ 5 %), most 
likely due to some contaminants left on the samples upon the processing techniques.  
     
In conclusion, it was very difficult to perform reliable evaluation on the surface coverage with the 
selected molecules. The evaluation of quantitative parameters able to provide indications on the 
reaction yield in terms of surface functionalization per unit was not easy and required assumptions that 
were difficult to define. However, the composition data indicated that the immobilization of p-
aminocinnamic acid led to an increase of O/C ratio and obviously of N/C ratio (as expected from the 
compounds elemental composition) and it was obtained in high yield.           
 
4.4.5.4 Attenuated total reflectance infrared spectroscopy (ATR-FTIR) analysis
1
  
In order to detect the presence of the anti-biofilm compounds grafted on the polymeric surface, 
Attenuated total reflectance (ATR) infrared spectroscopy analyses were carried out, considering that 
plasma surface modifications are confined only to few nanometers below the surface.  
FTIR spectroscopy in attenuated total reflection (ATR) mode is one of the main methods used to obtain 
finer surface information.[133] This technique was used to characterize the polymer surface and the 
spectra of the treated and the untreated samples were compared to observe the changes. 
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Materials and methods  
FTIR measurements were performed using a SpectrumOne spectrophotometer (Perkin-Elmer, USA), 
by placing the polyethylene samples on a diamond crystal mounted in ATR cell (Perkin-Elmer, USA). 
The spectra were collected over the wavenumber region 4000−650 cm−1 at 4 cm−1 resolution and 128 
scans. The FTIR-ATR measurements provide mostly qualitative information on the chemical changes 
of the near-surface region. The measured thickness of the layer was limited to 4 μm. Experiments were 
carried out under ambient conditions. 
 
Results and discussion 
The spectrum of the untreated LDPE is a typical polyethylene spectrum with a small number of 
characteristic peaks (Figure 45). 
 
 
Figure 45. ATR-FTIR spectrum of LDPE coupons. 
 
After plasma exposure of the original material, the characteristic functional groups containing oxygen 
were introduced and therefore significant changes in the measured spectrum should have been 
observed. These changes should have been caused by the incorporation of some hydroxy or peroxy 
groups after the plasma treatment of LDPE with the appearance of two broad peaks between 3.600–
3.050 cm
−1
 and 1.800–1.520 cm−1 respectively since carbonyl stretching is one of the easiest 
Chapter 4 – SECTION B 
105 
 
absorptions to recognize in an infrared spectrum and it usually has a very intense band. Unfortunately, 
according to the recorded spectra, no –OH or –OOH peaks were seen for any of the analyzed samples. 
This was probably due to the low concentration of the polar species upon the surface. Moreover, no 
changes are also observed for LDPE-HEMA-OH grafting as well as after the subsequent oxidation to 
carboxylic acid. 
Unexpectedly, after the covalent linkage with p-aminocinnamic acid and p-aminosalicylic acid the 
shape of the spectrum changed, as shown in Figure 46. 
 
 
Figure 46. ATR-FTIR spectra of treated and untreated samples. The typical peaks of the amide bond confirmed the presence of a 
covalent bond between p-aminosalicylic acid (b) and p-aminocinnamic acid (c) to the supporting material after graft-polymerization (a).  
 
These changes are significant especially in the infrared-region between 1.600-1.800 cm
-1
 (C-O 
stretching, N-H bending), suggesting that the treated samples are characterized by the typical peaks of 
the amide bond and confirming the presence of a covalent bond between the antibiofilm molecules and 
the supporting material.  
 
4.4.5.5 Fluorescence Spectroscopy analysis 
Fluorescence spectroscopy analyses were performed in order to prove the polyethylene  
functionalization with p-aminocinnamic acid and p-aminosalicylic acid. Firstly, the intrinsic 
fluorescence of these two molecules free in solution was evaluated and then it was used to estimate 
a 
b 
c 
Chapter 4 – SECTION B 
106 
 
their presence on the surface. The auto-fluorescence of cinnamic acid and salicylic acid immobilized 
scaffold was evaluated to verify the surface functionalization by Confocal Scanning Laser Microscopy 
(CLSM). A comparison between coupons activated with plasma cleaning system and plasma reactor 
was carried out. 
  
Material and methods 
Fluorescence spectra of p-aminocinnamic acid and p-aminosalicylic acid in solution were acquired in a 
Perkin-Elmer LS 50B spectrofluorometer. Emission spectra were recorded over the 250-600 nm range 
with emission and excitation slit widths set at 3.0 nm. Spectra were recorded by dissolving 2.6 mM of 
p-aminocinnamic acid and 5.0 mM p-aminosalicylic acid in 0.4 M NaHCO3, 1 M NaCl, 3% DMSO 
buffer (pH = 8.3) (dilution buffer). 
Untreated and functionalized coupons were visualized using a Leica SP5 Confocal Laser Scanning 
Microscope (CLSM) (405 nm laser excitation line, blue channel) before and after 10-fold used. Images 
were captured with a 40x, 0.8 NA water immersion objective and analysed with the software Imaris 
(Bitplane Scientific Software, Zurich, Switzerland). The experiments were repeated two times. 
 
Results and discussion  
When they were in solution,  p-aminosalicylic acid, excited at 325 nm, showed an emission peak at 395 
nm, while p-aminocinnamic acid, excited at 380 nm, showed an emission peak at 443 nm (Figure 47). 
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Figure 47. Fluorescent emission spectra of molecules in solution. A) p-aminocinnamic acid (λex 380 nm); B) p-aminosalicylic acid (λex 
325 nm).   
 
In the light of these results, both of the two compounds can be considered intrinsic fluorescent probes 
and can be used to prove the functionalization process. The best results were obtained using coupons 
activated by a plasma reactor system. 
Acquired pictures of LDPE, LDPE-HEMA-OH and LDPE-HEMA-COOH control samples revealed a 
completely black background with absence of fluorescence (Figure 48, line 1). On the contrary, 
acquired images of LDPE-CA and LDPE-SA samples revealed the presence of an intense fluorescence 
signal that, since no fluorescence was detected in the control samples, could be attributable to the 
cinnamic acid and salicylic acid moieties, immobilized on the surface, demonstrating the successful of 
the functionalization process (Figure 48, line 2).  
To prove the retention and the stability of the functionalized material, the CSLM analysis was repeated 
on 10-fold used coupons. Images of LDPE, LDPE-HEMA-OH and LDPE-HEMA-COOH 10-fold used 
control coupons revealed a completely black background with the absence of fluorescence. Pictures of 
LDPE-CA and LDPE-SA 10-fold used coupons still revealed the presence of an intense fluorescence 
signal comparable to that obtained from the not-used corresponding ones, confirming that coupons 
were not altered by their usage and that cinnamic acid and salicylic acid were successfully retained by 
the surface (Figure 48, line 3). 
  
0
50
100
150
200
350 400 450 500 550 600
Fl
u
o
re
sc
en
ce
, 
A
U
 
Wavelength, nm 
A 
0
100
200
300
400
500
600
700
800
300 350 400 450 500 550
Fl
u
o
re
sc
en
ce
, 
A
U
 
Wavelength, nm 
B 
Chapter 4 – SECTION B 
108 
 
  
  
    
 
Figure 48. Representative CLSM images of unused and 10-fold used functionalized and non-functionalized polyethylene surfaces 
activated using plasma reactor (405 nm laser excitation line; 40×, 0.8 NA water immersion objective). Blue fluorescence 
corresponds to the molecule presence on the surface. First line (not-used coupons): 1A) LDPE; 1B) LDPE-HEMA-OH; 1C) LDPE-
HEMA-COOH. Second line (not-used coupons): 2A) LDPE-SA; 2B) LDPE-CA. Third line (ten-fold used coupon): 3A) LDPE-SA; 3B) 
LDPE-CA. Scale bar = 40µm. 
 
1A 1B 1C 
2A 2B 1C 
3A 3B 1C 
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Also coupons activated and functionalized using a plasma cleaning system were submitted to confocal 
scanning laser microscopy analysis. The inadequate activation of plasma process led to coupons that 
showed a weak fluorescence signal probably due to a poor functionalization of the surface. Acquired 
pictures of LDPE, LDPE-HEMA-OH and LDPE-HEMA-COOH control samples revealed a grey 
background with absence of fluorescence (Figure 49, line 1), while acquired pictures of LDPE-CA and 
LDPE-SA samples revealed the presence of a weak non uniform fluorescence signal, confirming that 
plasma reactor led to a better polyethylene functionalization (Figure 49, line 2). 
       
   
Figure 49. Representative CLSM images of unused functionalized and non-functionalized polyethylene surfaces activated using 
plasma cleaner (405 nm laser excitation line; 40×, 0.8 NA water immersion objective). Blue fluorescence corresponds to the molecule 
presence on the surface. First line: 1A) LDPE; 1B) LDPE-HEMA-OH; 1C) LDPE-HEMA-COOH. Second line: 2A) LDPE-SA; 2B) 
LDPE-CA. 
 
  
1A 1B 1C 
2A 2B 1C 
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4.4.5 Biological evaluation 
In order to evaluate the antibiofilm properties of the modified material and to verify the effect of the 
grafting, the new surfaces were tested by using an in vitro system replicating the hydrodynamic flow 
conditions normally encountered in vivo. The Center for Disease Control (CDC) biofilm reactor was 
used to reproduce Escherichia coli biofilms under continuous liquid shear to simulate conditions to 
which medical devices could be subjected during their use. 
 
Materials and methods  
E. coli MG1655 was used as a model system for bacterial biofilms. The strain was stored at –80°C in 
suspensions containing 20 % glycerol and 2 % peptone, and was routinely grown in Luria-Bertani broth  
(LB, Sigma-Aldrich) at 37 °C.  E. coli biofilm was grown at 37 °C on functionalized and non-
functionalized coupons in the Center for Disease Control Bioreactor (CDC reactor, Biosurface 
Technologies, Bozeman, MT, USA). Inoculum of the bioreactor was prepared by inoculating 400 mL 
of sterile LB medium with an overnight colture of E.coli MG1655 strain and growing this colture at 37 
°C with continuous stirring for 24 hours. After the 24 hours adhesion phase, the peristaltic pump was 
started and sterile 10 % LB medium was continuously pumped into the reactor at a rate of 8.3 mL/min 
for 48 hours. 
After 48 hours of dynamic phase, functionalized and non-functionalized coupons were removed, gently 
washed with PBS and processed to be analyzed. Biofilm grown on both functionalized and non-
functionalized coupons was stained using 1x commercial solution of CellMask plasma membrane 
orange stain (Molecular Probes-Life Technologies) in sterile PBS. CellMask orange staining allowed to 
visualize total cell mass. Biofilms were incubated for 30 min in the dark at room temperature and then 
rinsed with sterile PBS.  
Coupons without biofilm were also stained with the dyes in order to exclude any false positive signals. 
Biofilm samples were visualized using a Nikon Eclipse E800 epifluorescent microsope with excitation 
at 581 nm and emission at 644 nm for the red channel. Images were captured with a 60x, 1.0 NA water 
immersion objective and analyzed via MetaMorph 7.5 software (Molecular Devices, Sunnyvale, CA, 
USA). Percent area threshold of stained cells was performed by calculating at least ten random images 
for each sample for at least three coupons per experiment. The efficacy of the anti-biofilm material was 
calculated as percentage reduction in stained cells threshold area respect to the control images. 
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ANOVA test, via a software run in MATLAB environment (Version 7.0, The MathWorks Inc, Natick, 
USA), was applied to statistically evaluate any significant differences among the samples. Tukey‟s 
honestly significant different test (HSD) was used for pairwise comparison to determine the 
significance of the data. Statistically significant results were depicted by p-values < 0.05. 
 
Results and discussion  
Epifluorescence microscopic techniques were used to provide image analysis and quantiﬁcation of 
bacterial cells in situ. 
Direct microscopic visualization of the total biofilm biomass on functionalized and non-functionalized 
coupons is shown in Figure 50, where in situ bioﬁlms have been stained with the CellMask plasma 
membrane orange stain. Pictures analysis showed significant differences in the percentage area 
threshold of stained cells between the control LDPE and the functionalized LDPE-CA and LDPE-SA 
materials (percentage threshold area of total cells: LDPE 91.04±3.88 %; LDPE-CA 29.96±6.06 %; 
LDPE-SA 35.45±4.54 %).  No significant differences were detected in the threshold area of stained 
cells between the LDPE control sample and the LDPE-HEMA-OH and LDPE-HEMA-COOH linker 
control samples (percentage threshold area of total cells: LDPE-HEMA-OH 87.40±3.73 %; LDPE-
HEMA-COOH 92.76±1.00 %), confirming that the used linker does not affect biofilm biomass (Figure 
51). The analysis of the images revealed that cinnamic acid and salicylic acid functionalized material 
reduced biofilm biomass by 73.7 % and 61.06 % respectively, compared to the control LDPE (Figure 
51). Coupons without biofilm and stained with the same dye did not produce detectable fluorescence 
suggesting that false positive signals were not produced (data not shown). 
The two different activation processes, one using the plasma cleaning system and the other one by 
plasma reactor, provided two different results confirming that this first step was fundamental for the 
efficiency of the final conjugate. 
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Figure 50. Representative epifluorescence microscope images of E. coli biofilm stained with CellMask plasma membrane orange 
and grown on functionalized and non-functionalized polyethylene surfaces (60x, 1.0 NA water immersion objective).  First line: 
1A) LDPE. Second line (coupons submitted to plasma reactor treatment): 2A) LDPE-CA; 2B) LDPE-SA. Third line (coupons submitted 
to plasma cleaning treatment): 3A) LDPE-CA; 3B) LDPE-SA. Red fluorescence corresponds to E. coli cells. λex: 554 nm and λem: 567. 
Scale bar = 20 µm.  
 
 
 
1A 
2A 2B 2C 
3A 3B 
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Figure 51. Percentage area threshold of CellMask plasma membrane orange stained cells on functionalized and non-
functionalized polyethylene surfaces. A) LDPE; B) LDPE-HEMA-OH; C) LDPE-HEMA-COOH; D) LDPE-CA; E) LDPE-SA. Error 
bars display the honestly significant difference (HSD) intervals using Tukey multiple comparison with a 95 % confidence level (Tukey's 
HSD, p < 0.05). According to post-hoc analysis, means sharing the same letter are not significantly different from each other. Values are 
based on results from at least three separate experiments. 
 
 
4.4.6 Antibiotic susceptibility test 
Materials and methods 
Biofilm on functionalized and non-functionalized coupons were soaked in 15 mL of 100 µg/mL 
Ampicillin (Amp, Fisher Scientific) for respectively 24 h. Functionalized and non-functionalized 
coupons were also soaked in 15 mL of PBS for 24 h as a negative control. After the treatment, coupons 
were soaked in distilled water for 10 min in order to neutralize the antimicrobial agent. Collected 
coupons were transferred to 5 mL PBS. Sessile cells were removed from the coupon surface by 30 s 
vortex mixing, 2 min sonication (Branson 3510, Branson Ultrasonic Corporation, Dunburry, CT) 
followed by other 30 s vortex mixing. Using this procedure, all the cells were dislodged from the 
coupons. Dispersed cells in the bulk liquid were washed by centrifugation at 8,000 g for 30 min and 
suspended in PBS. Serial dilutions of the resulting cell suspensions were plated on Tryptic Soy Agar 
(TSA, Fisher Scientific) and incubated overnight at 37 °C. CFUs were determined by standard colony 
counting method. Obtained data were expressed as log10/cm
2
 survived bacteria. The antimicrobial 
eﬃcacy percentage was also calculated as (no. of viable cells from bulk liquid x 100)/(no. of viable 
cells from bulk liquid + no. of viable cells from the remaining bioﬁlm). All antimicrobial experiments 
were conducted in triplicate. 
 
A B C D E 
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Results and discussion 
To evaluate the susceptibility of E. coli biofilm to 100 µg/mL ampicillin on control LDPE, LDPE-CA 
and LDPE-SA functionalized surfaces, viable cells in both the bioﬁlm and the bulk liquid were 
quantiﬁed by plate count analysis.  
The treatment with ampicillin did not significantly affect the number of viable cells in biofilm grown of 
LDPE surface, since the number of viable cells in biofilm treated with ampicillin did not show 
significant differences respect to the biofilm grown on the same surface but treated with PBS (viable 
adhered cells: LDPE/PBS 7.05±0.07 log10 CFU/cm
2
; LDPE/Amp 6.87±0.18 log10 CFU/cm
2
) (Figure 
50). On the contrary, the treatment with ampicillin drastically decreased the number of viable cells 
within the biofilm grown on both LDPE-CA and LDPE-SA functionalized surfaces, in comparison to 
the corresponding negative control treated with PBS (viable adhered cells: LDPE-CA/PBS 6.75±0.11 
log10 CFU/cm
2
; LDPE-CA/Amp 5.64±0.01 log10 CFU/cm
2
; LDPE-CA/PBS 6.70±0.05 log10 CFU/cm
2
; 
LDPE-SA/Amp 5.71±0.08 log10 CFU/cm
2
) (Figure 52). The enhanced susceptibility of the biofilm 
grown on functionalized surfaces to ampicillin was also confirmed by the antimicrobial efficacy 
percentage that appeared significantly higher on LDPE-CA and LDPE-SA surfaces respect to LDPE 
surface (ampicillin efficacy percentage: LDPE/Amp 47.56±7.13 %; LDPE-CA/Amp 85.59±0.84 %; 
LDPE-SA/Amp 85.47±1.92 %) (Figure 52). The combination of both LDPE-CA and LDPE-SA with 
ampicillin resulted in 96.2 % and 95.5 % biofilm biomass reduction respectively. 
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Figure 52. Ampicillin susceptibility test against E. coli biofilm pre-grown on functionalized and non-functionalized polyethylene 
surfaces. A) Biofilm growth after 24 h treatment with 100 µg/mL ampicillin and PBS (negative control). B) 100 µg/mL ampicillin 
efficacy percentage. Error bars display the honestly significant difference (HSD) intervals using Tukey multiple comparison with a 95 % 
confidence level (Tukey's HSD, p < 0.05). According to post-hoc analysis, means sharing the same letter are not significantly different 
from each other.  
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4.5 Final remarks 
 
In this section of my research project, I carried out the functionalization of low-density polethylene 
coupons with molecules selected from a formerly biological investigation, having known antibiofilm 
activities, with the aim to obtain a new material able to hinder the formation of the biofilm. 
Before performing the covalent linkage of these coumpounds to a polymeric surface, also the passive 
coating approach was explored. 
Preparing a polymer surface for the immobilisation of biologically active molecules often required a 
multi-step process. A low-pressure plasma reactor system was used for an efficient activation of the 
polymeric surfaces as well as for the grafting-polymerization process. Several analytic techniques used 
to characterize each step of the functionalization process were described and the obtained data reported. 
As for the biological evaluation, results showed that the changes made on the polyethylene due to the 
process of graft-polymerization did not affect the E. coli growth, while the grafting with p-
aminosalicylic acid and p-aminocinnamic acid led to a significant decrease of biofilm biomass (≥ 80 
%). Moreover, biofilm formed on the functionalized coupons was structurally weakened and 
disorganized, as confirmed from the subsequent treatment with a broad-spectrum antibiotic that 
completely removed bacteria from the surface. 
In conclusion, as result of my research project I have obtained two new materials by the covalent 
linkage of molecules able to inhibit biofilm formation. Although the final characterization of these 
surfaces was quite difficult, due to the physical features of polyethylene coupons (e.g. thickness, 
density), the biological evaluation highlighted that these materials are able to resist to bacterial 
adhesion showing excellent anti-biofilm properties. 
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5. EXPERIENCE ABROAD 
 
Constrained Diversity Oriented Synthesis for protein-protein 
interaction inhibitors: macrocyclic phosphopeptido-mimetics as Plk1 
inhibitors targeting the Polo-box Domain and the tyrosine pocket. 
 
During my PhD I had the opportunity to spend six months in the Department of Chemistry, 
University of Cambridge, under the guidance of Prof. David Spring, where I improved my skills and 
my knowledge on synthetic organic chemistry and chemical biology methodologies.  
The work I performed was focused on the synthesis of inhibitors of the Polo-like kinase 1 (Plk1), a 
serine/threonine-protein kinase which has been found constitutively activated in a broad spectrum 
of cancer cell lines and human tumors.  
 
5.1 Introduction 
 
Protein-Protein Interactions (PPIs) play a central role in a broad range of essential biological 
processes such as intercellular communication, cellular growth and DNA replication.[134] 
Therefore, it is unsurprising that many human diseases can be traced to aberrant PPIs, or 
interactions that occur at an unsuitable time or location.[135]  Hence the ability to understand and 
modulate their function is highly desirable. PPIs have historically been thought of as difficult to 
modulate with small molecules and were consequently referred to as "undruggable". This is because 
of the large, hydrophobic surface usually involved in the interaction and the absence of a natural 
small ligand to mimic. Indeed, current small molecule libraries have proven largely inadequate at 
addressing this target class. Despite the absence of a well-defined binding pocket it has been 
demonstrated that the majority of binding energy in the interaction between proteins derives from 
confined regions of space on the protein surface termed as "hot spots".[136] Disrupting PPIs with 
small molecules has particular relevance in cancer-related processes, where the functions of the 
aberrantly expressed proteins are manifested by their ability to communicate with their protein 
partners.[137]  For this reason cancer-triggering PPIs have become promising therapeutic targets. 
The Polo-like kinase 1 (Plk1) is a serine/threonine kinase which is essential for cell cycle 
progression and genomic stability.[138]  It is vastly over-expressed in a range of human tumours 
and is associated with poor prognosis. Interference with Plk1 functions induces apoptosis in most 
tumour cells, but not in normal cells and the enzyme is widely considered to be a promising target 
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for cancer drug development.[139] A number of small molecules have been developed as ATP-
competitive inhibitors of Plk1.[140] However, targeting the catalytic site incurs the problem of poor 
selectivity due to the high conservation of the binding site among the several kinases. Hence, there 
is a growing need for the development of specific Plk1 inhibitors with novel modes of action.  
Plk1 engages its protein substrates via a Polo-box domain (PBD), a phosphopeptide binding module 
that is unique to the Plk family.[141] The phosphopeptide-driven PBD interactions mediate the 
correct localization of Plk1 and regulate Plk1 kinase activity.[142] There are several high-resolution 
crystal structures of the PBD in both unliganded and phosphopeptide substrate-bound forms.[143, 
144] Substrate recognition via phospho-Ser or phospho-Thr is predominantly mediated by an 
extensive, water bridged hydrogen-bond network in the binding cleft. The large number of solvent-
mediated contacts, in addition to direct interactions, may allow Plk1 to engage via distinct 
"priming" phosphorylation with a wide variety of different substrates to mediate several cellular 
processes.  
In turn, this offers possibilities for selective inhibition of Plk1 via small molecules. Small molecules 
that can bind to the Plk1-PBD may disrupt recruitment of substrates by the enzyme (and/or interfere 
with other PBD-dependent PPIs required for normal Plk1 activity). This may provide a means of 
therapeutic intervention against Plk1-mediated cancers that avoids the selectivity and resistance 
issues associated with targeting ATP-competitive sites. We term this strategy "allo-targeting", 
because it bypasses the active site. 
The minimal binding phosphopeptide 
LHSpTA has been identified from studies 
with the Plk1 substrate PBIP1, showing 
that the serine-phosphothreonine (SpT) 
motif makes a key contribution to the 
binding energy (Figure 53, left).[145] In 
later studies a cryptic pocket was 
discovered, known as the tyrosine pocket, 
which can accommodate a hydrophobic aromatic residue (Figure 53, right).[146] Knowledge of 
these peptidic ligands and their binding modes combined with structural information about the 
protein surface and the hot spots involved have formed the basis for the rational design of the 
inhibitors described in this proposal. 
  
Figure 53. Left: Crystal structure of LHSpTA bound to the PBD 
(3FVH); right: crystal structure of FDPPLHSpTA bound to the PBD 
and the tyrosine pocket (3P37). 
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5.2 Project Description (C) 
 
The designed molecules were based on a macrocyclic core since macrocycles should be able to span 
more efficiently the extended binding interface associated with PPIs, allowing their functional 
groups to access more "hot spots" distributed across the binding surface. Their cyclic pre-
organization means they have less conformational freedom in respect to their linear analogues and 
so suffer less entropic penalty upon binding their target.[147] In recent years interest has grown in 
the potential of macrocycles for drug discovery, since they combine high affinity and selectivity in 
structures with drug-like properties.[148, 149] In order to increase the likelihood of finding allo-
inhibitors of Plk1 (that is, compounds that can bind to the Plk1-PBD), a diverse series of structures 
were prepared and evaluated. In this context, Diversity Oriented Synthesis (DOS) represents an 
excellent tool for the synthesis of diverse and structurally-complex new chemical entities. The 
overall aim of DOS - defined as the efficient, simultaneous synthesis of structurally diverse 
compounds - is to generate libraries with the greatest possible structural and functional variability 
through the most efficient path, thus interrogating the widest chemical space.[150]  
In this project a further advance of this diversity driven approach was also evaluated. The library 
was constructed within preselected criteria in order to incorporate features expressly prescribed for 
a defined target, an approach termed constrained DOS (cDOS). Indeed, knowledge of the structure 
of the binding groove and the binding mode of several Plk1-PBD natural partners has facilitated the 
computer-assisted rational design of a cDOS library with a high potential of producing inhibitors of 
PPIs required for normal Plk1 activity.  
Structural information about the target allowed to design complex molecules with a macrocyclic 
core presenting the chemical features to match 
PBD binding surface. The general structure is 
shown in Figure 54. The incorporation of the key 
serine-phosphothreonine motif (dipeptide) is 
envisioned to drive the binding towards the 
desired position while an aromatic ring spaced 
with an opportune linker (building block 4) 
designed to occupy the hydrophobic tyrosine pocket could also improve the binding affinity. The 
combination of various building blocks allowed to introduce diversity in the features and the 
position of functional groups that are envisioned to bind the PBD, so to have more chances to find 
promising hits. Indeed, the modular nature of the synthesis provides access to a large number of 
Figure 54: General skeleton of the proposed compounds 
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compounds in few steps. The subsequent coupling with the previously prepared phosphodipeptide 
SpT building block furnished the final compounds. Solid phase strategies were used to accomplish 
this goal, therefore cleavage from the resin and deprotection of the amino acid protecting groups 
occurred at the same time. Moreover, docking calculations to predict the ability of the planned 
molecule to bind the target were performed (the crystal structure of Plk1 with the opened tyrosine 
pocket was used). 
 
5.3 Docking studies 
 
The designed molecules were docked into the crystal structure of Plk1 (3RQ7) with the opened 
tyrosine pocket in order to predict their ability to bind the target, which is quantified by the docking 
score consisting of Van Der Waals, lipophilic, hydrogen bonding and metal interaction components, 
along with non-hydrogen bonding polar interactions in hydrophobic sites. On this basis the 
phosphopeptidomimetic compounds which would justify synthetic effort were selected. 
All calculations were performed by the Schrödinger small-molecule drug discovery suite. The 
Schrödinger knowledge base (schrodinger.com/kb/639) states that a docking score of < -8 might be 
very good. Output data were inspected and analysed using Maestro (version 9.1-9.3) visualisation 
interface.[151] Grid generation is based upon the PBD-FDPPLHSpTA (3RQ7) crystal complexes 
and was generated in Glide.[152]  The protein was prepared with the Protein Preparation Wizard 
(default settings).[153] The ligand was deleted and the binding site centroid specified by selection 
of the amino acid residues and water molecules that formerly surrounded the ligand. The chemical 
structures of the designed molecules were imported from an sdf file and processed initially using 
LigPrep (OPLS_2005 force field)[154] and then ConfGen (fast mode, default settings, OPLS_2005 
force field) which generated the conformations used in the docking. [155] Glide (standard precision, 
default settings, OPLS_2005 force field) was used to dock ligands flexibly into the receptor grid 
and perform post-docking energy minimisation.[153]  
The most suitable docking pose was recorded for the indole macrocycle since the presence of a side 
chain able to occupy the hydrophobic tyrosine pocket had improved binding affinity. 
One particular conformation of this derivative (Figure 55) was an example of a „good‟ docking pose 
(docking score = -12.207). The side chain was positioned correctly to interact with the residues of 
tyrosine pocket since the phenyl ring was lodged inside.  
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Figure 55. Docking pose for the indole macrocycle with side chain.  
 
Also the dimer, obtained from the attempt to synthetize the indole macrocycle (for detail see 
„Paragraph 5.4‟), was submitted to docking studies but it showed a bad docking score probably due 
to the large size of the molecule that could not reach and interact with the target. 
The removal of the side chain was expected to make a significantly difference to binding affinity 
because it was predicted not to be interacting with the key tyrosine pocket. Actually, the docking 
score found for the benzyl derivative is slightly lower to that obtained for the indole macrocycle 
(docking score = -10.241), suggesting that this macrocycle is potentially able to bind to the PBD 
surface (Figure 56).  
         
                                                                                    Figure 56. Docking pose for the benzyl derivative. 
 
Another well-ranked molecule, the m-coumaric acid derivative, achieved a docking score of -11.811 
with a sensible docking pose (Figure 57). As for the indole macrocycle, the side chain resided at the 
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tyrosine pocket binding site. It also appeared to fit well, spatially, within the phosphopeptide 
binding groove. 
  
                                                                                      Figure 57. Docking pose for m-coumaric derivative. 
Finally, the docking analysis of the tetrazolone derivative revealed that it seemed to bind with a 
reasonable pose to the PBD (docking score = -10.052) (Figure 58). 
 
                                                                                   Figure 58. Docking pose for tetrazolidinone derivative. 
Also in this case, the insertion of a side chain enhanced PBD binding affinity by hydrophobic 
interactions formed with the tyrosine pocket (docking score = -11.948) (Figure 59). 
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                                                                                 Figure 59. Docking pose for tetrazolidinone derivative with a side chain. 
 
On the basis of computational docking experiments, the designed molecules were potential plk1-
PBD inhibitors. Retrosynthetic analysis was carried out for each compound to ensure a reasonable 
synthetic route could be determined. Macrocycles were prepared according to the synthetic route 
proposed in „Paragraph 5.4‟. 
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5.4 General chemistry 
 
The construction of the macrocyclic compounds was based on a strategy previously developed in 
the Spring group and on new key reactions that allowed to introduce the desired functionalities. In 
the proposed strategy the structural diversity was achieved by exploiting the chemistry of the azide 
group (Scheme 9). Different starting units, synthesized with conventional chemistry, contributed to 
increase the diversity among the structures. In the first stage, structural diversity was introduced by 
varying the amine and the azide-bearing carboxylic acid. With a triple bond installed on the amine 
compound, intramolecular azide-alkyne cycloaddition with the "click" reaction furnished the 
corresponding 1,4-isomers (B) using Cu-catalysis for the cyclization.  
 
 
Scheme 9.  
 
Beyond the copper-catalysed cycloaddition, enyne metathesis was also used for the cyclization (D) 
(Scheme 10). 
 
Scheme 10. 
 
Moreover, a new one-pot reaction carried out in mild conditions, and without the use of any metal 
catalyst, was employed for the synthesis of tetrazolone derivatives (F) (Scheme 11).  
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Scheme 11. 
The proposed synthetic methodologies are appropriate for the obtainment of the macrocycle 
compounds as for the following key characteristics: i) the desired frameworks were rapidly obtained 
from easily accessible starting materials, ii) the building blocks are commercially available or easily 
synthesized and were combined in one or more synthetic iteration steps which allowed the 
generation of products with the desired features. The final compounds present natural product-like 
motifs with significantly structural diversity to increase the chances of getting new hits. 
 
5.4.1 Synthesis of benzyl macrocycle  
The final benzyl macrocycle B2 was synthesized as shown in Scheme 12. The starting unit B6 was 
prepared in two step from the commercially available propargyl amine. Alkylation with methyl 
bromoacetate led to N-propargyl glycine methyl ester B4 which was reacted with N-Boc β-alanine 
in the presence of the coupling agent 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-
b]pyridinium 3-oxid hexafluorophosphate (HATU)  and N-methylmorpholine (NMM) to afford the 
amido compound B5. Its Boc-protecting group was then hydrolysed with a 4N solution of HCl in 
dioxane to obtain the building block unit B6. Azido building block B7 was synthesized from the 
commercially available 3-chloromethyl benzoic acid which underwent a nucleophilic substitution 
with sodium azide in DMSO. The amidic coupling between compound B6 and B7 led to the 
formation of the linear precursor B8 which were subsequently macrocyclized using copper-
catalysed cycloadditions (CuAAC) providing the 1,4-isomers B3. A basic hydrolysis of the ester 
group was then performed and this led to the formation of the corresponding acid B2 (40% yield). 
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Scheme 12. Reagents and conditions: i) methyl bromoacetate, DIPEA, dry DCM, rt, overnight; ii) N-Boc β-alanine, NMM, HATU, 
dry DCM, rt, overnight; iii) HCL-dioxane 4N, dry DCM, rt, 3h; iv) NaN3, DMSO, 30°C, 5h; v) NMM, HATU, dry DCM, rt, 
overnight; vi) CuI, DIPEA, dry THF, reflux, 120h (C=0.00075M); vii) LiOH, THF/water (2:1), rt, 4h, then HCl-dioxane 4 N, 10min, 
rt.  
 
NovaSyn TGR resin was used to prepare peptide amides utilizing Fmoc chemistry (Scheme 13). 
The resin was pre-swelled in DCM and washed with DMF, then de-protected with 20% piperidine 
in DMF. The peptide sequence is assembled using the standard coupling procedure with HATU as 
the coupling agent and DIPEA as a base. To check if the coupling step had proceed to completion, 
the chloranyl testwas performed for the identification of unreacted amines. Finally the completed 
macrocyclic dipeptide B1 is cleaved from the resin under acidic conditions. 
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Scheme 13. Reagents and conditions: i) 20% piperidine in DMF, 2 x 10 min, rt; ii) Fmoc-Thr(HPO3Bzl)-OH, DIPEA, HATU, 
DMF, rt,  2h; iii) NH-Fmoc-tert-Bu-serine, DIPEA, HATU, DMF, rt, 2h; iv) Macrocycle, DIPEA, HATU, DMF, rt, 2h; v) 95% TFA, 
2.5% TIPS, 2.5% H2O, rt, 2h. 
 
5.4.2 Synthesis of indole macrocycle  
The synthesis of compounds I1 and I2 is shown in Scheme 14.  The commercially available 5-
nitroindole was carboxylated with trifluoroacetic anhydride and following hydrolysis with 1 M 
NaOH to obtain the 5-nitro-1H-indole 3-carboxylic acid I3. The subsequent hydrogenation of the 
nitro group provided the amine I4 which underwent a nucleophilic substitution on the diazonium 
intermediate with sodium azide to afford the azido unit I5. This latter was reacted with the 3-
bromo-1-phenylpropane in the presence of sodium hydride as a base providing compound I6 in 
moderate yield. Then the carboxylic group was condensed with the previously described 
intermediate B6 to obtain the amide I7. This reaction was performed with HATU in the presence of 
N-methylmorpholine at room temperature for 16 h. The subsequent macrocyclization using copper-
catalysed cycloadditions (CuAAC) provided the final compound I2. Unfortunately, the desired 
macrocycle could not be obtained, likely due to its highly strained nature, and only the dimer I2 was 
Chapter 5 – EXPERIENCE ABROAD 
128 
 
found. The basic hydrolysis of esters with lithium hydroxide led to the formation of the 
corresponding carboxylic acid I1. 
 
 
Scheme 14. Reagents and conditions: i) 1) TFAA, dry DMF, reflux, overnight; 2) NaOH 25%, reflux, overnight; ii) H2, Pd/C, 
MeOH, rt, overnight; iii) NaNO2, NaN3, rt, 2h; iv) 3-Br-1-phenylpropane, NaH (60% mineral oil), dry THF, rt, 24h. v) B6, NMM, 
HATU, dry DCM, rt, overnight; vi) CuI, DIPEA, dry THF, reflux, 168h (C=0.00075M); vii) LiOH, THF/water (2:1), rt, 4h, then 
HCl-dioxane 4 N, 10min, rt. 
 
5.4.3 Synthesis of the coumaric acid macrocycle 
As shown in Scheme 15, the precursor of the coumaric acid macrocycle was selected as the 
commercially available 5-bromo-2-hydroxy benzaldehyde. 5-bromo-2-hydroxy m-coumaric acid 
CA1 was synthetized through a one-pot reaction with malonic acid in pyridine. CA1 was then 
treated with allyl bromide and potassium carbonate to obtain the diallyl derivative, which was 
hydrolyzed in basic conditions to afford the allyl ether CA2. The amidic coupling with the 
intermediate B4 allowed the formation of the linear precursor CA3. The subsequent 
macrocyclization using enyne metathesis in the presence of Grubbs second-generation catalyst 
should have led to the coumaric acid macrocycle. Unfortunately, this reaction failed to proceed 
likely due to the interference of the internal double bond of the coumaric scaffold. 
Different reaction conditions were attempted providing in most cases undesired byproducts. The 
synthesis should have been completed by a Suzuki coupling and the final hydrolysis of the ester 
group. 
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Scheme 15. Reagents and conditions: i) malonic acid, piperidine (cat.), dry Py, reflux, 4h; ii) 1) allyl bromide, K2CO3, acetone, 
reflux, 20h; 2) 1 M NaOH, EtOH, reflux, 1h; iii) B4, NMM, HATU, dry DCM, rt, overnight;  
 
 
5.4.4 Synthesis of the urea macrocycle  
In order to synthesize the urea macrocycle, I followed a one-pot procedure described by 
Spyropoulos and Kokotos [156] to obtain the urea containing linear precursor U1 (Scheme 16). 
According to this procedure, the Boc-protected amine U2, obtained from the coupling reaction 
between the commercially available N-Boc ethylenediamine and the intermediate B7, could be 
transformed into a trisubstituted urea through in situ generation of the isocyanate with 2-
chloropyridine and triflic anhydride. Despite the screening of several reaction conditions (See Table 
“Reagents and conditions”), I obtained the linear precursor U2 only as traces.  
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Scheme 16. Reagents and conditions: i) NMM, HATU, dry DCM, rt, overnight; ii) 1.Tf2O, 2-ClPy, 50min, rt; 2. B4, see Table. 
 
 
Starting 
material 
B4 Tf2O NEt3 2-ClPy Solvent Time T 
1 3 1,5 0 3 DCM 20h rt 
1 3 2,5 0 5 DCM 20h rt 
1 3 1,5 6 3 DCM 20h rt 
1 3 1,5 0 3 toluene 20h reflux 
 
The main product I‟ve obtained using toluene as solvent under reflux was the cyclic tetrazolone 
(Scheme 17).   
 
 
Scheme 17. Reagents and conditions: i) NMM, HATU, dry DCM, rt, overnight; ii) 1.Tf2O, 2-ClPy, toluene, 50min, rt; 2. B5, 20h, 
reflux. 
 
This reaction was interesting since it could be a new method to cyclise linear scaffold in one-pot 
reaction without using any metal catalyst and could be applied to several starting building blocks 
X 
X 
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with different chain lengths in order to provide macrocycle of different sizes. Indeed, this reaction 
was employed for the synthesis of the following tetrazole derivative T1. 
 
5.4.5 Synthesis of the tetrazolone macrocycle T1 
As depicted in Scheme 18, the synthesis of tetrazolone macrocycle T1 started from the 
commercially available N-Boc diethylamine which was alkylated with methyl bromoacetate to 
afford compound T2. Then this latter was coupled with the previously synthetized benzyl azide B7 
to provide compound T3. Also in this case, different conditions to obtain the final tetrazolone T1 
were performed (See Table “Reagents and conditions”): reactions carried out at room temperature 
led to the starting material, while changing the solvent and increasing the temperature T1 was 
obtained unfortunately only in low yield.  
 
Scheme 18. Reagents and conditions: i) methyl bromoacetate, DIPEA, dry DCM, rt, overnight;  ii) NMM, HATU, dry DCM, rt, 
overnight; iii) see Table; iv) LiOH, THF/water (2:1), rt, 4h.  
Starting 
material 
Tf2O NEt3 2-ClPy Solvent Time T Yield 
1 1,5 0 3 DCM 20h rt SM 
1 1,5 3 3  toluene 20h rt SM 
1 1,5 0 3 DCE 20h 60°C traces 
1 1,5 0 3 toluene 20h 70°C 15% 
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5.5 Experimental Session  
 
5.5.1 Materials and methods 
Except as otherwise indicated, reactions were carried out using oven-dried glassware under nitrogen 
with dry, freshly distilled solvents. Tetrahydrofuran was distilled from calcium hydride and LiAlH4 in 
the presence of triphenyl methane. Diethyl ether was distilled from calcium hydride and LiAlH4. 
CH2Cl2, MeOH, toluene, MeCN and hexane were distilled from calcium hydride. Petroleum ether 
refers to the 40-60 °C fractions. All other reagents were used as obtained from commercial sources. 
Thin layer chromatography was carried out on glass Merck Kieselgel 60 F254 plates, visualised by 
ultraviolet irradiation (254 and 365 nm) or stains as ninhydrin and potassium permanganate, prepared 
by standard procedures. Retention factors (Rf) are quoted to 0.01. Flash column chromatography was 
carried out using slurry-packed Merck 9385 Kieselgel 60 silica gel under a positive pressure of air or 
nitrogen.  
Preparative HPLC purification was performed on an Agilent 1260 Infinity system fitted with a 
Supelcosil ABZ+Plus column (250 mm x 21.2 mm, 5 μm) using linear gradient systems (solvent A: 
0.1% (v/v) TFA in water, solvent B: 0.05% (v/v) TFA in acetonitrile) at a flow rate of 20 mL min
-1
. 
Analytical HPLC analysis was performed on an Agilent 1260 Infinity system fitted with a Supelcosil 
ABZ+Plus column (150 mm x 4.6 mm, 3 μm) using linear gradient systems (solvent A: 0.05% (v/v) 
TFA in water, solvent B: 0.05% (v/v) TFA in acetonitrile) over 15 min at a flow rate of 1 mL min
-1
. 
Retention times (tr) are reported to the nearest 0.01 min. Peak area percentages are calculated for the 
UV absorbance at 220 nm and reported to the nearest 1%  
Nuclear magnetic resonance (NMR) spectra were recorded using an internal deuterium lock on Bruker 
DPX 400 (400MHz), Bruker Avance 400 QNP Ultrashield (400 MHz), Bruker Avance 500 BB ATM 
(500 MHz) and Bruker Avance 500 Cryo Ultrashield (500 MHz) spectrometers. Chemical shifts (δ) are 
referenced to the solvent signal and are quoted in ppm to the nearest 0.01 ppm for δH and to the nearest 
0.1 ppm for δC. Coupling constants (J) are reported in Hertz to the nearest 0.1 Hz. Assignments are 
supported by DEPT-135, 
1
H-
1
H COSY, HMQC, HMBC and NOESY spectra where necessary. Data 
are reported as follows: chemical shift, multiplicity (br, broad; s, singlet; d, doublet; t, triplet; q, quartet; 
quint, quintet; m, multiplet; or as a combination of these), integration, assignment and coupling 
constant(s). Low resolution mass spectra (ESI) were recorded using an LCMS system (Agilent 1200 
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series LC with an ESCi Multi-Mode Ionization Waters ZQ spectrometer using MassLynx 4.0 
software). High resolution mass spectrometry (HRMS) was carried out with a Micromass Q-TOF or a 
Waters LCT Premier Mass Spectrometer using electrospray ionisation [ESI] or electron ionisation [EI].  
The dipeptide was synthesized on NovaSyn TGR resin (0.25mmol x g) using standard Fmoc-solid 
phase protocol. Fmoc-phosphothreonine and Fmoc tert butyl-serine were purchase from Novabiochem 
and used without any further purification.  
 
5.5.2 General procedures 
5.5.2.1 GP1- Amide formation 
At 0 °C,  the appropriate carboxylic acid (1 eq) was dissolved in dry DCM (0.6 M) followed by 
addition of N-methylmorpholine (1.2 eq) and HATU (1.2 eq). The reaction mixture was stirred for 20 
min at 0 °C then the amine (1.2 eq), dissolved in the minimum amount of solvent, was added. The 
reaction was stirred at room temperature for 16 h. Then the mixture was diluted with water (20 mL) 
and extracted with dichloromethane (3 × 10 mL). The organic layers were washed with a 10 % solution 
of citric acid (3 x 10 mL), dried over MgSO4 and concentrated in vacuo. Purification conditions are 
specified in the description of each product. 
 
5.5.2.2. GP2 – CuAAC macrocyclization 
The linear precursor (1.0 eq) was dissolved in dry THF (0.75 mM) and DIPEA (3 eq) was added. After 
bubbling argon through the solution for 20 min, CuI (2 eq) was added and the mixture was heated to 
reflux until HPLC analysis indicated complete turnover. Subsequently, the solvent was removed and 
the residue was dissolved in CH2Cl2/MeOH (9:1), filtered through a pad of SiO2 and further purified as 
indicated. 
 
5.5.2.3 GP3 - Metathesis macrocyclization 
The linear precursor (1.0 eq) was dissolved in dry CH2Cl2 (1 mM) and ethylene was bubbled through 
the solution for 10 min. Grubbs 2
nd
 generation catalyst (0.2 eq) was added and the reaction was heated 
to reflux under an ethylene atmosphere. When HPLC indicated complete formation of the diene 
intermediate (typically after 4 h), the atmosphere was changed to argon. Refluxing was continued until 
HPLC indicated reaction completion; if an incomplete conversion was observed, additional catalyst 
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was added in portions of 0.1 eq. The solvent was removed under reduced pressure and the crude 
product was purified as indicated. 
 
5.5.2.4 GP4 – Hydrolysis 
The suitable macrocycle (1.0 eq) was dissolved in THF (20 mM) and a solution of LiOH (2.0 eq) in 
water (half of the THF volume) was added at 0 °C. After stirring at room temperature until TLC 
indicated complete reaction (~2 h), the reaction was quenched by the addition of HCl in dioxane (4 M; 
2.5 eq) and stirred for another 10 minutes. The solvent was removed under a stream of nitrogen and the 
residue was purified using preparative HPLC.  
 
5.5.2.5 GP5 - Coupling with dipeptide 
Activation of resin 
The NovaSyn TGR resin (0.25 mmol x g, 1eq) was swelled in dichloromethane (3 x 1 mL) and washed 
with DMF (3 x 1 mL). the Fmoc protecting group is removed by treatment with 20% piperidine in 
DMF under continuous stirring (x 1 min) and then under mild stirring (2 x 10 min). Finally, the resin 
was washed with DMF (3 x 1 mL). 
Chloranil test [157] 
This sensitive test has been developed for reliable detection of primary and secondary amino groups. 
The solution consists of 50 µL chloranil in toluene and 200 µL acetaldehyde. A few beads of resin are 
placed in a small test tube and 2-5 drops of solution are added. After a short mixing the mixture is left 
at room temperature for 5 min and the beads inspected. 
Results: 
colourless to yellowish beads: negative (absence of free amine in the mixture); 
dark blue to green beads: positive, the coupling should be repeated. 
Coupling of aminoacids to the resin 
NH-Fmoc-phosphothreonine was dissolved in the minimum amount of DMF (1 mL) and HATU (2.25 
eq) and DIPEA (4.5 eq) were added. The mixture was stirred at room temperature for 10 min. Then the 
solution was added to the activated resin and stirred for 2 hours at room temperature. 
The coupling was monitored by chloranil test until completion. The resin was washed with DCM (3 x 1 
mL) and dried before the test. 
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The Fmoc protecting group was removed by treatment with 20% piperidine in DMF as described in  
„Activation of resin‟.  
Fmoc tert-butyl serine (4 eq) was coupled to the resin in the presence of HATU (4 eq) and DIPEA (8 
eq) with the same procedure used for NH-Fmoc-pThr. The chloranil color test was performed before 
proceeding to the next step. 
Coupling of macrocycle to the resin. 
The resin was washed with DMF (3 x 1 mL) and the coupling with macrocycle was performed. A 
solution of suitable macrocycle (1 eq), HATU (1 eq) and DIPEA (2 eq) in DMF (1 mL) was added to 
the peptide resin. The mixture was stirred at room temperature for 16 h.  If the chloranil color test has 
been positive, the functionalized resin was washed with DMF (3 x 1 mL), dried with DCM (3 x 1 mL) 
and the TFA cleavage was carried out. 
Cleavage from the resin 
The dipeptide macrocycle was cleaved from the resin by treatment with 2 mL of trifluoroacetic acid: 
triisopropylsilane:H2O (95:2.5:2.5) for 4 h at room temperature. The resin was filtered off and the 
filtrate was concentrated under vacuo. After the addition of cold Et2O, a precipitation of a white solid 
occurred. The precipitate was washed with diethyl ether (3 x 1 mL). The resulting solid was dissolved 
in DMSO and purified with a reverse phase preparative HPLC to afford the final product. 
 
5.5.3 Synthesis of benzyl derivatives (B1-9) 
Synthesis of N-propargyl-glycine methyl ester B4 
 
 
 
DIPEA (570 µL, 3.27 mmol) and methyl bromoacetate (309 µL, 3.27 mmol) were added dropwise to a 
solution of propargyl amine (418 µL, 6.54 mmol, 2.00 eq) in dry CH2Cl2 (11.6 mL). The reaction 
mixture was stirred at room temperature for 16 h and then the solvent was removed. After purification 
by flash column chromatography (petroleum ether/EtOAc 8:2 to 6:4) the title compound B4 was 
isolated. 
Yield: 77 %. Yellow pale oil. Rf = 0.25 (Petroleum ether/ EtOAc 5:5). 
1
H NMR (500 MHz, CDCl3) δ = 
3.76 (s, 3H, CH3), 3.55 (s, 2H, CH2), 3.51 (d, 2H, CH2, J=2.4 Hz,), 2.25 (t, 1H, CH, J = 2.4), 1.55 (br s, 
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1H, NH). 
13
C NMR (125 MHz, CDCl3) δ = 172.3, 81.0, 72.0, 51.9, 49.0, 37.6. HRMS consistent with 
literature data. 
 
Synthesis of N-tert-Butoxycarbonyl-L-alanyl-N-propargyl-L-glycine methyl ester B5 
 
 
 
At 0 °C, to a solution of Boc β-alanine (572 mg, 3.02 mmol) in dry DCM (41 mL) N-methylmorpholine 
(322 μL, 3.02 mmol) was added, followed by HATU (931 mg, 3.02 mmol). The reaction mixture was 
stirred for 20 min at 0 °C whereupon B4 (320 mg, 2.52 mmol), dissolved in the minimum amount of 
solvent, was added. The reaction was stirred at room temperature for 16 h. Then the mixture was 
diluted with water (20 mL) and extracted with dichloromethane (3 × 10 mL). The organic layers were 
washed with a 10 % solution of citric acid (3 x 10 mL), dried over MgSO4 and concentrated in vacuo. 
The crude product was purified by flash chromatography (petroleum ether/EtOAc 8:2 to 6:4) to afford 
compound B5 as a mixture of two rotamers (B5a, B5b) (80 % yield, 1:1.5 ratio). 
Colourless oil. Rf = 0.54 (DCM/MeOH 9:1). 
1
H NMR (400 MHz, CDCl3) (B5a) δ = 4.35 (d, 2H, CH2, 
J = 2.4), 4.22 (s, 2H, CH2), 3.79 (s, 3H, CH3), 3.49 - 3.42 (m, 2H, CH2), 2.46 (t, 2H, CH2, J = 5.6), 2.27 
(t, 1H, CH, J = 2.4), 1.59 (s, 9H, 3CH3); (B5b) δ = 4.25 (s, 2H, CH2), 4.17 (d, 2H, CH2, J = 2.4), 3.76 
(s, 3H, CH3), 3.49 - 3.42 (m, 2H, CH2), 2.67 (t, 2H, CH2, J = 5.6), 2.35 (t, 1H, CH, J = 2.4), 1.45 (s, 9H, 
3CH3); 
13
C NMR (125 MHz, CDCl3) (B5a) δ = 172.1, 169.5, 155.9, 79.2, 73.5, 52.6, 47.6, 38.1, 33.3, 
28.4. (B5b) δ = 171.9, 169.2, 155.9, 78.0, 73.0, 52.2, 46.3, 35.1, 33.2, 28.4. HRMS (ESI+) found m/z 
= 299.1606 [M-H]
+
, C14H23N2O5
+
 required 299.1607. 
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Synthesis of L-alanyl-N-propargyl-L-glycine methyl ester hydrochloride B6 
 
 
 
A solution of Boc-protected methyl ester B5 (605 mg, 2.2 mmol) in dry CH2Cl2 (1.8 mL) was cooled to 
0 °C and 4 M HCl in 1,4-dioxane (2 mL) was added dropwise. The reaction was stirred for 5 h at room 
temperature. The solvent was removed under a stream of N2 to yield amine B6 as a mixture of  two 
rotamers (B6a, B6b) (90 % yield, 1:1.5 ratio) used in the next step without any further purification. 
Orange foam. Rf = 0.12 (DCM/MeOH 9:1). 
1
H NMR (400 MHz, MeOD) (B6a) δ = 4.37 (s, 2H, CH2), 
4.33 – 4.31 (m, 2H, CH2), 3.80 (s, 3H, CH3), 3.26 – 3.20 (m, 2H, CH2), 2.90 (t, 1H, CH, J = 2.4), 2.76 – 
2.72 (m, 2H, CH2). (B6b) δ = 4.33 – 4.31 (m, 2H, CH2), 4.27 (s, 2H, CH2), 3.75 (s, 3H, CH3), 3.26 – 
3.20 (m, 2H, CH2), 2.97 (t, 1H, CH, J = 6.5), 2.76 – 2.72 (m, 1H, CH). 
13
C NMR (100 MHz, MeOD) 
(B6a) δ = 172.3, 171.1, 78.7, 74.4, 53.0, 39.1, 36.9, 36.6, 30.8. (B6b) δ = 172.3, 171.2, 78.4, 75.2, 52.7, 
38.9, 36.8, 36.3, 30.8. HRMS (ESI+) found m/z = 199.1081 [M-H]
+
, C9H15N2O3
+
 required 199.1083. 
 
Synthesis of 3-(Azidomethyl)benzoic acid B7 [158] 
 
 
 
3-(Chloromethyl)benzoic acid (500 mg, 2.93 mmol) was dissolved in DMSO (10 mL, C = 0.3M), and 
sodium azide (230 mg, 3.52 mmol) was added. After stirring at 30 °C for 5 h, the reaction mixture was 
diluted with water (10 mL) and extracted with EtOAc (4 × 3 mL). The combined organic layers were 
washed with water and brine and dried over Mg2SO4. The solvent was removed under reduced pressure 
to give the crude azide B7. 
Yield: 86 %. White solid. Rf = 0.42 (Hexane/ EtOAc 5:5); m.p. 68-69°C. 
1
H NMR (500 MHz, CDCl3) 
δ = 8.10 (dt, 1H, ArH, J = 7.7, J = 1.5), 8.07 (s, 1H, ArH), 7.60 (dt, 1H; ArH, J = 7.7, J = 1.4), 7.52 (t, 
1H, ArH, J = 7.7), 4.44 (s, 2H, CH2). 
13
C NMR (125 MHz, CDCl3, 27 °C) δ = 170.9, 136.5, 133.8, 
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130.5, 130.2, 130.1, 129.6, 54.7. HRMS (ESI-) found m/z = 176.0465 [M-H]
-
, C8H6N3O2
-
 required 
176.0465.  
 
Synthesis of the linear benzyl amide B8 
  
 
 
GP1 was followed to prepare the linear compound B8 from intermediates B6 and B7. The crude 
product was purified by flash chromatography (petroleum ether/EtOAc 8:2 to 5:5) as a mixture of two 
rotamers (B8a, B8b) (88 % yield, 1.5:1 ratio). 
Colourless oil. Rf = 0.28  (Hexane/EtOAc 3:7). HPLC tr = 12.52 min (10-60 % B). 
1
H NMR (400 
MHz, CDCl3) (B8a) δ = 7.77 – 7.71 (m, 2H, ArH), 7.48 – 7.45 (m, 2H, ArH), 7.12 (br s, 1H, NH), 4.42 
(s, 2H, CH2), 4.36 (d, 1H, CH2, J = 2.4), 4.18 (t, 1H, CH2, J = 2.4), 3.87 – 3.79 (m, 2H, CH2), 3.77 (s, 
3H, CH3), 2.82 (t, 2H, CH2, J = 5.6), 2.33 (t, 1H, CH, J = 2.4); (B8b) δ = 7.77 – 7.71 (m, 2H, ArH), 
7.48 – 7.45 (m, 2H, ArH), 7.12 (br s, 1H, NH), 4.27 (s, 2H, CH2), 4.23 (d, 1H, CH2, J = 2.4), 4.18 (d, 
1H, CH2, J = 2.4), 4.15 (s, 1H, CH2), 4.13 (s, 1H, CH2), 3.78 (s, 3H, CH3), 2.60 (t, 2H, CH2, J = 5.6), 
2.27 (t, 1H, CH, J = 2.4). 
13
C NMR (125 MHz, CDCl3) (B8a)  δ = 172.3, 169.5, 166.8, 136.0, 135.1, 
131.0, 129.0, 126.9, 126.7, 77.8, 73.8, 54.4, 52.3, 46.7, 38.3, 35.4, 32.6; (B8b)  δ = 172.0, 169.1, 166.8, 
135.9, 135.1, 131.0, 129.0, 126.9, 126.7, 77.8, 73.2, 54.4, 52.6, 47.7, 35.4, 35.3, 32.7. HRMS (ESI+) 
found m/z = 358.1515 [M-H]
+
, C17H20N5O4
+
 required 358.1508. 
 
Synthesis of benzyl macrocycle ester B3 
 
The linear precursor B8 (50 mg, 0.140 mmol) was reacted according to general procedure GP2 for 120 
h. The reaction progress was monitored by analytical HPLC (Figure 60). After purification by 
preparative HPLC (10-60 % B), title compound B3 was isolated. 
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Yield: 50 %. White foam. Rf = 0.20 (DCM/MeOH 9:1). HPLC tr = 6.13 min (10-60 % B); 
1
H NMR 
(400 MHz, MeOD) δ = 8.27 (s, 1H, ArHtetrazole), 7.56 (d, 2H, ArH, J = 7.6), 7.48 (t, 1H, ArH, J = 7.6), 
6.14 (s, 1H, ArH), 5.90 (d, 1H, CH2, J = 16.8), 5.75 (d, 1H, CH2, J = 16.8), 5.41 (d, 1H, CH2, J = 14.4), 
4.60 (d, 1H, CH2, J = 18.6), 4.38 (d, 1H, CH2, J = 18.6), 4.07 (d, 1H, CH2, J = 14.4), 3.70 (dd, 1H, CH2, 
J = 2.8, J = 13.2), 3.48 (td, 1H, CH2, J = 2.8, J = 13.2), 3.60 (s, 3H, CH3), 2.77 – 2.68 (m, 1H, CH2), 
2.44 (d, 1H, CH2, J = 15.2). 
13
C NMR (125 MHz, MeOD)  δ = 173.6, 171.7, 171.4, 145.4, 138.2, 
138.0, 130.3, 129.5, 128.8, 127.0, 125.4, 53.6, 53.0, 52.4, 45.1, 36.7, 33.0. HRMS (ESI+) found m/z = 
358.1512 [M-H]
+
, C17H20N5O4
+
 required 358.1515. 
 
Synthesis of benzyl macrocycle carboxylic acid B2 
 
 
 
Benzyl macrocyclic ester B3 (50 mg, 0.140 mmol) was reacted according to general procedure GP4. 
After purification by preparative HPLC (2.5-50 % B) title compound B2 was isolated. 
Yield: 49 %. White foam. HPLC tr = 7.88 min (2.5-50 % B). 
1
H NMR (400 MHz, MeOD) δ = 8.24 (s, 
1H, CH), 7.54 (d, 2H, ArH, J = 7.6), 7.47 (t, 1H, ArH, J = 7.6), 6.10 (s, 1H, ArH), 5.82 (q, 1H, CH2, J = 
0
20
40
60
80
100
120
0 48 69 94 118 150
A
re
a 
%
 
Time (h) 
Product
Byproduct
Linear precursor
Figure 60. Reaction progress.   
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16.8), 5.40 (d, 1H, CH2, J = 14.8), 4.38 (d, 1H, CH2, J = 16.8), 4.08 (d, 1H, CH2, J = 14.8), 3.50 (td, 
1H, CH2, J = 2.8, J = 13.6), 3.49 (dd, 1H, CH2, J = 2.8, J = 13.6), 2.87 – 2.78 (m, 1H, CH2), 2.40 (d, 
1H, CH2, J = 16.8). 
13
C NMR (125 MHz, MeOD)  δ = 172.1, 171.5, 170.2, 144.1, 136.9, 136.4, 128.8, 
128.5, 127.9, 127.5, 125.6, 124.4, 52.3, 44.3, 36.3, 30.7. HRMS (ESI+) found m/z = 344.1344 [M-H]
+
, 
C16H18N5O4
+
 required 344.1353. 
 
Synthesis of dipeptidic benzyl macrocycle B1 
 
 
 
The dipeptidic benzyl macrocycle B1 was synthesized according to GP5 using standard Fmoc-solid 
phase protocol. Purification was performed by preparative HPLC (2.5-20 % B).    
Yield: 17 %. White foam. HPLC tr = 8.025 min (2.5-50 % B). HRMS (ESI+) found m/z = 611.1956 
[M-H]
+
, C23H32N8O10P1
+
 required 611.1974. 
 
5.5.4 Synthesis of indole derivatives (I1-7) 
Synthesis of 5-nitro-1H-indole 3-carboxylic acid I3 [159] 
 
 
 
5-Nitroindole (2 g, 12.33 mmol) was dissolved in dry DMF (30.8 mL) under an atmosphere of 
nitrogen. At 0 °C trifluoroacetic anhydride (3.43 mL, 24.66 mmol) was added dropwise and the 
reaction mixture was stirred at reflux for 16 h. DMF was then removed under reduced pressure and 25 
% NaOH was added. The resulting solution was stirred at reflux for another 16 h. After the completion 
of the reaction monitored by TLC, the black solid was filtered off and the solution was cooled to 0°C 
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and adjusted to pH = 2 by the careful addition of concentrated hydrochloric acid. The precipitate was 
collected by filtration and dried. 
Yield: 90 %. Brown solid. Rf = 0.50 (Hexane/EtOAc 1:1). 
1
H NMR, 
13
C NMR, HRMS consistent 
with literature data. 
 
Synthesis of 5-nitro-1H-indole 3-carboxylic acid I4 [158] 
 
 
 
5-Nitro-1H-indole-3-carboxylic acid I3 (900 mg, 4.36 mmol) and Pd/C (180 mg, 0.2 eq) were 
suspended in dry MeOH (30 mL) and stirred vigorously under an atmosphere of hydrogen at room 
temperature overnight. The catalyst was removed by filtration through a pad of Celite and and the 
solvent removed under reduced pressure affording 5-amino-1H-indole-3-carboxylic acid I4.  
Yield: 97 %. Dark brown solid. Rf = 0.16 (CH2Cl2/MeOH 9:1); mp 155 °C; 
1
H NMR (400 MHz, 
DMSO-d6) δ = 11.30 (s, 1H; NH), 7.71 (s, 1H, CH), 7.26 (d, 1H, ArH, J = 2.0), 7.10 (d, 1H, ArH, J = 
8.5), 6.52 (dd, 1H, ArH, J = 8.5, J = 2.0), 4.63 (br s, 2H, NH2); 
13
C NMR (100 MHz, DMSO-d6) δ = 
167.4, 143.0, 131.0, 129.9, 127.6, 112.1, 112.0, 107.5, 104.2; HRMS (ESI+) m/z = 132.0685 [M-
CO2]
+
 found, C8H8N2
+
 required 132.0682. 
 
Synthesis of 5-Azido-1H-indole-3-carboxylic acid I5 
 
 
 
5-Amino-1H-indole-3-carboxylic acid I4 (750 mg, 4.26 mmol) was dissolved in 2 M HCl (13.3 mL) at 
-10 °C (ice/NaCl bath). Then NaNO2 (308 g, 4.47 mmol, dissolved in 13 mL of water) was added 
dropwise and the solution was stirred for 20 min at -10 °C. The mixture was added to a solution of 
NaN3 (290 mg, 4.47 mmol) in ice water (13 mL). The reaction was warmed to room temperature and 
stirred for 2 h. Then concentrated HCl (2.7 mL) was added and the mixture was filtered. The resulting 
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solid was washed with water (10 mL) and petroleum ether (10 mL) and subsequently dried in vacuo 
affording 5-azido-1H-indole-3-carboxylic acid I5. 
Yield: 66 %. Brown solid. Rf = 0.34 (CH2Cl2/MeOH 9:1); mp 160 °C decomposition; 
1
H NMR (400 
MHz, DMSO-d6) δ = 12.05 (br s, 1H; CO2H), 11.93 (br s, 1H; NH), 8.05 (d, 1H, CH, J = 3.0), 7.69 (d, 
1H, ArH, J = 2.3), 7.50 (d, 1H, ArH, J = 8.6), 6.93 (dd, 1H, ArH, J = 8.6, J = 2.3); 
13
C NMR (100 
MHz, DMSO-d6) δ = 165.6, 134.1, 133.5, 132.5, 126.9, 114.2, 113.7, 109.7, 107.0; HRMS (ESI+) m/z 
= 174.0423 [M-N2]
+
 found, C9H6N2O2
+
 required 174.0424. 
 
Synthesis of 5-azido-1-(3-phenylpropyl)-indole-3-carboxylic acid I6 
 
 
 
To a solution of I5 (200 mg, 0.99 mmol) in dry THF (1.6 mL), NaH (60% in mineral oil, 60 mg, 2.47 
mmol) and a 3 M solution of 3-bromo-1-phenyl propane (165 µL, 1.08 mmol) in THF were added. The 
mixture was stirred at room temperature for 24 h. The solvent was evaporated under reduced pressure 
and the residue was diluted with 2 M HCl and extracted with ethyl acetate (3 x 4 mL). The organic 
layers were collected, dried over anhydrous MgSO4 and evaporated under reduced pressure. Upon 
purification by flash chromatography (CH2Cl2/MeOH  from 98:2 to 95:5) the final product I6 was 
obtained. 
Yield: 25 %. Brown solid. Rf = 0.30 (Hexane/EtOAc 4:6). 
1
H NMR (400 MHz, CDCl3) δ = 7.94 (d, 
1H, CH, J = 1.6), 7.33 (t, 1H, ArH, J = 7.2), 7.18 (d, 1H, ArH, J = 5.6), 6.96 (dd, 1H, ArH, J = 7.2, J = 
1.6), 4.17 (t, 2H, CH2, J = 6.0), 2.69 (t, 2H, CH2, J = 6.0), 2.26 (t, 2H, CH2, J = 6). 
13
C NMR (125 
MHz, CDCl3) δ = 202.3, 168.7, 140.0, 136.1, 134.8, 134.2, 128.7, 128.3, 127.9, 126.4, 115.1, 111.4, 
111.2, 105.8, 53.4, 46.5, 32.7, 31.0. HRMS (ESI+) found m/z = 321.1354 [M-H]
+
, C18H17N4O2
+
 
required 321.1352. 
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Synthesis of the linear azido indole I7 
 
 
GP1 was followed to prepare the linear compound I7 from intermediates (I6, B6). The crude product 
was purified by flash chromatography (petroleum ether/EtOAc 8:2 to 2:8). 
Yield: 55 %. Jelly-like orange solid. Rf = 0.25 (Hexane/EtOAc 2:8). 
1
H NMR and 
13
C NMR 
Appropriate NMR data could not be obtained for this compound due to the existence of rotamers (I7a, 
I7b) at a temperature range of 25-120 °C. The purity of the final compound was determinated by 
HPLC analysis and were > 95 %. HRMS (ESI+) found m/z = 501.2290 [M-H]
+
, C27H29N6O4
+
 required 
501.2250. 
 
Synthesis of indole macrocycle ester I2 
 
 
 
The linear precursor  I7 (50 mg, 0.10 mmol) was reacted according to GP2 for 150 h (Figure 61). After 
purification by preparative HPLC (50-100 % B), title compound I2 was isolated. 
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Dimer formation as a result of an intermolecular cyclization was mainly observed (for details see 
„Chapter 5.4.2‟) .  
Yield: 20%. Yellow foam. Rf = 0.33 (DCM/MeOH 9:1). HPLC tr = 6.641 min (50-100 % B); 
1
H 
LCMS (ESI+) m/z = 1001.6 [M+H]
+
.  
 
Synthesis of indole macrocycle carboxylic acid I1 
 
 
 
Indole macrocycle ester I2 (20 mg, 0.04 mmol) was reacted according to GP4. After purification by 
preparative HPLC (40-70 % B), title compound I1 was isolated. 
Yield: 20 %. White foam. HPLC tr = 8.681 min (40-70 % B). HRMS (ESI-) found m/z = 971.4005 
[M-H]
-
, C16H18N5O4
+
 required 971.3953. 
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Figure 61. Reaction progress.   
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5.5.5 Synthesis of m-coumaric acid derivatives (CA1-3) 
Synthesis of 2-bromo-5-hydroxy cinnamic acid CA1 
 
 
 
To a solution of 2-bromo-5-hydroxybenzaldehyde (1 g, 4.97 mmol) in pyridine (6.6 mL), malonic acid 
(1.139 g, 10.95 mmol) and piperidine (86 µL, 0.99 mmol) were added. The reaction mixture was stirred 
under reflux for 4 h and then cooled to room temperature. The solution was poured into 2N ice-cold 
aqueous HCl (2 mL) and the precipitate was collected by filtration, washed with water and died under 
vacuum. 
Yield: 69 %. White solid. Rf = 0.39 (DCM/MeOH 9:1). 
1
H NMR (400 MHz, MeOD) δ = 7.94 (d, 1H, 
CH, J = 16), 7.42 (d, 1H, ArH, J = 8.8), 7.13 (d, 1H, ArH, J = 2.8), 6.75 (dd, 1H, ArH, J = 2.8, J = 8.8), 
6.36 (d, 1H, CH, J = 16). 
13
C NMR (125 MHz, MeOD)  δ = 158.6, 144.3, 136.1, 135.1, 120.3, 115.1, 
115.0. HRMS (ESI+) found m/z = 264.9466 [M-Na]
+
, C9H7O3
79
Br
23
Na
+
 required 264.9471. 
 
Synthesis of 2-bromo-5allyloxy-cinnamic acid CA2 
 
 
 
Allyl bromide (21.3 µL, 0.246 mmol) and potassium carbonate (57 mg, 0.410 mmol) were added to a 
solution of 2-bromo-5-hydroxy cinnamic acid CA1 (50 mg, 0.205 mmol) in acetone (5 mL). The 
resulting mixture was stirred under reflux for 18 h. Then the solvent was removed in vacuo and the 
remaining residue was poured into water and extracted with ethyl acetate (1 x 3 mL). Flash 
chromatography (eluent: petroleum ether/ethyl acetate from 10 to 9:1) of the crude product gave the 
diallyl compound. 
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Yield: 85 %. White solid. Rf = 0.47 (Hexane/EtOAc 8:2). 
1
H NMR (400 MHz, CDCl3) δ = 8.05 (d, 1H, 
CH, J = 16), 7.50 (d, 1H, ArH, J = 8.8), 7.16 (d, 1H, ArH, J = 2.8), 6.85 (dd, 1H, ArH, J = 2.8, J = 8.8), 
6.40 (d, 1H, CH, J = 16), 6.06 – 5.99 (m, 2H, CH), 5.43 (ddd, 2H, CH2, J = 1.6, J = 2.8, J = 10), 5.32 
(ddd, 2H, CH2, J = 1.6, J = 2.8, J = 10), 4.75 (dt, 2H, CH2, J = 1.2, J = 5.6), 4.57 (dt, 2H, CH2, J = 1.2, J 
= 5.6). 
13
C NMR (125 MHz, CDCl3)  δ = 165.9, 157.9, 143.4, 135.0, 134.0, 132.5, 132.1, 120.7, 118.4, 
118.3, 118.1, 116.1, 113.5, 69.1, 65.4. HRMS (ESI+) found m/z = 345.0083 [M-Na]
+
, 
C15H15O3
79
Br
23
Na
+
 required 245.0097. 
 
 
 
The allyl 2-bromo-5-allyoxy cinnamate (56 mg, 0.173 mmol) was dissolved in ethanol (1 mL) and an 
aqueous solution of 1 N NaOH (0.259 mL, 1.5 eq) was added. The solution was stirred at reflux for 1 h. 
Then the solvent was removed under reduced pressure and the residue was diluted with water (5 mL) 
and extracted with ethyl acetate (1 x 2 mL). The aqueous layer was acidified with 2 N HCl (1 mL) and 
extracted with ethyl acetate (3 x 2 mL). The organic layer was dried over MgSO4 anhydrous and 
evaporated under reduced pressure to afford 2-bromo-5-allyloxy cinnamic acid CA2 which was used in 
the next step without any further purification. 
Yield: quantitative. Brown solid. Rf = 0.57 (DCM/MeOH 8.5:1.5). 
1
H NMR (400 MHz, MeOD) δ = 
7.99 (d, 1H, CH, J = 16), 7.54 (d, 1H, ArH, J = 8.8), 7.30 (d, 1H, ArH, J = 2.8), 6.94 (dd, 1H, ArH, J = 
2.8, J = 8.8), 6.47 (d, 1H, CH, J = 16), 6.11 – 6.07 (m, 1H, CH), 5.44 (dd, 1H, CH2, J = 1.2, J = 17.6), 
5.29 (dd, 1H, CH2, J = 1.2, J = 17.6), 4.61 (dt, 2H, CH2, J = 1.2, J = 5.2). 
13
C NMR (125 MHz, MeOD)  
δ = 169.7, 159.7, 144.2, 136.3, 135.1, 134.4, 122.6, 119.8, 117.9, 116.7, 114.6, 70.1. HRMS (ESI+) 
found m/z = 304.9780 [M-Na]
+
, C12H11O3
79
Br
23
Na
+
 required 304.9784. 
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Synthesis of linear methyl 2-(3-(5-(allyloxy)-2-bromophenyl)-N-(prop-2-ynyl)acrylamido) 
acetate CA3 
 
 
 
GP1 was followed to prepare the linear compound CA3 from intermediates CA2 and B4. The crude 
product was purified by flash chromatography (petroleum ether/EtOAc 8:2 to 6:4) and linear 
compound CA3 was isolated as a mixture of two rotamers (CA3a, CA3b) (88 % yield, 1.6:1 ratio). 
Colourless oil. Rf = 0.36 (Hexane/EtOAc 6:4). HPLC tr = 8.802 min (60-100 % B); 
1
H NMR (500 
MHz, CDCl3) (CA3a) δ = 7.92 (d, 1H, CH, J = 16), 7.48 (d, 1H, ArH, J = 8.8), 7.06 (s, 1H, ArH), 6.83 
– 6.79 (m, 1H, ArH), 6.55 (d, 1H, CH, J = 15), 6.08 – 6.00 (m, 1H, CH), 5.43 (d, 1H, CH2, J = 17.5), 
5.33 (d, 1H, CH2, J = 10.5), 4.56 (d, 2H, CH2, J = 5), 4.44 (s, 2H, CH2), 4.32 (s, 3H, CH3), 3.77 (d, 2H, 
CH2, J = 13.5), 2.28 (s, 1H, CH); (CA3b) δ = 7.97 (d, 1H, CH, J = 16), 7.48 (d, 1H, ArH, J = 8.8), 7.15 
(d, 1H, ArH, J = 2.5), 6.83 – 6.79 (m, 2H, CH, ArH), 6.08 – 6.00 (m, 1H, CH), 5.43 (d, 1H, CH2, J = 
17.5), 5.33 (d, 1H, CH2, J = 10.5), 4.56 (d, 2H, CH2, J = 5), 4.35 (s, 2H, CH2), 4.32 (dd, 2H, CH2, J = 
2.5, J = 10.5), 3.77 (s, 3H, CH3), 2.39 (s, 1H, CH). 
13
C NMR (125 MHz, CDCl3) (CA3a) δ = 169.3, 
166.2, 157.9, 142.4, 135.8, 134.0, 132.6, 119.9, 118.3, 177.2, 115.8, 114.4, 78.0, 73.1, 69.2, 52.6, 48.1, 
35.7; (CA3b) δ = 169.6, 166.3, 157.9, 142.4, 135.8, 134.0, 132.6, 119.6, 118.3, 177.4, 115.9, 114.2, 
77.8, 73.7, 69.2, 52.3, 47.1, 38.6. HRMS (ESI+) found m/z = 392.0519 [M-H]
+
, C18H19NO4Br
+
 
required 392.0497. 
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5.5.5 Synthesis of tetrazolone derivatives (T1-3) 
Synthesis of methyl 2-(2-(tert-butoxycarbonylamino)ethylamino)acetate T2 
 
 
 
DIPEA (114 µL, 0.654 mmol) and methyl bromoacetate (62 µL, 0.654 mmol) were added dropwise to 
a solution of N-Boc ethylenediamine (207 µL, 1.30 mmol) in dry CH2Cl2 (2.32 mL). The reaction 
mixture was stirred at room temperature for 16 h and then the solvent was removed. After purification 
by flash column chromatography (petroleum ether/EtOAc 8:2 to 1:9), the title compound T2 was 
isolated. 
Yield: 57 %. Yellow pale oil. Rf = 0.44 (DCM/MeOH 9:1). 
1
H NMR (400 MHz, CDCl3) δ = 5.02 (br s, 
1H, NH), 3.70 (s, 3H, CH3), 3.46 (s, 2H, CH2), 3.25 (q, 2H, CH2, J = 5.6), 2.79 (t, 2H, CH2, J = 5.6), 
1.86 (br s, 1H, NH), 1.47 (t, 9H, 3CH3). 
13
C NMR (125 MHz, CDCl3) δ = 172.7, 156.1, 79.3, 51.9, 
50.2, 48.8, 40.0. HRMS (ESI+) found m/z = 233.1505 [M-H]
+
, C10H21N2O4
+
, required 233.1501. 
 
Synthesis of the linear methyl 2-(3-(azidomethyl)-N-(2-(tert-butoxycarbonylamino) 
ethylbenzamido) acetate T3 
 
 
 
GP1 was followed to prepare the linear compound T3 from intermediates T2, B7). The crude product 
was purified by flash chromatography (petroleum ether/EtOAc 8:2 to 4:6) as a mixture of two rotamers 
(T3a, T3b) (61 % yield, 1:1.5 ratio) 
Colourless oil. Rf = 0.25 (Petroleum ether/ EtOAc 1:1). 
1
H NMR (400 MHz, CDCl3) (T3a) δ = 7.43 (t, 
2H, ArH, J = 8), 7.39 (dd, 1H, ArH, J = 2, J = 8), 7.38 (s, 1H, ArH), 4.40 (s, 2H, CH2), 4.25 (s, 2H, 
CH2), 3.84 (s, 3H, CH3), 3.48 – 3.46 (m, 2H, CH2), 3.20 (d, 2H, CH2, J = 5), 1.41 (s, 9H, 3 CH3); (T3b) 
δ = 7.43 (t, 2H, ArH, J = 8), 7.39 (dd, 1H, ArH, J = 2, J = 8), 7.38 (s, 1H, ArH), 4.35 (s, 2H, CH2), 4.03 
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(s, 2H, CH2), 3.72 (s, 3H, CH3), 3.68 (s, 2H, CH2), 3.48 – 3.46 (m, 2H, CH2), 1.43 (s, 9H, 3 CH3). 
13
C 
NMR (125 MHz, CDCl3) (T3a) δ =172.0, 170.3, 155.6, 136.0, 129.2, 126.8, 126.5, 79.6, 54.3, 52.5, 
50.7, 47.6, 38.6, 28.4; (T3b) δ =172.2, 170.0, 155.9, 136.0, 129.6, 126.4, 126.3, 79.6, 54.3, 52.5, 51.4, 
46.8, 38.5, 28.4. HRMS (ESI+) found m/z = 392.1957 [M-H]
+
, C18H26N5O5
+
, required 392.1934. 
 
Synthesis of methyl ester tetrazolone macrocycle T1 
 
 
 
Boc-protected amine T3 (100 mg, 0.255 mmol) was dissolved in dry toluene (10.5 mL) and 2-
chloropyridine (72 µL, 0.762 mmol) and trifluoromethanesulfonic anhydride (64 µL, 0.384 mmol) 
were added. The reaction mixture was stirred at room temperature for 2 hours. After the formation of 
the isocyanate intermediate, the reaction was heated at 70 °C for 1 hours. Then the solvent was 
evaporated, the residue diluted with CH2Cl2 (10 mL) and washed with a solution of 10 % citric acid (3 
x 3 mL). The organic phase was dried over Mg2SO4, filtered and evaporated under reduced pressure. 
The crude was purified by flash column chromatography (petroleum ether/EtOAc 5:5 to 4:6) to afford 
the final product T1. 
Yield: 15 %. Colourless oil. Rf = 0.33 (Petroleum ether/ EtOAc 3:7). 
1
H NMR (400 MHz, CDCl3) δ =  
7.59 (dd, 1H, ArH, J = 2, J = 8), 7.57 (s, 1H, ArH), 7.48 – 7.41 (m, 2H, ArH), 4.42 (s, 2H, CH2), 4.10 
(t, 2H, CH2, J = 7.2), 4.05 (s, 2H, CH2), 3.79 (s, 3H, CH3), 3.67 (t, 2H, CH2, J = 7.6). 
13
C NMR (125 
MHz, CDCl3) δ = 169.7, 168.8, 154.5, 135.0, 134.9, 130.8, 128.6, 128.3, 128.0, 54.4, 52.4, 44.9, 41.7, 
40.8. HRMS (ESI+) found m/z = 318.1210 [M-H]
+
, C14H16N5O4
+
, required 318.1202.  
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5.6 Final remarks 
In conclusion, during my experience abroad several derivatives, potentially targeting the Plk1 polo-box 
like domain and the tyrosine pocket were designed and synthesized. This work is a part of a wider 
research project, in which various classes of derivatives will be investigated in order to identify lead 
compounds to further develop as Plk1 inhibitors. Several techniques will be exploited to assess the in 
vitro biological activity of the synthesized compounds. Fluorescent Polarization (FP) will be used to 
test not only the final compounds, but also the linear precursors and the key fragments in order to 
investigate the importance of the macrocyclic scaffold. Isothermal Titration Calorimetry (ITC), Mass 
Spectroscopy (MS) and Surface Plasmon Resonance (SPR) will also be used for the most powerful hits 
to identify compounds that bind to the targeted protein interface, followed by X-ray crystallography to 
define the precise location and orientation of binding.    
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6. APPENDIX 
 
APPENDIX 1a 
Zosteric acid derivatives 
 
  
Planktonic growth Cells adhesion 
Cmp Conc. (µM) Average (OD600/min) St.dev (OD600/min) err% ANOVA diff cont % Level Average (n°cell) St.dev (n°cell) err% ANOVA diff cont % Level 
ZA 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,32E-03 6,23E-05 4,72 a 2,86 0 2,77E+07 1,68E+06 6,08 d 44,59 + 
1,83 1,31E-03 3,80E-05 2,91 a 1,76 0 1,54E+07 2,91E+06 18,91 c -19,76 0 
18,3 1,29E-03 3,92E-05 3,05 a 0,11 0 1,55E+07 1,92E+06 12,44 c -19,34 0 
183 1,30E-03 4,12E-05 3,17 a 1,07 0 1,39E+07 1,33E+06 9,59 c -27,67 - 
1830 1,30E-03 4,35E-05 3,35 a 1,21 0 5,64E+06 1,16E+06 20,51 a -70,56 - - - 
2 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,31E-03 2,54E-05 1,94 ab 2,06 0 2,29E+07 1,62E+06 7,09 b 19,37 0 
1,83 1,26E-03 4,50E-05 3,56 abc -1,72 0 1,03E+07 1,35E+06 13,08 ce -46,05 - - - 
18,3 1,23E-03 1,50E-05 1,22 abc -3,99 0 1,42E+07 2,42E+06 17,00 de -25,80 - 
183 1,23E-03 6,03E-05 4,88 abc -3,87 0 1,49E+07 1,43E+06 9,60 de -22,36 - 
1830 9,74E-04 3,80E-05 3,91 e -24,17 - - 1,22E+07 2,67E+06 21,92 cde -36,38 - - 
3 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 bef 0,00 0 
0,183 1,24E-03 4,33E-05 3,49 abcd -3,32 0 1,25E+07 4,29E+06 34,40 cdef -34,95 - - 
1,83 1,22E-03 9,79E-06 0,80 abcdf -4,74 0 1,17E+07 1,67E+06 14,20 cdf -38,77 - - 
18,3 1,19E-03 4,10E-05 3,46 bcdef -7,58 0 1,78E+07 1,04E+06 5,85 bcef -7,37 0 
183 1,14E-03 4,83E-05 4,25 def -11,37 - 1,44E+07 1,54E+06 10,75 bcdef -25,03 - 
1830 8,33E-04 2,11E-05 2,53 h -35,10 - - - 1,32E+07 2,77E+06 20,95 cdef -31,11 - - 
4 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 bceh 0,00 0 
0,183 1,24E-03 2,45E-05 1,97 ac -3,14 0 1,92E+07 2,64E+06 13,73 bcefgh 0,37 0 
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1,83 1,23E-03 3,23E-05 2,62 ac -4,12 0 1,17E+07 1,10E+06 9,47 defl -39,15 - - 
18,3 1,14E-03 8,20E-06 0,72 df -11,53 - 1,58E+07 1,26E+06 7,97 bcdefghl -17,47 0 
183 1,15E-03 6,23E-05 5,42 de -10,43 - 1,36E+07 2,44E+06 17,90 bcdefghl -28,79 - 
1830 9,42E-04 4,27E-05 4,54 g -26,65 - - 1,14E+07 2,55E+06 22,35 df -40,52 - - - 
5 
0 1,28E-03 2,54E-05 1,98 ab 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,34E-03 7,14E-05 5,33 ab 4,38 0 1,82E+07 4,40E+06 24,16 bcd -4,88 0 
1,83 1,29E-03 5,23E-05 4,06 abc 0,19 0 1,82E+07 1,14E+06 6,26 bcd -5,16 0 
18,3 1,22E-03 5,23E-05 4,28 bc -4,95 0 1,63E+07 2,90E+06 17,75 bcd -14,70 0 
183 1,21E-03 2,90E-05 2,39 c -5,56 0 1,54E+07 2,97E+06 19,36 cd -19,83 0 
1830 9,87E-04 2,77E-05 2,80 d -23,12 - - 1,30E+07 3,33E+06 25,60 d -32,21 - - 
6 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,25E-03 4,30E-05 3,44 a -2,79 0 1,75E+07 2,13E+06 12,19 bcd -8,89 0 
1,83 1,27E-03 2,98E-05 2,34 a -0,79 0 1,43E+07 2,46E+06 17,30 cde -25,63 - 
18,3 1,30E-03 4,51E-05 3,48 a 1,06 0 1,18E+07 3,11E+06 26,45 de -38,64 - - 
183 1,12E-03 2,07E-06 0,18 b -12,86 - 1,40E+07 3,07E+06 21,98 cde -27,19 - 
1830 8,31E-04 2,10E-05 2,52 c -35,27 - - - 1,14E+07 2,18E+06 19,06 de -40,36 - - - 
7 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,30E-03 4,13E-05 3,18 a 1,24 0 1,84E+07 2,97E+06 16,13 b -3,87 0 
1,83 1,27E-03 3,05E-05 2,40 a -0,96 0 1,82E+07 1,60E+06 8,81 b -5,10 0 
18,3 1,24E-03 4,17E-05 3,35 a -3,05 0 1,13E+07 7,40E+05 6,57 c -41,17 - - - 
183 1,29E-03 1,80E-05 1,39 a 0,38 0 7,85E+06 1,06E+06 13,45 a -59,02 - - - 
1830 7,73E-04 1,98E-05 2,57 c -39,82 - - - 1,09E+07 1,77E+06 16,19 c -43,00 - - - 
8 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,26E-03 4,50E-05 3,57 a -1,86 0 1,81E+07 1,82E+06 10,06 bcdf -5,41 0 
1,83 1,24E-03 2,10E-05 1,69 a -3,08 0 1,47E+07 1,73E+06 11,83 cdef -23,51 - 
18,3 1,24E-03 2,28E-05 1,83 a -3,14 0 1,19E+07 2,25E+06 18,92 deg -37,94 - - 
183 1,25E-03 5,88E-05 4,70 a -2,43 0 1,57E+07 1,81E+06 11,54 cdf -18,09 0 
1830 8,68E-04 2,46E-05 2,83 d -32,40 - - - 1,10E+07 2,81E+06 25,41 deg -42,38 - - - 
9 0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
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0,183 1,29E-03 2,82E-05 2,19 a 0,12 0 1,73E+07 3,18E+06 18,34 bcd -9,57 0 
1,83 1,26E-03 1,80E-05 1,43 a -1,99 0 1,75E+07 3,70E+06 21,10 bc -8,60 0 
18,3 1,31E-03 3,99E-07 0,03 a 1,90 0 1,88E+07 4,12E+06 21,95 bc -1,95 0 
183 1,28E-03 4,72E-05 3,69 a -0,41 0 1,56E+07 2,04E+06 13,06 bcd -18,67 0 
1830 9,65E-04 4,19E-05 4,35 c -24,88 - - 1,18E+07 2,26E+06 19,18 cd -38,63 - - 
10 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,25E-03 3,64E-05 2,92 abc -2,93 0 2,26E+07 1,58E+06 6,99 b 18,06 0 
1,83 1,24E-03 2,43E-05 1,95 abc -3,19 0 1,53E+07 1,70E+06 11,07 d -20,05 - 
18,3 1,31E-03 1,21E-05 0,93 ab 2,04 0 1,43E+07 2,78E+06 19,49 d -25,44 - 
183 1,24E-03 3,54E-05 2,86 ac -3,38 0 3,98E+06 6,49E+05 16,31 a -79,23 - - - 
1830 8,66E-04 9,35E-06 1,08 f -32,56 - - - 4,82E+06 3,41E+05 7,08 a -74,86 - - - 
11 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,30E-03 4,49E-05 3,45 a 1,13 0 1,63E+07 3,66E+06 22,45 b -14,90 0 
1,83 1,26E-03 5,01E-05 3,97 a -1,68 0 1,14E+07 1,95E+06 17,03 c -40,28 - - - 
18,3 1,27E-03 2,54E-05 2,00 a -1,14 0 1,06E+07 1,75E+06 16,61 c -44,92 - - - 
183 1,28E-03 4,65E-05 3,64 a -0,51 0 1,14E+07 1,08E+06 9,49 c -40,73 - - - 
1830 1,11E-03 9,30E-06 0,83 b -13,24 - 2,19E+07 2,82E+06 12,86 d 14,29 0 
12 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,23E-03 6,43E-05 5,24 abd -4,42 0 1,26E+07 1,45E+06 11,57 ce -34,41 - 
1,83 1,33E-03 2,80E-05 2,11 ac 3,46 0 7,30E+06 6,92E+05 9,49 ade -61,92 - - - 
18,3 1,32E-03 3,01E-05 2,27 ac 3,08 0 1,04E+07 2,27E+06 21,90 cde -45,97 - - - 
183 1,28E-03 4,79E-05 3,73 abc -0,03 0 1,17E+07 2,79E+06 23,90 ce -39,12 - - 
1830 1,02E-03 9,59E-06 0,94 e -20,44 - - 1,33E+07 7,73E+05 5,82 ce -30,69 - - 
13 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,30E-03 6,78E-05 5,22 a 1,21 0 2,30E+07 6,19E+06 26,94 b 19,90 0 
1,83 1,25E-03 4,56E-05 3,64 a -2,36 0 2,05E+07 1,97E+06 9,59 b 7,00 0 
18,3 1,31E-03 1,00E-05 0,76 a 2,38 0 1,12E+07 2,08E+06 18,55 c -41,44 - - - 
183 1,16E-03 3,06E-05 2,65 b -10,03 - 1,25E+07 2,49E+06 20,02 c -34,97 - - 
1830 8,51E-04 2,53E-05 2,97 d -33,69 - - - 1,39E+07 2,26E+06 16,24 c -27,4594 - 
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14 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,33E-03 2,65E-05 1,99 a 3,41 0 1,86E+07 2,31E+06 12,43 bcd -3,15 0 
1,83 1,32E-03 3,12E-05 2,37 a 2,66 0 4,71E+06 9,06E+05 19,22 a -75,40 - - - 
18,3 1,26E-03 6,50E-05 5,18 a -2,23 0 1,50E+07 1,83E+06 12,20 cde -21,94 - 
183 1,28E-03 6,93E-05 5,42 a -0,48 0 1,39E+07 3,16E+06 22,71 de -27,44 - 
1830 8,66E-04 3,24E-05 3,75 b -32,54 - - - 1,40E+07 2,81E+06 20,10 de -27,01 - 
15 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,32E-03 3,89E-05 2,94 a 2,92 0 1,71E+07 1,56E+06 9,10 bcd -10,57 0 
1,83 1,30E-03 1,36E-05 1,05 a 0,95 0 1,60E+07 1,78E+06 11,14 cde -16,42 0 
18,3 1,30E-03 4,55E-05 3,48 a 1,62 0 1,72E+07 2,26E+06 13,18 bcd -10,51 0 
183 1,32E-03 5,18E-07 0,04 a 2,52 0 1,34E+07 1,82E+06 13,59 def -30,22 - - 
1830 1,03E-03 3,59E-05 3,50 b -20,07 - - 1,24E+07 1,56E+06 12,58 def -35,24 - - 
16 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 bcef 0,00 0 
0,183 1,21E-03 1,78E-05 1,47 abcde -5,68 0 1,93E+07 6,07E+05 3,15 bcefg 0,68 0 
1,83 1,27E-03 1,13E-05 0,89 abc -1,20 0 1,70E+07 1,39E+06 8,18 bcef -11,20 0 
18,3 1,23E-03 4,45E-05 3,61 abcd -3,89 0 1,33E+07 2,12E+06 15,93 abcef -30,56 - - 
183 1,30E-03 2,20E-05 1,69 abc 1,57 0 2,29E+07 5,05E+06 22,02 bcef 19,62 0 
1830 1,14E-03 3,39E-05 2,97 bde -10,95 - 4,25E+07 1,35E+07 31,90 hi 121,57 + 
17 
0 1,28E-03 2,54E-05 1,98 abc 0,00 0 1,92E+07 1,82E+06 9,49 bd 0,00 0 
0,183 1,28E-03 2,84E-05 2,22 abcd -0,29 0 3,62E+07 3,74E+06 10,33 c 88,79 + 
1,83 1,30E-03 6,57E-05 5,07 abcd 0,87 0 1,76E+07 7,52E+05 4,27 bdf -8,09 0 
18,3 1,33E-03 3,87E-05 2,91 ab 3,62 0 1,37E+07 1,40E+06 10,18 ef -28,33 - 
183 1,29E-03 2,13E-05 1,65 abc 0,68 0 1,49E+07 1,95E+06 13,06 def -22,26 - 
1830 1,05E-03 3,50E-05 3,32 ef -17,95 - 1,08E+07 1,55E+06 14,34 h -43,68 - - - 
18 
0 1,28E-03 2,54E-05 1,98 ac 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,29E-03 1,68E-05 1,30 ac 0,41 0 1,78E+07 4,71E+05 2,64 bce -7,13 0 
1,83 1,22E-03 7,55E-05 6,16 ab -4,66 0 1,75E+07 1,89E+06 10,81 bce -8,79 0 
18,3 1,31E-03 1,58E-05 1,20 ac 2,40 0 1,31E+07 2,37E+06 17,99 cdef -31,41 - - 
183 1,25E-03 2,65E-05 2,12 abc -2,47 0 1,59E+07 1,82E+06 11,44 de -17,14 0 
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1830 9,96E-04 1,83E-05 1,84 d -22,39 - - 1,19E+07 2,42E+06 20,32 df -37,93 - - 
19 0 1,28E-03 2,54E-05 1,98 ab 0,00 0 1,92E+07 1,82E+06 9,49 bcd 0,00 0 
 
0,183 1,28E-03 2,30E-05 1,79 ab 0,07 0 2,16E+07 1,48E+06 6,85 bc 12,75 0 
 
1,83 1,26E-03 3,81E-05 3,02 abc -1,68 0 1,89E+07 1,88E+06 9,94 bcd -1,22 0 
 
18,3 1,31E-03 4,07E-05 3,11 ab 1,79 0 1,61E+07 2,28E+06 14,19 bd -16,05 0 
 
183 1,20E-03 2,64E-05 2,21 bc -6,82 0 1,95E+07 2,49E+06 12,78 bcd 1,50 0 
 
1830 1,00E-03 5,16E-05 5,16 c -22,04 - - 2,79E+07 4,58E+06 16,42 e 45,65 + 
20 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,30E-03 5,77E-05 4,45 a 0,88 0 1,93E+07 4,39E+06 22,72 bcd 0,81 0 
1,83 1,29E-03 4,61E-05 3,57 a 0,50 0 1,67E+07 1,18E+06 7,04 bcd -12,94 0 
18,3 1,30E-03 1,15E-05 0,88 a 1,58 0 1,65E+07 1,86E+06 11,30 cd -13,94 0 
183 1,32E-03 4,13E-05 3,13 a 2,69 0 1,80E+07 2,77E+06 15,40 bcd -6,18 0 
1830 1,05E-03 3,95E-05 3,75 b -18,13 - 1,61E+07 1,39E+06 8,61 cd -15,75 0 
21 0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bf 0,00 0 
 
0,183 1,29E-03 3,87E-05 3,01 a 0,21 0 3,59E+07 3,71E+06 10,33 c 87,42 + 
 
1,83 1,31E-03 5,42E-05 4,14 a 2,05 0 1,46E+07 1,87E+06 12,79 def -23,68 - 
 
18,3 1,28E-03 3,80E-05 2,97 a -0,29 0 1,36E+07 1,93E+06 14,12 de -28,82 - 
 
183 1,29E-03 5,08E-05 3,95 a 0,13 0 1,74E+07 1,15E+06 6,58 bdf -8,95 0 
 
1830 1,03E-03 4,71E-05 4,59 d -20,16 - - 1,33E+07 1,70E+06 12,78 de -30,57 - - 
22 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,31E-03 4,76E-05 3,64 a 1,90 0 1,76E+07 7,64E+05 4,33 bce -7,98 0 
1,83 1,27E-03 5,49E-05 4,33 a -1,23 0 1,72E+07 1,78E+06 10,34 bce -10,36 0 
18,3 1,30E-03 1,43E-05 1,10 a 1,46 0 1,41E+07 1,36E+06 9,61 de -26,16 - 
183 1,29E-03 2,68E-05 2,07 a 0,63 0 1,53E+07 2,29E+06 14,93 cde -19,96 0 
1830 8,64E-04 2,05E-05 2,37 b -32,67 - - - 1,58E+07 2,59E+06 16,36 cde -17,47 0 
23 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,30E-03 2,88E-05 2,21 a 1,40 0 1,91E+07 3,34E+06 17,48 bcd -0,13 0 
1,83 1,31E-03 2,52E-05 1,92 a 2,18 0 1,58E+07 1,04E+06 6,55 cde -17,44 0 
18,3 1,30E-03 4,25E-05 3,27 a 1,14 0 1,52E+07 2,26E+06 14,88 de -20,60 - 
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183 1,29E-03 3,61E-05 2,81 a 0,12 0 5,96E+06 4,46E+05 7,48 a -68,90 - - - 
1830 1,13E-03 1,57E-05 1,38 b -11,61 - 7,22E+06 1,30E+06 17,96 a -62,34 - - - 
24 0 1,28E-03 2,54E-05 1,98 acd 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
 
0,183 1,21E-03 1,34E-05 1,10 bcdf -5,58 0 3,07E+07 1,70E+06 5,54 c 60,29 + 
 
1,83 1,29E-03 3,26E-05 2,52 acd 0,75 0 2,66E+07 2,31E+06 8,66 ce 38,91 + 
 
18,3 1,29E-03 1,98E-05 1,54 acd 0,43 0 1,37E+07 6,17E+05 4,50 deg -28,42 - 
 
183 1,24E-03 7,21E-06 0,58 abcdf -3,61 0 1,18E+07 3,28E+06 27,88 df -38,53 - - 
 
1830 1,17E-03 6,13E-05 5,25 bcf -9,14 0 9,94E+06 4,33E+05 4,36 degh -48,14 - - - 
25 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,32E-03 1,73E-05 1,31 a 2,93 0 2,26E+07 2,25E+06 9,96 c 17,80 0 
1,83 1,29E-03 7,38E-05 5,73 a 0,37 0 1,22E+07 1,54E+06 12,57 d -36,25 - - 
18,3 1,31E-03 5,72E-05 4,35 a 2,26 0 1,50E+07 1,64E+06 10,96 d -21,75 - 
183 1,12E-03 2,66E-05 2,37 b -12,66 - 1,24E+07 1,46E+06 11,78 d -35,24 - - 
1830 5,61E-04 1,66E-05 2,96 c -56,28 - - - 1,47E+07 2,29E+06 15,56 d -23,17 - 
26 
0 1,28E-03 2,54E-05 1,98 ab 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,31E-03 2,41E-05 1,84 ab 2,18 0 1,63E+07 1,27E+06 7,84 bcd -15,20 0 
1,83 1,27E-03 3,99E-05 3,15 abc -1,37 0 1,58E+07 1,67E+06 10,57 cd -17,76 0 
18,3 1,26E-03 5,97E-05 4,74 abc -1,92 0 1,52E+07 2,46E+06 16,18 cd -20,80 - 
183 1,25E-03 3,01E-05 2,41 abc -2,92 0 1,47E+07 1,06E+06 7,21 cd -23,44 - 
1830 8,08E-04 2,57E-05 3,18 e -37,06 - - - 1,62E+07 2,03E+06 12,53 cd -15,63 0 
27 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,26E-03 3,10E-05 2,45 a -1,69 0 4,77E+07 4,72E+06 9,90 c 148,78 + 
1,83 1,29E-03 1,36E-05 1,05 a 0,37 0 1,83E+07 2,16E+06 11,86 b -4,76 0 
18,3 1,31E-03 1,28E-05 0,97 a 2,32 0 1,96E+07 1,21E+06 6,15 b 2,38 0 
183 1,15E-03 3,39E-05 2,95 b -10,36 - 4,16E+07 5,39E+06 12,96 c 117,10 + 
1830 1,09E-03 1,01E-05 0,93 b -15,26 - 9,52E+07 1,19E+07 12,52 e 396,86 + 
28 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,31E-03 2,29E-05 1,76 a 1,67 0 1,94E+07 1,48E+05 0,76 b 1,10 0 
1,83 1,28E-03 1,77E-05 1,38 a -0,20 0 1,99E+07 1,46E+06 7,35 b 3,77 0 
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18,3 1,28E-03 2,93E-05 2,30 a -0,61 0 1,76E+07 9,69E+05 5,50 b -8,15 0 
183 1,28E-03 5,05E-05 3,93 a 0,01 0 1,26E+07 1,83E+06 14,57 c -34,39 - - 
1830 8,60E-04 1,56E-05 1,81 c -33,01 - - - 9,20E+06 1,37E+06 14,85 d -52,00 - - - 
29 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bde 0,00 0 
0,183 1,28E-03 3,81E-05 2,98 a -0,57 0 2,52E+07 4,53E+06 17,96 c 31,74 + 
1,83 1,29E-03 5,70E-05 4,43 a 0,23 0 1,99E+07 2,26E+06 11,33 bd 4,07 0 
18,3 1,29E-03 4,59E-05 3,57 a 0,20 0 1,95E+07 1,06E+06 5,41 bd 1,79 0 
183 1,29E-03 2,31E-05 1,79 a 0,60 0 1,67E+07 1,78E+06 10,64 be -12,90 0 
1830 1,15E-03 2,87E-05 2,50 b -10,65 - 1,71E+07 1,57E+06 9,22 be -10,97 0 
30 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,27E-03 1,18E-05 0,92 a -0,72 0 2,60E+07 1,54E+06 5,92 c 35,59 + 
1,83 1,29E-03 2,37E-05 1,83 a 0,83 0 1,73E+07 1,62E+06 9,36 b -9,71 0 
18,3 1,24E-03 5,06E-05 4,08 a -3,48 0 1,67E+07 7,99E+05 4,79 b -12,95 - 
183 1,12E-03 4,35E-05 3,87 b -12,58 - 1,64E+07 2,41E+06 14,67 b -14,33 - 
1830 5,53E-04 1,03E-05 1,86 c -56,89 - - - 1,12E+07 1,46E+06 13,04 d -41,78 - - - 
31 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bd 0,00 0 
0,183 1,29E-03 5,32E-05 4,13 a 0,29 0 2,56E+07 2,58E+06 10,06 c 33,75 + 
1,83 1,29E-03 4,10E-05 3,18 a 0,23 0 1,79E+07 1,07E+06 5,97 bd -6,83 0 
18,3 1,31E-03 5,95E-05 4,56 a 1,72 0 1,93E+07 2,42E+06 12,53 bd 0,73 0 
183 1,28E-03 4,88E-05 3,81 a -0,43 0 2,14E+07 1,48E+06 6,95 bcd 11,51 0 
1830 7,64E-04 2,17E-05 2,84 b -40,52 - - - 1,42E+07 2,75E+06 19,32 d -25,78 - 
32 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 be 0,00 0 
0,183 1,23E-03 1,22E-05 0,99 a -3,95 0 2,38E+07 2,11E+06 8,88 ce 24,26 + 
1,83 1,29E-03 2,47E-05 1,92 a 0,31 0 1,82E+07 1,76E+06 9,68 be -5,29 0 
18,3 1,32E-03 2,96E-05 2,24 a 2,86 0 1,97E+07 1,93E+06 9,80 be 2,99 0 
183 1,26E-03 4,72E-05 3,75 a -2,10 0 2,06E+07 2,17E+06 10,57 bce 7,33 0 
1830 8,28E-04 2,75E-05 3,32 b -35,51 - - - 1,40E+07 1,59E+06 11,39 f -26,98 - 
33 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,23E-03 3,27E-05 2,65 a -3,94 0 2,85E+07 4,28E+06 15,02 c 48,69 + 
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1,83 1,26E-03 4,71E-06 0,37 a -2,14 0 1,58E+07 2,89E+06 18,31 b -17,68 0 
18,3 1,29E-03 1,43E-05 1,11 a 0,61 0 1,99E+07 4,27E+06 21,44 b 4,02 0 
183 1,24E-03 4,07E-05 3,28 a -3,25 0 1,85E+07 2,23E+06 12,03 b -3,23 0 
1830 8,19E-04 1,93E-05 2,36 d -36,19 - - - 9,43E+06 1,87E+06 19,87 e -50,79 - - - 
34 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bd 0,00 0 
0,183 1,26E-03 4,07E-05 3,24 a -2,04 0 3,21E+07 3,89E+06 12,11 cd 67,46 + 
1,83 1,24E-03 2,69E-05 2,16 a -3,05 0 1,90E+07 2,02E+06 10,64 bcd -0,85 0 
18,3 1,29E-03 5,44E-05 4,22 a 0,56 0 1,92E+07 1,57E+06 8,15 bcd 0,24 0 
183 1,31E-03 2,61E-05 1,99 a 2,23 0 1,93E+07 2,81E+06 14,58 bcd 0,60 0 
1830 8,18E-04 2,53E-05 3,09 b -36,31 - - - 1,39E+07 2,44E+06 17,56 bd -27,57 - 
35 
0 1,28E-03 2,54E-05 1,98 ab 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,29E-03 1,11E-05 0,87 abc 0,16 0 3,30E+07 5,29E+06 16,02 c 72,26 + 
1,83 1,31E-03 4,72E-05 3,61 abc 1,96 0 1,84E+07 1,46E+06 7,93 b -3,76 0 
18,3 1,33E-03 1,47E-05 1,10 bc 3,53 0 1,78E+07 1,76E+06 9,88 b -7,28 0 
183 1,30E-03 1,00E-05 0,77 abc 1,04 n.b. 1,68E+07 2,86E+06 16,98 b -12,13 0 
1830 1,03E-03 1,76E-05 1,70 d -19,39 - 2,23E+07 3,77E+06 16,90 d 16,50 0 
36 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,29E-03 3,40E-05 2,64 a 0,31 0 1,86E+07 3,49E+06 18,80 b -3,07 0 
1,83 1,27E-03 3,51E-05 2,76 a -0,89 0 1,94E+07 3,36E+06 17,34 b 1,04 0 
18,3 1,26E-03 5,95E-05 4,74 a -2,16 0 1,98E+07 2,45E+06 12,33 b 3,58 0 
183 1,27E-03 1,87E-05 1,48 a -1,39 0 2,10E+07 5,01E+06 23,91 b 9,41 0 
1830 9,54E-04 4,57E-05 4,79 b -25,66 - - 1,83E+07 1,94E+06 10,60 b -4,37 0 
37 
0 1,28E-03 2,54E-05 1,98 ac 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,27E-03 3,52E-05 2,77 abc -0,89 0 2,09E+07 4,03E+06 19,24 b 9,15 0 
1,83 1,24E-03 3,65E-05 2,94 ab -3,19 0 1,63E+07 2,14E+06 13,18 d -15,16 0 
18,3 1,24E-03 2,74E-05 2,21 ab -3,45 0 1,87E+07 2,03E+06 10,84 bd -2,50 0 
183 1,33E-03 3,00E-05 2,25 ac 3,88 0 1,13E+07 3,81E+06 33,76 ae -41,15 - - - 
1830 1,16E-03 3,19E-05 2,76 d -9,88 0 7,03E+06 7,53E+05 10,70 ae -63,30 - - - 
38 0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bd 0,00 0 
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0,183 1,31E-03 1,31E-04 9,96 a 2,28 0 3,79E+07 6,05E+06 15,95 c 98,02 + 
1,83 1,31E-03 1,40E-05 1,07 a 1,66 0 3,69E+07 4,08E+06 11,06 c 92,49 + 
18,3 1,31E-03 2,70E-05 2,05 a 2,24 0 3,54E+07 2,01E+06 5,68 c 84,50 + 
183 1,24E-03 3,32E-05 2,68 a -3,39 0 2,11E+07 1,45E+06 6,88 bd 9,90 0 
 
1830 1,22E-03 3,40E-05 2,79 a -4,98 0 4,30E+07 1,01E+07 23,51 c 124,16 + 
39 
0 1,28E-03 2,54E-05 1,98 ab 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,32E-03 4,49E-05 3,41 ab 2,71 0 2,46E+07 1,71E+06 6,93 b 28,52 + 
1,83 1,28E-03 7,43E-05 5,82 ab -0,56 0 2,36E+07 2,59E+06 10,98 b 23,00 + 
18,3 1,30E-03 3,17E-05 2,44 ab 1,27 0 1,35E+07 2,84E+06 21,08 b -29,61 - 
183 1,24E-03 4,70E-05 3,78 a -3,17 0 5,08E+07 5,26E+06 10,36 c 164,82 + 
1830 8,78E-04 2,41E-05 2,74 c -31,64 - - - 5,43E+07 7,58E+06 13,97 c 183,29 + 
40 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bc 0,00 0 
0,183 1,29E-03 7,27E-05 5,64 a 0,30 0 1,39E+07 1,53E+06 11,00 abc -27,34 - 
1,83 1,27E-03 5,23E-05 4,11 a -0,88 0 1,64E+07 1,11E+06 6,80 bc -14,39 0 
18,3 1,27E-03 3,63E-05 2,87 a -1,26 0 1,83E+07 1,44E+06 7,84 bc -4,30 0 
183 1,28E-03 6,25E-05 4,87 a -0,16 0 1,62E+07 1,88E+06 11,59 bc -15,26 0 
1830 1,25E-03 1,54E-05 1,23 a -2,25 0 5,45E+07 9,96E+06 18,28 e 184,36 + 
41 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,26E-03 2,54E-05 2,03 a -2,19 0 5,75E+07 3,24E+06 5,63 e 199,95 + 
1,83 1,28E-03 5,09E-05 3,96 a 0,08 0 1,93E+07 1,64E+06 8,48 bc 0,83 0 
18,3 1,29E-03 4,08E-05 3,16 a 0,64 0 1,14E+07 8,92E+05 7,81 bc -40,43 - - - 
183 1,10E-03 1,97E-05 1,79 b -14,41 - 3,02E+07 1,19E+06 3,95 d 57,49 + 
1830 9,98E-04 3,95E-05 3,96 c -22,27 - - 2,64E+07 3,14E+06 11,89 d 37,76 + 
42 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bcd 0,00 0 
0,183 1,26E-03 4,54E-05 3,61 a -2,19 0 2,87E+07 5,60E+06 19,53 bc 49,69 + 
1,83 1,25E-03 6,63E-05 5,30 a -2,61 0 1,72E+07 1,86E+06 10,78 bd -10,13 0 
18,3 1,16E-03 3,10E-05 2,68 b -9,96 0 1,12E+07 1,38E+06 12,33 e -41,80 - - - 
183 9,20E-04 5,21E-05 5,66 c -28,33 - - 2,85E+07 3,12E+06 10,94 f 48,83 + 
1830 5,53E-04 1,58E-05 2,85 d -56,93 - - - 5,72E+07 2,53E+06 4,42 h 198,51 + 
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43 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,25E-03 5,90E-05 4,73 a -2,75 0 3,90E+07 2,73E+06 7,00 c 103,54 + 
1,83 1,26E-03 3,38E-05 2,67 a -1,49 0 1,88E+07 8,81E+05 4,69 b -1,99 0 
18,3 1,32E-03 2,38E-05 1,81 a 2,61 0 1,45E+07 1,90E+06 13,07 d -24,08 - 
 
183 1,13E-03 2,97E-05 2,63 b -12,31 - 1,31E+07 2,36E+06 17,98 d -31,43 - - 
 
1830 7,41E-04 2,27E-05 3,06 de -42,25 - - - 1,51E+07 1,64E+06 10,90 d -21,25 - 
44 
0 1,28E-03 2,54E-05 1,98 ab 0,00 0 1,92E+07 1,82E+06 9,49 bdf 0,00 0 
0,183 1,23E-03 1,65E-05 1,34 abc -4,03 0 2,87E+07 5,60E+06 19,53 c 49,69 + 
1,83 1,24E-03 1,93E-05 1,56 abc -3,79 0 1,78E+07 2,36E+06 13,28 bd -7,38 0 
18,3 1,21E-03 3,31E-05 2,74 bcd -5,71 0 1,13E+07 1,68E+06 14,81 e -40,87 - - - 
183 1,15E-03 4,22E-05 3,68 cd -10,75 - 2,27E+07 1,68E+06 7,40 bf 18,70 0 
1830 1,08E-03 2,24E-05 2,07 d -15,57 - 5,60E+07 6,49E+06 11,59 h 192,07 + 
45 
0 1,28E-03 2,54E-05 1,98 a 0,00 0 1,92E+07 1,82E+06 9,49 bd 0,00 0 
0,183 1,28E-03 4,46E-05 3,49 a -0,38 0 2,67E+07 4,51E+06 16,91 cd 39,31 + 
1,83 1,29E-03 4,54E-05 3,51 a 0,55 0 2,00E+07 2,76E+06 13,78 bcd 4,48 0 
18,3 1,30E-03 2,32E-05 1,78 a 1,61 0 1,99E+07 3,30E+06 16,55 bd 4,03 0 
183 1,27E-03 2,71E-05 2,14 a -1,19 0 1,95E+07 3,44E+06 17,61 bcd 1,86 0 
1830 1,03E-03 4,01E-05 3,89 b -19,67 - 1,66E+07 3,32E+06 19,98 bd -13,31 0 
 
 
Appendix 1a. Planktonic growth and cells adhesion in the presence of each ZA related compound. Percentage reduction respect to the negative control is reported. a) Percentage 
reduction of the maximum specific growth rate: code (0) x > -10 %; code (-)  -10 % ≤ x < -20 %; code (--) -20 % ≤ x < -30 %; code (---) x ≤ -30 %; b) Percentage reduction of the 
number of adhered cells: code (+) x > +20 %; code (0) +20 % ≤ x < -20 %; code (-)  -20 % ≤ x <  -30 %; code (--) -30 % ≤ x < -40 %; code (--) x ≤ -40 %.  
According to post hoc analysis (Tukey‟s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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APPENDIX 1b 
 
Salicylic acid derivatives 
  
Planktonic growth Cells adhesion 
Cmp Conc. (µM) Average (OD600/min) St.dev (OD600/min) err% ANOVA diff cont % Level Average (n°cell) St.dev (n°cell) err% ANOVA diff cont % Level 
SA 
0 1,28E-03 2,54E-05 1,98 
 
0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,27E-03 4,56E-05 3,59 
 
-1,08 0 1,37E+07 2,43E+06 17,79 
 
-28,76 - 
1,83 1,29E-03 6,33E-05 4,92 
 
0,28 0 1,31E+07 2,56E+06 19,54 
 
-31,57 - - 
18,3 1,32E-03 1,16E-05 0,88 
 
2,75 0 1,02E+07 2,34E+06 23,02 
 
-46,99 - - - 
183 1,28E-03 4,16E-05 3,25 
 
-0,18 0 6,24E+06 9,21E+05 14,75 
 
-67,42 - - - 
1830 7,19E-04 1,26E-05 1,75 
 
-44,02 - - - 9,59E+06 1,54E+06 16,06 
 
-49,97 - - - 
47 
0 1,28E-03 2,54E-05 1,98 
 
0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,24E-03 3,30E-05 2,66 
 
-3,37 0 2,21E+07 2,93E+06 13,22 
 
15,57 0 
1,83 1,27E-03 5,96E-05 4,68 
 
-0,88 0 5,61E+06 6,43E+05 11,45 
 
-70,71 - - - 
18,3 1,30E-03 3,74E-05 2,87 
 
1,32 0 5,28E+06 1,22E+06 23,09 
 
-72,47 - - - 
183 1,31E-03 7,41E-05 5,64 
 
2,29 0 8,50E+06 4,65E+05 5,47 
 
-55,63 - - - 
1830 9,89E-04 1,27E-05 1,28 
 
-22,93 - - 1,51E+07 3,04E+06 20,16 
 
-21,21 - 
48 
0 1,28E-03 2,54E-05 1,98 
 
0,00 0 1,92E+07 1,82E+06 9,49 b 0,00 0 
0,183 1,28E-03 1,18E-04 9,19 
 
-0,05 0 3,22E+07 3,87E+06 12,05 
 
67,79 + 
1,83 1,30E-03 7,41E-06 0,57 
 
1,38 0 1,12E+07 1,18E+06 10,53 
 
-41,31 - - - 
18,3 1,28E-03 6,66E-05 5,18 
 
0,00 0 1,12E+07 1,41E+06 12,59 
 
-41,42 - - - 
183 1,21E-03 2,43E-05 2,01 
 
-5,66 0 1,17E+07 2,45E+06 20,99 
 
-38,98 - - 
1830 1,05E-03 2,70E-05 2,56 
 
-18,03 - - 8,69E+06 1,53E+06 17,56 
 
-54,65 - - - 
  
Appendix 1b. Planktonic growth and cells adhesion in the presence of each SA related compound. Percentage reduction respect to the negative control is reported. a) Percentage 
reduction of the maximum specific growth rate: code (0) x > -10 %; code (-)  -10 % ≤ x < -20 %; code (--) -20 % ≤ x < -30 %; code (---) x ≤ -30 %; b) Percentage reduction of the 
number of adhered cells: code (+) x > +20 %; code (0) +20 % ≤ x < -20 %; code (-)  -20 % ≤ x <  -30 %; code (--) -30 % ≤ x < -40 %; code (--) x ≤ -40 %.  
According to post hoc analysis (Tukey‟s HSD, p < 0.05), data sharing the same letter indicates no signiﬁcant diﬀerence. 
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APPENDIX 2 
Cmp 0 µM 0.183 µM 1.83 µM 18.3 µM 183µM 1830 µM TREND 
5             
1 
9             
19             
20             
36             
27             
2 
29             
35             
45             
31             
32             
33             
34             
37             
3 
11             
16             
22             
26             
2             
3             
4             
6             
7             
8             
10             
12             
13             
14             
15             
18             
23             
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25             
28             
SA             
47             
ZA             
4 
24             
41             
42             
44             
17             
21             
30             
43             
48             
38             
5 39             
40             
 
Appendix 2. Biological activity of each ZA related compound at different concentrations. 
  no biological activity 
  anti-biofilm activity 
  increased biofilm formation 
  transition from planktonic to biofilm mode of life  
  
biocidal effect 
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APPENDIX 3 
 
 
 
 
      
 
≥3 2 1 0 -1 -2 ≤-3 
        Cmpd 0 µM 0.183 µM 1.83 µM 18.3 µM 183µM 1830 µM AP 
ZA             -3 
2             -5 
3             -3 
4             -2 
5             0 
6             -3 
7             -6 
8             -3 
9             0 
10             -5 
11             -8 
12             -9 
13             -2 
14             -3 
15             -2 
16             0 
17             -3 
18             -2 
19             3 
20             1 
21             -1 
22             2 
23             -6 
24             -4 
25             -2 
26             1 
min                                            Anti-biofilm performance  (AP)                                            max                                                                                                  
max 
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27             5 
28             -2 
29             2 
30             2 
31             3 
32             3 
33             3 
33             1 
35             2 
36             2 
37             -6 
38             4 
39             6 
40             0 
41             3 
42             5 
43             1 
44             1 
45             2 
SA             -9 
47             -8 
48             -8 
 
Appendix 3. Anti-biofilm performance of each ZA related compound. Total and related to each concentration values are reported.  
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